	ARTICLE	ARTICLE DATE	SENTENCE NUM	SENTENCE	IGNORANCE CATEGORIES	NUM IGNORANCE CATEGORIES	OBO ID (LABEL)	CLUSTER	PREPROCESSED_SENTENCE
S0-PMC2581757	PMC2581757	11/2008	S0-PMC2581757	['ROLE of Vitamins C and e in Regulating antioxidant and pro-oxidant markers in Preeclampsia\n\nabstract\nwe compared three groups of Pregnant women: placebo with normotensive women, group a which included preeclamptics, and group b which comprised preeclamptics who were supplemented their diets with Vitamins C and e. Mda increased from 6.22\xa0±\xa02.8 (Placebo) to 8.48\xa0±\xa01.2 (a) and 8.02\xa0±\xa01.8\xa0nmol/ghb (b).']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27306', 'vitamin B6', 8, 'Vitamins C'), ('PR_000027594', 'histone H3', 8, 'Vitamins C'), ('GO_0065007', 'biological regulation', 28, 'Regulating'), ('GO_0007128', 'meiotic prophase I', 78, 'Preeclampsia'), ('GO_0007565', 'female pregnancy', 129, 'pregnant'), ('CHEBI_27300', 'vitamin D', 297, 'vitamins C'), ('CHEBI_34840', 'methyl methacrylate', 315, 'MDA'), ('CHEBI_26130', 'biological pigment', 346, 'placebo')]	0	['role vitamins c e  antioxidant pro-oxidant preeclampsia\n\nabstract\nwe three pregnant women: placebo normotensive women, preeclamptics, b comprised preeclamptics supplemented diets  e. mda 6.22\xa0±\xa02.8 (placebo) 8.48\xa0±\xa01.2 (a) 8.02\xa0±\xa01.8\xa0nmol/ghb (b).']
S4-PMC2581757	PMC2581757	11/2008	S4-PMC2581757	['THUS, we conclude that the use of Vitamins C and e SHOULD BE CONSIDERED for the Control of certain IMPORTANT biochemical indices during the development of Preeclampsia; HOWEVER, FURTHER STUDIES ARE NEEDED to develop methods for the PREVENTION of Preeclampsia in women at high RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('FUTURE_WORK', 51), ('FUTURE_WORK', 61), ('IMPORTANT_CONSIDERATION', 61), ('IMPORTANT_CONSIDERATION', 99), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 169), ('FUTURE_WORK', 178), ('FUTURE_WORK', 186), ('SUPERFICIAL_RELATIONSHIP', 232), ('IMPORTANT_CONSIDERATION', 276)]	10	[('CHEBI_27300', 'vitamin D', 34, 'vitamins C'), ('PR_000004900', 'complement C3', 43, 'C'), ('GO_0065007', 'biological regulation', 80, 'control'), ('GO_0007128', 'meiotic prophase I', 155, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 246, 'preeclampsia')]	0	['thus,  e  biochemical indices preeclampsia; however, preeclampsia women risk.']
S36-PMC2581757	PMC2581757	11/2008	S36-PMC2581757	['in VIEW of the CONTRADICTORY REPORTS and the SERIOUSNESS of preeclampsia, the PRESENT STUDY included the determination of the activities of catalase, sod, Gpx and Grx in the Blood of normal and Preeclamptic women with and without vitamin treatment, along-with the contents of mda, Gsh, gssg, gssg/Gsh, no and Uric Acid, TO collectively EVALUATE the ROLES of Vitamins C and e in the Regulation of these factors.']	[('INCOMPLETE_EVIDENCE', 3), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 15), ('INCOMPLETE_EVIDENCE', 29), ('IMPORTANT_CONSIDERATION', 45), ('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('QUESTION_ANSWERED_BY_THIS_WORK', 320), ('QUESTION_ANSWERED_BY_THIS_WORK', 336), ('SUPERFICIAL_RELATIONSHIP', 349)]	8	[('PR_000008210', 'glutathione peroxidase 1', 155, 'GPx'), ('PR_000008290', 'eukaryotic peptide chain release factor GTP-binding subunit ERF3A', 163, 'GRx'), ('UBERON_0000178', 'blood', 174, 'blood'), ('GO_0007565', 'female pregnancy', 194, 'preeclamptic'), ('CHEBI_16856', 'glutathione', 281, 'GSH'), ('CHEBI_16856', 'glutathione', 297, 'GSH'), ('CHEBI_27226', 'uric acid', 309, 'uric acid'), ('CHEBI_27300', 'vitamin D', 358, 'vitamins C'), ('GO_0065007', 'biological regulation', 382, 'regulation')]	0	['preeclampsia, determination activities catalase, sod, gpx grx blood normal preeclamptic women vitamin treatment, along-with contents mda, gsh, gssg, gssg/gsh, uric acid, collectively  e  factors.']
S200-PMC2581757	PMC2581757	11/2008	S200-PMC2581757	['THUS, we conclude that use of Vitamins C and E DEFINITELY Controls certain IMPORTANT biochemical indices during the development of Preeclampsia, and that FURTHER STUDIES ARE NEEDED to DEVELOP STRATEGIES for the PREVENTION of Preeclampsia in women at high RISK.']	[('PROBABLE_UNDERSTANDING', 0), ('PROBABLE_UNDERSTANDING', 47), ('IMPORTANT_CONSIDERATION', 75), ('FUTURE_WORK', 154), ('FUTURE_WORK', 162), ('FUTURE_WORK', 184), ('FUTURE_WORK', 192), ('SUPERFICIAL_RELATIONSHIP', 211), ('IMPORTANT_CONSIDERATION', 255)]	9	[('CHEBI_27300', 'vitamin D', 30, 'vitamins C'), ('PR_000004900', 'complement C3', 39, 'C'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 45, 'E'), ('GO_0065007', 'biological regulation', 58, 'controls'), ('GO_0007128', 'meiotic prophase I', 131, 'preeclampsia'), ('GO_0007128', 'meiotic prophase I', 225, 'preeclampsia')]	0	['thus,  e  biochemical indices preeclampsia, preeclampsia women risk.']
S89-PMC2582131	PMC2582131	11/2008	S89-PMC2582131	['first, Vitamin D MAY directly OR indirectly Modulate Pancreatic Β-Cell function and secretion by binding its circulating active form, 1,25-[Oh]D, to Β-Cell Vitamin D receptor and Regulating the balance between the Extracellular and Intracellular Β-Cell calcium pools[12],[30].']	[('INCOMPLETE_EVIDENCE', 17), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 30)]	2	[('CHEBI_27300', 'vitamin D', 7, 'vitamin D'), ('GO_0065007', 'biological regulation', 44, 'modulate'), ('CL_0000173', 'pancreatic D cell', 53, 'pancreatic β-cell'), ('UBERON_0001264', 'pancreas', 53, 'pancreatic'), ('CHEBI_84441', '13(S)-HOTrE', 134, '1,25-[OH]D'), ('CL_0000623', 'natural killer cell', 149, 'β-cell'), ('CHEBI_27300', 'vitamin D', 156, 'vitamin D'), ('GO_0065007', 'biological regulation', 179, 'regulating'), ('GO_0005576', 'extracellular region', 214, 'extracellular'), ('GO_0005622', 'intracellular anatomical structure', 232, 'intracellular'), ('CL_0000623', 'natural killer cell', 246, 'β-cell')]	0	['first,   pancreatic β-cell secretion binding circulating form, 1,25-[oh]d, β-cell  receptor  balance extracellular intracellular β-cell calcium pools[12],[30].']
S3-PMC2685863	PMC2685863	5/2009	S3-PMC2685863	['they IDENTIFIED a Vitamin D response element (vdre)—a short stretch of dna that is a signature of Genes Regulated by Vitamin D—next to the Gene.']	[('INCOMPLETE_EVIDENCE', 5)]	1	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('SO_0000704', 'gene', 98, 'genes'), ('GO_0065007', 'biological regulation', 104, 'regulated'), ('CHEBI_27300', 'vitamin D', 117, 'vitamin D'), ('SO_0000704', 'gene', 139, 'gene')]	0	[' response element (vdre)—a stretch dna genes  —next gene.']
S6-PMC2685863	PMC2685863	5/2009	S6-PMC2685863	['“this is the FIRST DIRECT EVIDENCE that Vitamin D Regulates the Gene,” says ebers.']	[('INCOMPLETE_EVIDENCE', 13), ('SUPERFICIAL_RELATIONSHIP', 50)]	2	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0065007', 'biological regulation', 50, 'regulates'), ('SO_0000704', 'gene', 64, 'gene')]	0	['“this   gene,” says ebers.']
S8-PMC2685863	PMC2685863	5/2009	S8-PMC2685863	['the next step is determining HOW Vitamin D and Hla-Drb1*15 MIGHT INTERACT to Modulate the Autoimmune nature of ms. epidemiologic and Animal studies of ms POINT TO involvement of the Thymus Gland early in development.']	[('EXPLICIT_QUESTION', 29), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 65), ('INCOMPLETE_EVIDENCE', 154)]	4	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('PR_000002011', 'MHC class I histocompatibility antigen C alpha chain', 47, 'HLA-DRB1'), ('GO_0065007', 'biological regulation', 77, 'modulate'), ('UBERON_0001442', 'skeleton of manus', 90, 'autoimmune'), ('NCBITaxon_33208', 'Metazoa', 133, 'animal'), ('UBERON_0002370', 'thymus', 182, 'thymus gland')]	0	[' hla-drb1*15  autoimmune nature ms. epidemiologic animal ms thymus gland development.']
S117-PMC2722583	PMC2722583	1/2009	S117-PMC2722583	['iron deficiency is an IMPORTANT RISK FACTOR for increased maternal mortality, low Birth weight and Preterm Delivery (brabin et al 2001) and the availability of calcium, Iodine, Folate and Vitamins A and D MAY Modulate fetal development (bartley et al 2005).']	[('IMPORTANT_CONSIDERATION', 22), ('SUPERFICIAL_RELATIONSHIP', 32), ('INCOMPLETE_EVIDENCE', 205)]	3	[('GO_0007567', 'parturition', 82, 'birth'), ('GO_0007565', 'female pregnancy', 99, 'preterm'), ('GO_0007567', 'parturition', 107, 'delivery'), ('CHEBI_24859', 'iodine atom', 169, 'iodine'), ('CHEBI_30863', '5-azaorotic acid', 177, 'folate'), ('CHEBI_27300', 'vitamin D', 188, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 203, 'D'), ('GO_0065007', 'biological regulation', 209, 'modulate')]	0	['iron maternal mortality, birth preterm delivery (brabin et al 2001) availability calcium, iodine, folate   fetal (bartley et al 2005).']
S120-PMC2963768	PMC2963768	10/2010	S120-PMC2963768	['hypothetical mechanisms that MAY CONTRIBUTE to risk of maternal-infant Vitamin D deficiency in south asiageneral mechanismexamples of specific HYPOTHESIZED mechanismsendogenous cutaneous Vitamin D Production\nconservative clothing practices (33)\nlimited time spent outdoors\ndark skin pigmentation (34)\ncloud-cover and outdoor air pollution (12)\ngeographic/Genetic/dietary factors that alter Epidermal 7-Dehydrocholesterol composition or concentrationdietary Vitamin D intake\ninadequate intake of Liver, eggs, fish, or fish oils, or fortified dairy products\ndiminished natural Vitamin d content of farmed fish (35)\nreduction in Vitamin D content of fish due to Cooking (e.g.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 33), ('INCOMPLETE_EVIDENCE', 143)]	3	[('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 187, 'vitamin D'), ('GO_0071611', 'granulocyte colony-stimulating factor production', 187, 'vitamin D production'), ('PR_000006444', 'diacylglycerol kinase delta', 195, 'D'), ('SO_0000704', 'gene', 355, 'genetic'), ('UBERON_0007376', 'outer epithelium', 390, 'epidermal'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 400, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 457, 'vitamin D'), ('UBERON_0002107', 'liver', 495, 'liver'), ('CHEBI_33229', 'vitamin (role)', 575, 'vitamin'), ('CHEBI_27300', 'vitamin D', 626, 'vitamin D'), ('GO_0065007', 'biological regulation', 659, 'cooking')]	0	['hypothetical mechanisms maternal-infant  south asiageneral mechanismexamples mechanismsendogenous cutaneous  production\nconservative clothing practices (33)\nlimited spent outdoors\ndark skin pigmentation (34)\ncloud-cover outdoor air pollution (12)\ngeographic/genetic/dietary alter epidermal 7-dehydrocholesterol composition concentrationdietary  intake\ninadequate intake liver, eggs, fish, fish oils, fortified dairy products\ndiminished natural vitamin content farmed fish (35)\nreduction  content fish  (e.g.']
S167-PMC2996405	PMC2996405	11/2010	S167-PMC2996405	['it is THEREFORE POSSIBLE that the same Genes COULD BE Regulated by Vitamin D levels also in Neurons during Brain Development that, in turn, HAVE BEEN ASSOCIATED to schizophrenia [47].']	[('PROBABLE_UNDERSTANDING', 6), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 45), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 150)]	5	[('SO_0000704', 'gene', 39, 'genes'), ('GO_0065007', 'biological regulation', 54, 'regulated'), ('CHEBI_27300', 'vitamin D', 67, 'vitamin D'), ('CL_0000540', 'neuron', 92, 'neurons'), ('GO_0007420', 'brain development', 107, 'brain development'), ('UBERON_0000955', 'brain', 107, 'brain')]	0	['genes   levels neurons brain that, turn, schizophrenia [47].']
S192-PMC2996405	PMC2996405	11/2010	S192-PMC2996405	['winac MAY rearrange the Nucleosome array around the positive and negative Vitamin D responsive elements (vdres), thereby facilitating the Coregulatory Complexes access for further transcription Control.']	[('INCOMPLETE_EVIDENCE', 6)]	1	[('GO_0000786', 'nucleosome', 24, 'nucleosome'), ('CHEBI_27300', 'vitamin D', 74, 'vitamin D'), ('GO_0065007', 'biological regulation', 138, 'coregulatory'), ('GO_0032991', 'protein-containing complex', 151, 'complexes'), ('GO_0065007', 'biological regulation', 194, 'control')]	0	['winac rearrange nucleosome array positive  responsive elements (vdres), facilitating  complexes access transcription .']
S10-PMC3075531	PMC3075531	7/2010	S10-PMC3075531	['introduction\nmultiple sclerosis (ms) is a chronic PROBABLY with Autoimmune basis and UNCERTAIN etiology characterized by Demyelinative and inflammatory physiopathology causing Axonal damages.12this disease AFFECTS females more than males with ordinary 10 years Relapsing-remitting course and secondary progressive phase.2on histological basis, T Helper Cells type 1 (th1) is the MOST RESPONSIBLE cause for pathologies SEEN in ms.1–3there are multiple RISK FACTORS for ms in a COMPLEX RELATIONSHIP with each other from Genetic ones to environmental FACTORS BUT exact mechanism leading to ms has REMAINED UNCLEAR yet.45from GUESSED environmental RISK FACTORS for ms, past infection with Ebv, smoking and low Serum level of Vitamin D are more favorable.67the MOST IMPORTANT Vitamin in calcium and Phosphor Homeostasis is Vitamin D. this Vitamin has PROPOSED POTENTIAL power for Modulating Immune System.48this is achieved via enhancing the Phagocytic function of Monocytes9And decreasing the secretion of Il-6, Il-12, Tnf-Α and Pge2 by Monocytes.10also, immature or semi mature Apc’S cannot mature in presence of 1,25 (Oh)2D.8MANY STUDIES SHOWED a ROLE of paracrine function and Nerve Growth Factor Synthesis Of Vitamin D in Cns and also, SHOWED that deficiency of this Vitamin in Pregnancy Period CAN cause Neural System disorder in Animal cases.811–14then, Vitamin D has a near RELATION with ms and the results of DIFFERENT studies can be summarized as follows: first, the EFFECT of latitude via exposure to sun light and Serum level of Vitamin D on ms prevalence, that increases with distance from equator, with ONLY one EXCEPTION in norway.23815second, vander et al.']	[('PROBABLE_UNDERSTANDING', 50), ('FULL_UNKNOWN', 85), ('SUPERFICIAL_RELATIONSHIP', 206), ('PROBABLE_UNDERSTANDING', 379), ('PROBABLE_UNDERSTANDING', 384), ('INCOMPLETE_EVIDENCE', 418), ('SUPERFICIAL_RELATIONSHIP', 451), ('DIFFICULT_TASK', 476), ('SUPERFICIAL_RELATIONSHIP', 484), ('SUPERFICIAL_RELATIONSHIP', 548), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 556), ('INCOMPLETE_EVIDENCE', 594), ('FULL_UNKNOWN', 603), ('INCOMPLETE_EVIDENCE', 622), ('SUPERFICIAL_RELATIONSHIP', 644), ('PROBABLE_UNDERSTANDING', 756), ('IMPORTANT_CONSIDERATION', 761), ('INCOMPLETE_EVIDENCE', 846), ('INCOMPLETE_EVIDENCE', 855), ('INCOMPLETE_EVIDENCE', 1123), ('INCOMPLETE_EVIDENCE', 1136), ('SUPERFICIAL_RELATIONSHIP', 1145), ('INCOMPLETE_EVIDENCE', 1236), ('INCOMPLETE_EVIDENCE', 1295), ('SUPERFICIAL_RELATIONSHIP', 1377), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1413), ('SUPERFICIAL_RELATIONSHIP', 1472), ('ANOMALY_CURIOUS_FINDING', 1612), ('ANOMALY_CURIOUS_FINDING', 1621)]	29	[('UBERON_0001442', 'skeleton of manus', 64, 'autoimmune'), ('GO_0006188', 'IMP biosynthetic process', 121, 'demyelinative'), ('GO_0030424', 'axon', 176, 'axonal'), ('GO_0065007', 'biological regulation', 261, 'relapsing'), ('CL_0000545', 'T-helper 1 cell', 344, 'T helper cells'), ('SO_0000704', 'gene', 518, 'genetic'), ('NCBITaxon_10088', 'Mus <genus>', 685, 'EBV'), ('UBERON_0001977', 'blood serum', 706, 'serum'), ('CHEBI_27300', 'vitamin D', 721, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 771, 'vitamin'), ('CHEBI_30215', 'muonide', 794, 'phosphor'), ('GO_0042592', 'homeostatic process', 803, 'homeostasis'), ('CHEBI_27300', 'vitamin D', 818, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 834, 'vitamin'), ('GO_0065007', 'biological regulation', 875, 'modulating'), ('UBERON_0002405', 'immune system', 886, 'immune system'), ('GO_0006909', 'phagocytosis', 937, 'phagocytic'), ('CL_0002198', 'oncocyte', 960, 'monocytes9and'), ('PR_000001470', 'interleukin-28B', 1002, 'IL-6'), ('PR_000001470', 'interleukin-28B', 1008, 'IL-12'), ('PR_000000134', 'tumor necrosis factor alpha', 1015, 'TNF-α'), ('PR_000012560', 'peroxisomal membrane protein PEX14', 1025, 'PGE2'), ('CL_0000576', 'monocyte', 1033, 'monocytes'), ('PR_000004122', 'adenomatous polyposis coli protein', 1075, 'APC'), ('PR_000011000', 'N-alpha-acetyltransferase 60', 1079, 's'), ('CHEBI_82784', 'PVP38-Ag NP', 1110, '1,25 (OH)2D'), ('UBERON_0001021', 'nerve', 1176, 'nerve'), ('GO_0040007', 'growth', 1182, 'growth factor'), ('GO_0030474', 'spindle pole body duplication', 1196, 'synthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 1209, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 1222, 'CNS'), ('CHEBI_33229', 'vitamin (role)', 1267, 'vitamin'), ('GO_0007565', 'female pregnancy', 1278, 'pregnancy'), ('UBERON_0018298', 'stylocone', 1278, 'pregnancy period'), ('UBERON_0023879', 'neural system', 1305, 'neural system'), ('NCBITaxon_33208', 'Metazoa', 1331, 'animal'), ('CHEBI_27300', 'vitamin D', 1356, 'vitamin D'), ('UBERON_0001977', 'blood serum', 1521, 'serum'), ('CHEBI_27300', 'vitamin D', 1536, 'vitamin D')]	0	['introduction\nmultiple sclerosis (ms) chronic autoimmune etiology demyelinative inflammatory physiopathology axonal damages.12this disease females males ordinary 10 -remitting course secondary progressive phase.2on histological basis, helper cells type (th1) pathologies ms.1–3there ms genetic ones environmental exact ms yet.45from environmental ms, infection ebv, smoking serum  favorable.67the vitamin calcium phosphor homeostasis . vitamin  immune system.48this achieved via phagocytic monocytes9and decreasing secretion il-6, il-12, tnf-α pge2 monocytes.10also, immature semi mature apc’s mature presence 1,25 (oh)2d.8many paracrine nerve synthesis  cns also, vitamin pregnancy period neural system disorder animal cases.811–14then,  ms results follows: first, latitude via exposure sun serum  ms prevalence, distance equator, norway.23815second, vander et al.']
S11-PMC3075531	PMC3075531	7/2010	S11-PMC3075531	['SHOWED that sun exposure in Childhood period PREVENTS from ms.16third, it SEEMS low risk of ms in white population is ASSOCIATED with high Serum level of vitamin d or high oral Intake via supplements or oily fish in SOME STUDIES.217–19fourth, it HAVE BEEN SHOWN that Vitamin D CAN be a PROTECTIVE agent against experimental Autoimmune encephalitis in Mice (like ms in Humans).48finally, some scientists administered 100-1700 iu/day Vitamin D supplements in ms patients and OBSERVED the reduction of relapses.20–22the CANDIDATE for estimating Serum level of Vitamin D is 25-Hydroxy Vitamin D, BECAUSE of its prolonged half-Life.823–25it is used to assess an Individual’s overall Vitamin D nutritional status, BECAUSE its formation, UNLIKE that of 1, 25-Dihydroxy Vitamin D, is not tightly Regulated and it has a relatively long half-life (20-60 days).']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 45), ('ANOMALY_CURIOUS_FINDING', 74), ('SUPERFICIAL_RELATIONSHIP', 118), ('INCOMPLETE_EVIDENCE', 216), ('INCOMPLETE_EVIDENCE', 246), ('INCOMPLETE_EVIDENCE', 277), ('SUPERFICIAL_RELATIONSHIP', 286), ('INCOMPLETE_EVIDENCE', 473), ('INCOMPLETE_EVIDENCE', 517), ('PROBABLE_UNDERSTANDING', 592), ('PROBABLE_UNDERSTANDING', 708), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 731)]	13	[('UBERON_0013628', 'pollical pad', 28, 'childhood'), ('UBERON_0001977', 'blood serum', 139, 'serum'), ('GO_0007631', 'feeding behavior', 177, 'intake'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 324, 'autoimmune'), ('NCBITaxon_10088', 'Mus <genus>', 351, 'mice'), ('NCBITaxon_9606', 'Homo sapiens', 368, 'humans'), ('CHEBI_27300', 'vitamin D', 432, 'vitamin D'), ('UBERON_0001977', 'blood serum', 542, 'serum'), ('CHEBI_27300', 'vitamin D', 557, 'vitamin D'), ('CHEBI_62218', '23,24-dihydrocucurbitacin D', 570, '25-hydroxy vitamin D'), ('UBERON_0000104', 'life cycle', 622, 'life'), ('NCBITaxon_1', 'root', 657, 'individual'), ('CHEBI_27300', 'vitamin D', 678, 'vitamin D'), ('CHEBI_43176', 'hydroxy group', 752, 'dihydroxy'), ('CHEBI_27300', 'vitamin D', 762, 'vitamin D'), ('GO_0065007', 'biological regulation', 788, 'regulated')]	0	['showed sun exposure childhood period ms.16third, ms white population serum vitamin oral intake via supplements oily fish studies.217–19fourth,  agent autoimmune encephalitis mice (like ms humans).48finally, scientists administered 100-1700 iu/day  supplements ms patients reduction relapses.20–22the serum  25-hydroxy vitamin d, prolonged half-life.823–25it individual’s  nutritional status, formation, 1, 25-dihydroxy tightly  half-life (20-60 days).']
S104-PMC3235789	PMC3235789	12/2011	S104-PMC3235789	['there is EMERGING EVIDENCE that Vitamin D Regulates a KEY Antimicrobial peptide with broad Antimicrobial properties against gram-negative and gram-positive bacteria [40].']	[('INCOMPLETE_EVIDENCE', 9), ('IMPORTANT_CONSIDERATION', 54)]	2	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 42, 'regulates'), ('CHEBI_65381', 'albizoside C', 58, 'antimicrobial'), ('CHEBI_65381', 'albizoside C', 91, 'antimicrobial')]	0	['  antimicrobial peptide broad antimicrobial properties gram-negative gram-positive bacteria [40].']
S127-PMC3271033	PMC3271033	1/2012	S127-PMC3271033	['regardless, Serum calcium in the Cord Blood and in the first days of Life is LIKELY Controlled by a VARIETY of FACTORS, of which Vitamin D is ONLY one FACTOR.']	[('PROBABLE_UNDERSTANDING', 77), ('DIFFICULT_TASK', 100), ('SUPERFICIAL_RELATIONSHIP', 111), ('INCOMPLETE_EVIDENCE', 142), ('SUPERFICIAL_RELATIONSHIP', 151)]	5	[('UBERON_0001977', 'blood serum', 12, 'serum'), ('UBERON_0002240', 'spinal cord', 33, 'cord'), ('UBERON_0000178', 'blood', 38, 'blood'), ('UBERON_0000104', 'life cycle', 69, 'life'), ('GO_0065007', 'biological regulation', 84, 'controlled'), ('CHEBI_27300', 'vitamin D', 129, 'vitamin D')]	0	['regardless, serum calcium cord blood days life  factors,  factor.']
S2-PMC3277098	PMC3277098	12/2011	S2-PMC3277098	['it has since been RECOGNIZED that the active form of Vitamin D, 1α,25(Oh)2D3, has direct AFFECTS on Naïve and Activated Helper T cells, Regulatory T Cells, Activated B Cells and Dendritic Cells.']	[('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 89)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CHEBI_73394', 'Ala-Ser', 67, '25(OH)2D3'), ('CL_0000540', 'neuron', 100, 'naïve ...'), ('CL_0002627', 'mature astrocyte', 110, 'activated'), ('CL_0000545', 'T-helper 1 cell', 120, 'helper T'), ('CL_0000815', 'regulatory T cell', 136, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 136, 'regulatory'), ('CL_0002063', 'type II pneumocyte', 156, 'activated B cells'), ('CL_0000451', 'dendritic cell', 178, 'dendritic cells')]	0	['form 1α,25(oh)2d3, activated helper cells,  cells, activated b cells dendritic cells.']
S45-PMC3277098	PMC3277098	12/2011	S45-PMC3277098	['in Human studies there is SOME EVIDENCE of a non-linear response to Vitamin D, in that both high and low levels HAVE BEEN ASSOCIATED with increased th2 activity, but also EVIDENCE of an increased Regulatory response.']	[('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 112), ('SUPERFICIAL_RELATIONSHIP', 122), ('INCOMPLETE_EVIDENCE', 171)]	4	[('NCBITaxon_9606', 'Homo sapiens', 3, 'human'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0065007', 'biological regulation', 196, 'regulatory')]	0	['human non-linear response levels th2 activity,  response.']
S46-PMC3277098	PMC3277098	12/2011	S46-PMC3277098	['ACCORDINGLY, there is INCREASING EVIDENCE that the immunomodulatory effect of Vitamin D MAY act not ONLY through Modulation of Helper T Cell function, but also through induction of Cd4+Cd25+ Regulatory T Cells (Tregs) [29].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 100)]	4	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0065007', 'biological regulation', 113, 'modulation'), ('CL_0000912', 'helper T cell', 127, 'helper T cell'), ('GO_0006283', 'transcription-coupled nucleotide-excision repair', 134, 'T cell'), ('PR_000001204', 'C-C chemokine receptor type 8', 181, 'CD4'), ('PR_000002030', 'alpha-type platelet-derived growth factor receptor', 185, 'CD25'), ('CL_0000815', 'regulatory T cell', 191, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 191, 'regulatory'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 211, 'Tregs')]	0	['accordingly, immunomodulatory   helper cell function, induction cd4+cd25+  cells (tregs) [29].']
S56-PMC3277098	PMC3277098	12/2011	S56-PMC3277098	['given that B and T Cells are INFLUENCED by Vitamin D (section 4.1), there is SPECULATION that Orally Ingested Vitamin D COULD have the POTENTIAL to directly Modulate the function of Lymphocytes in the local Gut micro-environment.']	[('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 77), ('INCOMPLETE_EVIDENCE', 120), ('INCOMPLETE_EVIDENCE', 135)]	4	[('CL_0000969', 'regulatory B cell', 11, 'B ...'), ('CL_0000084', 'T cell', 17, 'T cells'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('UBERON_0000065', 'respiratory tract', 94, 'orally'), ('GO_0007631', 'feeding behavior', 101, 'ingested'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('GO_0065007', 'biological regulation', 157, 'modulate'), ('CL_0000542', 'lymphocyte', 182, 'lymphocytes'), ('UBERON_0001555', 'digestive tract', 207, 'gut')]	0	['given b cells  (section 4.1), orally ingested   lymphocytes local gut micro-environment.']
S70-PMC3277098	PMC3277098	12/2011	S70-PMC3277098	['the exact physiological mechanisms behind these OBSERVATIONS REMAINS unanswered, however there is GROWING EVIDENCE of Genetic variability that Modulates sensitivity to, and EFFECTS of, Vitamin D exposure.']	[('INCOMPLETE_EVIDENCE', 48), ('INCOMPLETE_EVIDENCE', 61), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 173)]	4	[('SO_0000704', 'gene', 118, 'genetic'), ('GO_0065007', 'biological regulation', 143, 'modulates'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]	0	['exact physiological mechanisms behind unanswered, genetic  sensitivity to, of,  exposure.']
S197-PMC3277098	PMC3277098	12/2011	S197-PMC3277098	['these CONTRASTING results HIGHLIGHT THE NEED for randomised controlled trials (rct) to provide clearer picture of ROLE of Vitamin D during infancy in Regulation of Allergic disease, including uptake, Metabolism and Immunomodulation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 26), ('INCOMPLETE_EVIDENCE', 36), ('FUTURE_WORK', 40), ('SUPERFICIAL_RELATIONSHIP', 114), ('SUPERFICIAL_RELATIONSHIP', 150)]	6	[('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('GO_0065007', 'biological regulation', 150, 'regulation'), ('GO_0040011', 'locomotion', 164, 'allergic'), ('GO_0008152', 'metabolic process', 200, 'metabolism'), ('GO_0050900', 'leukocyte migration', 215, 'immunomodulation')]	0	['results randomised (rct) picture  infancy  allergic disease, uptake, metabolism immunomodulation.']
S171-PMC3338544	PMC3338544	4/2012	S171-PMC3338544	['taken together these findings INDICATE that attentional processing is largely intact in a c57bl/6 Mouse MODEL of Prenatal Vitamin D deficiency, SUGGESTING that Dvd deficiency has LITTLE TO NO effect on the systems Governing attention in the Mouse.']	[('INCOMPLETE_EVIDENCE', 30), ('INCOMPLETE_EVIDENCE', 104), ('INCOMPLETE_EVIDENCE', 144), ('FULL_UNKNOWN', 179)]	4	[('NCBITaxon_10088', 'Mus <genus>', 98, 'mouse'), ('GO_0007565', 'female pregnancy', 113, 'prenatal'), ('CHEBI_27300', 'vitamin D', 122, 'vitamin D'), ('PR_000006770', 'cytoplasmic dynein 1 heavy chain 1', 160, 'DVD'), ('GO_0065007', 'biological regulation', 214, 'governing'), ('NCBITaxon_10088', 'Mus <genus>', 241, 'mouse')]	0	['taken attentional processing intact c57bl/6 mouse prenatal  deficiency, dvd systems  mouse.']
S15-PMC3347007	PMC3347007	4/2012	S15-PMC3347007	['in the unborn child, Vitamin D is IMPORTANT for fetal Bone Development through its ROLE in Regulating Calcium Homeostasis [6,7].']	[('IMPORTANT_CONSIDERATION', 34), ('SUPERFICIAL_RELATIONSHIP', 83)]	2	[('CHEBI_27300', 'vitamin D', 21, 'vitamin D'), ('GO_0048539', 'bone marrow development', 54, 'bone development'), ('GO_0065007', 'biological regulation', 91, 'regulating'), ('GO_0055073', 'cadmium ion homeostasis', 102, 'calcium homeostasis')]	0	['unborn child,  fetal bone  calcium homeostasis [6,7].']
S0-PMC3348565	PMC3348565	4/2012	S0-PMC3348565	['EFFECT on the incidence of pneumonia of Vitamin D supplementation by quarterly bolus dose to infants in kabul: a randomised controlled superiority trial\n\nabstractsummary\n\nbackground\nVitamin D has a ROLE in Regulating Immune function, and its deficiency is a SUGGESTED risk factor for childhood pneumonia.']	[('SUPERFICIAL_RELATIONSHIP', 0), ('SUPERFICIAL_RELATIONSHIP', 198), ('INCOMPLETE_EVIDENCE', 258)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 182, 'Vitamin D'), ('GO_0065007', 'biological regulation', 206, 'regulating'), ('UBERON_0002405', 'immune system', 217, 'immune')]	0	['effect pneumonia  supplementation quarterly bolus dose infants kabul: randomised superiority trial\n\nabstractsummary\n\nbackground\nvitamin  immune function, childhood pneumonia.']
S50-PMC3355895	PMC3355895	1/2011	S50-PMC3355895	['the Regulation of this process is AS YET UNKNOWN, but at least one of the Isoforms of Pmca HAS BEEN shown to be Regulated by 1,25(Oh)-Vitamin D (kip and strehler,2004), and in SOME Animals, BUT NOT OTHERS, 1,25(Oh)2-Vitamin D APPEARS necessary for maintenance of the maternofetal calcium gradient (lester,1986).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 34), ('FULL_UNKNOWN', 37), ('INCOMPLETE_EVIDENCE', 91), ('INCOMPLETE_EVIDENCE', 176), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 190), ('ANOMALY_CURIOUS_FINDING', 226)]	7	[('GO_0065007', 'biological regulation', 4, 'regulation'), ('SO_0001060', 'sequence_variant', 74, 'isoforms'), ('PR_000012924', 'bifunctional polynucleotide phosphatase/kinase', 86, 'PMCA'), ('GO_0065007', 'biological regulation', 112, 'regulated'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 130, 'OH)-'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 181, 'animals'), ('CHEBI_75874', 'para-terphenyl', 206, '1,25(OH)2-'), ('CHEBI_27300', 'vitamin D', 216, 'vitamin D')]	0	[' process unknown, isoforms pmca  1,25(oh)- (kip strehler,2004), animals, others, 1,25(oh)2- maintenance maternofetal calcium (lester,1986).']
S171-PMC3355895	PMC3355895	1/2011	S171-PMC3355895	['1,25(oh)-Vitamin D HAS BEEN SHOWN to Regulate OTHER Pmca Isoforms (kip and strehler,2004) and is THEREFORE a POTENTIAL CANDIDATE.']	[('INCOMPLETE_EVIDENCE', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 46), ('PROBABLE_UNDERSTANDING', 97), ('INCOMPLETE_EVIDENCE', 109), ('INCOMPLETE_EVIDENCE', 119)]	5	[('CHEBI_37958', 'dye', 0, '1,'), ('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0065007', 'biological regulation', 37, 'regulate'), ('PR_000012924', 'bifunctional polynucleotide phosphatase/kinase', 52, 'PMCA'), ('SO_0001060', 'sequence_variant', 57, 'isoforms')]	0	['1,25(oh)-  pmca isoforms (kip strehler,2004) candidate.']
S32-PMC3356951	PMC3356951	4/2012	S32-PMC3356951	['[614–16] the local Production Of 1,25(Oh)2D MAY BE responsible for Regulating up to 200 Genes[17] that MAY facilitate MANY of the pleiotropic health benefits that HAVE BEEN REPORTED for Vitamin D.[38914]\n\nVitamin D deficiency: prevalence\nvdd HAS BEEN historically defined and RECENTLY RECOMMENDED by the institute of medicine (iom) AS a 25(Oh)D of less than 0.8 iu.']	[('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 103), ('INCOMPLETE_EVIDENCE', 118), ('INCOMPLETE_EVIDENCE', 163), ('INCOMPLETE_EVIDENCE', 242), ('INCOMPLETE_EVIDENCE', 276), ('FUTURE_WORK', 285), ('PROBABLE_UNDERSTANDING', 332)]	8	[('GO_0008283', 'cell proliferation', 19, 'production of ... )2D'), ('CHEBI_37958', 'dye', 33, '1,'), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 35, '25(OH)2D'), ('GO_0065007', 'biological regulation', 67, 'regulating'), ('SO_0000704', 'gene', 88, 'genes'), ('CHEBI_27300', 'vitamin D', 186, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 205, 'Vitamin D'), ('CHEBI_71657', 'versiconol acetate', 337, '25(OH)D')]	0	['[614–16] local production 1,25(oh)2d  200 genes[17] pleiotropic .[38914]\n\nvitamin deficiency: prevalence\nvdd institute medicine (iom) 25(oh)d 0.8 iu.']
S88-PMC3356951	PMC3356951	4/2012	S88-PMC3356951	['[68] another example of Extrarenal Regulation of 1α-hydroxylase is that the increased Production Of 1,25(Oh)2D by Keratinocytes in wounds[69] THEREFORE provides a good ESTIMATE of Vitamin D status, BUT Regulation of 1α-hydroxylase activity SHOULD also BE CONSIDERED.']	[('SUPERFICIAL_RELATIONSHIP', 35), ('PROBABLE_UNDERSTANDING', 142), ('INCOMPLETE_EVIDENCE', 168), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 198), ('FUTURE_WORK', 240), ('ANOMALY_CURIOUS_FINDING', 252), ('FUTURE_WORK', 255)]	7	[('UBERON_0001691', 'external ear', 24, 'extrarenal'), ('GO_0065007', 'biological regulation', 35, 'regulation'), ('GO_0034205', 'amyloid-beta formation', 86, 'production of ... 2D'), ('CHEBI_82784', 'PVP38-Ag NP', 100, '1,25(OH)2D'), ('CL_0000312', 'keratinocyte', 114, 'keratinocytes'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('GO_0065007', 'biological regulation', 202, 'regulation')]	0	['[68] example extrarenal  1α-hydroxylase production 1,25(oh)2d keratinocytes wounds[69]  status,  1α-hydroxylase activity considered.']
S258-PMC3407995	PMC3407995	7/2012	S258-PMC3407995	['a recent review of studies LINKING maternal Vitamin D status during Pregnancy with maternal, foetal and Postnatal outcomes SUPPORTS a ROLE of maternal Vitamin D status, PARTICULARLY early in Pregnancy, in Modulating the risk of Pregnancy complications and in sustaining foetal growth, body composition, Skeletal Development, Immune Maturation and Respiratory health [141].']	[('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 134), ('IMPORTANT_CONSIDERATION', 169)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin D'), ('GO_0007565', 'female pregnancy', 68, 'pregnancy'), ('GO_0007567', 'parturition', 104, 'postnatal'), ('CHEBI_27300', 'vitamin D', 151, 'vitamin D'), ('GO_0007565', 'female pregnancy', 191, 'pregnancy'), ('GO_0065007', 'biological regulation', 205, 'modulating'), ('GO_0007565', 'female pregnancy', 228, 'pregnancy'), ('GO_0001501', 'skeletal system development', 303, 'skeletal development'), ('UBERON_0004288', 'skeleton', 303, 'skeletal'), ('GO_0050900', 'leukocyte migration', 325, 'immune maturation'), ('UBERON_0002405', 'immune system', 325, 'immune'), ('UBERON_0001004', 'respiratory system', 347, 'respiratory')]	0	['maternal  status pregnancy maternal, foetal postnatal outcomes maternal  status, pregnancy,  pregnancy sustaining foetal growth, composition, skeletal development, immune maturation respiratory [141].']
S14-PMC3427192	PMC3427192	4/2012	S14-PMC3427192	['Vitamin D overview\nVitamin D, a fat-soluble Nutrient, is a Secosteroid Hormone which is widely recognized as a modulator of calcium absorption and bone health and further Regulates Neuromuscular function, Cellular Differentiation, Insulin secretion, and Blood pressure.25,26vitamin D also plays an IMPORTANT ROLE in Immune Regulation through interactions between 1,25-Dihydroxyvitamin D and Vitamin D receptors ( vdrs ) .']	[('IMPORTANT_CONSIDERATION', 298), ('SUPERFICIAL_RELATIONSHIP', 308)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin'), ('CHEBI_28384', 'vitamin K', 19, 'Vitamin D'), ('CHEBI_33284', 'nutrient', 44, 'nutrient'), ('CHEBI_26661', 'shidasterone', 59, 'secosteroid hormone'), ('GO_0065007', 'biological regulation', 171, 'regulates'), ('UBERON_0001016', 'nervous system', 181, 'neuromuscular'), ('GO_0030154', 'cell differentiation', 205, 'cellular differentiation'), ('PR_000045358', 'insulin family protein', 231, 'insulin'), ('UBERON_0000178', 'blood', 254, 'blood'), ('PR_000006444', 'diacylglycerol kinase delta', 282, 'D'), ('UBERON_0002405', 'immune system', 316, 'immune'), ('GO_0065007', 'biological regulation', 323, 'regulation'), ('CHEBI_67472', '15-epi-lupulin B', 363, '1,25-dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 391, 'vitamin D')]	0	['vitamin overview\nvitamin d, fat-soluble nutrient, secosteroid hormone modulator calcium absorption bone  neuromuscular function, cellular differentiation, insulin secretion, blood pressure.25,26vitamin plays immune  1,25-dihydroxyvitamin  receptors vdrs .']
S15-PMC3427192	PMC3427192	4/2012	S15-PMC3427192	['vdrs are Expressed on a variety of Airway Immune Cells, where they function as classic Nuclear Steroid Hormone receptors and ultimately Regulate the transcription of numerous Genes associated with inflammation and Immunomodulation.27vitamin d also plays an IMPORTANT ROLE in Respiratory infection by facilitating Toll-Like Receptor Signaling through increased Synthesis of Human Cathelicidin Antimicrobial peptide,28-30which is cleaved to generate the active Cationic peptide, Ll-37.31,32vitamin D also exerts direct EFFECTS on target cells independent of Gene transcription33and MAY THEREFORE be of relevance to Airway inflammatory disorders.34while Vitamin D can suppress il-1735and Il-4-mediated Expression of Il-13,35,36it CAN also shift the th1/th2 balance toward th2 dominance.37THESE CONTRADICTORY actions MAY BE DUE to the direct actions of Vitamin D on cd4+T Cells to promote an Il-10-secreting T-Regulatory population.38\n\nBiosynthesis Of Vitamin D\nBiosynthesis Of Vitamin D begins PRIMARILY with absorption of solar ultravoilet-b (uvb) radiation and secondarily via Consumption of Vitamin D-rich and fortified foods, such as oily fish, fortified grains and dairy products.26following exposure to uvb radiation, 7-Dehydrocholesterol within the skin is converted to Previtamin D3( fig.']	[('IMPORTANT_CONSIDERATION', 257), ('SUPERFICIAL_RELATIONSHIP', 267), ('SUPERFICIAL_RELATIONSHIP', 517), ('INCOMPLETE_EVIDENCE', 580), ('PROBABLE_UNDERSTANDING', 584), ('INCOMPLETE_EVIDENCE', 727), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 783), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 791), ('INCOMPLETE_EVIDENCE', 813), ('IMPORTANT_CONSIDERATION', 820), ('PROBABLE_UNDERSTANDING', 991)]	11	[('GO_0010467', 'gene expression', 9, 'expressed'), ('UBERON_0001005', 'respiratory airway', 35, 'airway'), ('CL_0000738', 'leukocyte', 42, 'immune cells'), ('UBERON_0002405', 'immune system', 42, 'immune'), ('GO_0005634', 'nucleus', 87, 'nuclear'), ('CHEBI_26764', 'steroid hormone', 95, 'steroid hormone'), ('GO_0065007', 'biological regulation', 136, 'regulate'), ('SO_0000704', 'gene', 175, 'genes'), ('GO_0050900', 'leukocyte migration', 214, 'immunomodulation'), ('UBERON_0001004', 'respiratory system', 275, 'respiratory'), ('GO_0002770', 'T cell inhibitory signaling pathway', 313, 'Toll-like receptor signaling'), ('GO_0009057', 'macromolecule catabolic process', 360, 'synthesis'), ('NCBITaxon_9606', 'Homo sapiens', 373, 'human'), ('PR_000006009', 'alpha-catulin', 379, 'cathelicidin'), ('CHEBI_65381', 'albizoside C', 392, 'antimicrobial'), ('CHEBI_36916', 'cation', 459, 'cationic'), ('PR_000009809', 'leukocyte immunoglobulin-like receptor subfamily B member 2', 477, 'LL-37'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 496, 'D'), ('SO_0000704', 'gene', 556, 'gene'), ('UBERON_0001005', 'respiratory airway', 613, 'airway'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 685, 'IL-4'), ('GO_0010467', 'gene expression', 699, 'expression'), ('PR_000001470', 'interleukin-28B', 713, 'IL-13'), ('CHEBI_27300', 'vitamin D', 849, 'vitamin D'), ('CL_0000084', 'T cell', 866, 'T cells'), ('PR_000001470', 'interleukin-28B', 888, 'IL-10'), ('CL_0000895', 'naive thymus-derived CD4-positive, alpha-beta T cell', 904, 'T'), ('CL_0000232', 'erythrocyte', 906, 'regulatory'), ('GO_0065007', 'biological regulation', 906, 'regulatory'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 932, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 948, 'vitamin D'), ('GO_0033593', 'BRCA2-MAGE-D1 complex', 958, 'Biosynthesis of vitamin D'), ('CHEBI_27300', 'vitamin D', 974, 'vitamin D'), ('GO_0007631', 'feeding behavior', 1076, 'consumption'), ('CHEBI_27300', 'vitamin D', 1091, 'vitamin D'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 1221, '7-dehydrocholesterol'), ('PR_000014709', 'neuroserpin', 1274, 'previtamin D3')]	0	['vdrs expressed airway immune cells, nuclear steroid hormone receptors  transcription genes inflammation immunomodulation.27vitamin plays respiratory infection facilitating toll-like receptor signaling synthesis human cathelicidin antimicrobial peptide,28-30which cleaved generate cationic peptide, ll-37.31,32vitamin exerts cells gene transcription33and airway inflammatory disorders.34while  suppress il-1735and il-4-mediated expression il-13,35,36it th1/th2 balance toward th2 dominance.37these actions  cd4+t cells il-10-secreting t- population.38\n\nbiosynthesis \nbiosynthesis  begins absorption solar ultravoilet-b (uvb) radiation secondarily via consumption -rich fortified foods, oily fish, fortified grains dairy products.26following exposure uvb radiation, 7-dehydrocholesterol skin converted previtamin d3( fig.']
S42-PMC3427192	PMC3427192	4/2012	S42-PMC3427192	['studies of Vitamin D status in school-age children with asthmaauthoryearn(% male)age (years)study designsampleoutcome measuresfindingsbrehm412009616 (60)8.7cross-sectionalmild-to-severe persistent asthmaasthma exacerbationsincreased 25(Oh)D ASSOCIATED with reduced hospitalization, reduced Anti-Inflammatory Medication use and reduced Airway hyperresponsivenessbrehm6920101024 (60)8.9prospective cohortmild-to-moderate persistent asthmahospitalization or emergency Department visitbaseline 25(Oh)D levels < 30 ng/ml ASSOCIATED with higher odds of hospitalization or emergency department over 4 ychinellato70201175 (60)9.6cross-sectionalwell-controlled and POORLY controlled asthmaspirometry, asthma controlpositive CORRELATIONS NOTED between 25(Oh)d and asthma controlchinellato71201145 (60)10cross-sectionalintermittent asthmalung function and Airway hyperresponsivenesslower Serum 25(Oh)D ASSOCIATED with decreased Lung function and increased Airway hyperresponsiveness with exercisefreishtat72201092 (63)11.1cross-sectionalafrican americans with and without asthmaphysician-diagnosed asthmadecreased 25(Oh)D in asthmatics vs. controlsmajak73201148 (67)11.5randomized, double-blind, parallel arm clinical trialnewly diagnosed asthmaasthma exacerbationsfewer exacerbations in children with Vitamin D3Supplementation added to inhaled Budesonidesearing742010100 (64)7cross-sectionalmoderate to severe persistent asthmacorticosteroid use and Airflow limitationdecreased 25(Oh)D ASSOCIATED with lower Lung function and higher Corticosteroid requirementsurashima752010217 (57)10.0randomized, double-blind clinical trialschoolchildren (allcomers), subgroup with physician-diagnosed asthmaasthma exacerbationsreduced risk of asthma exacerbations in the subgroup with asthma after Vitamin D3Supplementation\nother cross-sectional studies of Vitamin D status have also examined the ASSOCIATIONS between 25(Oh)D concentrations and asthma Control in school-age children.']	[('SUPERFICIAL_RELATIONSHIP', 241), ('SUPERFICIAL_RELATIONSHIP', 516), ('PROBLEM_COMPLICATION', 656), ('SUPERFICIAL_RELATIONSHIP', 715), ('ANOMALY_CURIOUS_FINDING', 728), ('SUPERFICIAL_RELATIONSHIP', 891), ('SUPERFICIAL_RELATIONSHIP', 1476), ('SUPERFICIAL_RELATIONSHIP', 1873)]	8	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 233, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 233, '25(OH)D'), ('CHEBI_60426', 'dioleoyl phosphatidylglycerol', 290, 'anti-inflammatory medication'), ('UBERON_0001005', 'respiratory airway', 335, 'airway'), ('UBERON_0008247', 'tube foot', 465, 'department'), ('CHEBI_71657', 'versiconol acetate', 490, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 490, '25(OH)D'), ('CHEBI_63056', 'zinc cation', 742, '25(OH'), ('UBERON_0001005', 'respiratory airway', 845, 'airway'), ('UBERON_0001977', 'blood serum', 877, 'serum'), ('CHEBI_71657', 'versiconol acetate', 883, '25(OH)D'), ('PR_000003010', 'moesin isoform 1', 885, '(OH ... D'), ('UBERON_0002048', 'lung', 917, 'lung'), ('UBERON_0001005', 'respiratory airway', 945, 'airway'), ('CHEBI_71657', 'versiconol acetate', 1103, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1103, '25(OH)D'), ('CHEBI_52915', 'phosphatediyl group', 1291, 'vitamin D3supplementation'), ('CHEBI_72362', 'phosphatidylethanolamine 44:1-OH', 1334, 'budesonideSearing742010100'), ('UBERON_0001005', 'respiratory airway', 1440, 'airflow'), ('CHEBI_71657', 'versiconol acetate', 1468, '25(OH)D'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 1468, '25(OH)D'), ('UBERON_0002048', 'lung', 1498, 'lung'), ('CHEBI_36916', 'cation', 1523, 'corticosteroid'), ('CHEBI_52915', 'phosphatediyl group', 1774, 'vitamin D3supplementation'), ('CHEBI_27300', 'vitamin D', 1833, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 1894, '25(OH)D'), ('PR_000006444', 'diacylglycerol kinase delta', 1900, 'D'), ('GO_0065007', 'biological regulation', 1928, 'control')]	0	['studies  status school-age children designsampleoutcome measuresfindingsbrehm412009616 (60)8.7cross-sectionalmild-to-severe asthmaasthma exacerbationsincreased 25(oh)d hospitalization, anti-inflammatory medication airway hyperresponsivenessbrehm6920101024 (60)8.9prospective cohortmild-to-moderate asthmahospitalization department visitbaseline 25(oh)d levels 30 ng/ml higher hospitalization department 4 ychinellato70201175 (60)9.6cross-sectionalwell-controlled asthmaspirometry, asthma controlpositive 25(oh)d asthma controlchinellato71201145 (60)10cross-sectionalintermittent asthmalung airway hyperresponsivenesslower serum 25(oh)d decreased lung airway hyperresponsiveness exercisefreishtat72201092 (63)11.1cross-sectionalafrican americans asthmaphysician-diagnosed asthmadecreased 25(oh)d asthmatics vs. controlsmajak73201148 (67)11.5randomized, double-blind, arm trialnewly diagnosed asthmaasthma exacerbationsfewer exacerbations children vitamin d3supplementation added inhaled budesonidesearing742010100 (64)7cross-sectionalmoderate asthmacorticosteroid airflow limitationdecreased 25(oh)d lung higher corticosteroid requirementsurashima752010217 (57)10.0randomized, double-blind trialschoolchildren (allcomers), subgroup physician-diagnosed asthmaasthma exacerbationsreduced asthma exacerbations subgroup asthma vitamin d3supplementation\nother cross-sectional  status 25(oh)d concentrations asthma  school-age children.']
S45-PMC3427192	PMC3427192	4/2012	S45-PMC3427192	['WHILE these studies SHOW INTRIGUING ASSOCIATIONS between Vitamin D insufficiency (or deficiency) and asthma Control, the cross-sectional nature of the 25(Oh)D measurement and outcome assessment prevents causal INTERPRETATION.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 20), ('ANOMALY_CURIOUS_FINDING', 25), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 210)]	5	[('CHEBI_27300', 'vitamin D', 57, 'vitamin D'), ('GO_0065007', 'biological regulation', 108, 'control'), ('CHEBI_71657', 'versiconol acetate', 151, '25(OH)D')]	0	[' (or deficiency) asthma cross-sectional nature 25(oh)d outcome causal interpretation.']
S47-PMC3427192	PMC3427192	4/2012	S47-PMC3427192	['given the LIMITATIONS ASSOCIATED with these epidemiologic studies, randomized controlled TRIALS of Vitamin D ARE NEEDED in children to BETTER UNDERSTAND the causal RELATIONSHIP between Vitamin D status and Respiratory outcomes such as asthma Control in this population.']	[('INCOMPLETE_EVIDENCE', 10), ('SUPERFICIAL_RELATIONSHIP', 22), ('FUTURE_WORK', 89), ('FUTURE_WORK', 109), ('INCOMPLETE_EVIDENCE', 135), ('SUPERFICIAL_RELATIONSHIP', 164)]	6	[('CHEBI_27300', 'vitamin D', 99, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 206, 'respiratory'), ('GO_0065007', 'biological regulation', 242, 'control')]	0	['given epidemiologic children causal  status respiratory outcomes asthma  population.']
S53-PMC3427192	PMC3427192	4/2012	S53-PMC3427192	['Vitamin D in Adults with asthma\nin Adults, the RECOMMENDED dietary intake for Vitamin D ranges from 600 to 800 iu daily.47HOWEVER, DESPITE the large variety of Foods supplemented with Vitamin D, a large proportion of the Adult population remains Vitamin D deficient,77,78perhaps DUE IN PART to INADEQUATE sun exposure and the rising PREVALENCE of obesity which CAN LEAD TO decreased Vitamin D bioavailability.79SIMILAR to the studies in school age children, a NUMBER OF cross-sectional studies in Adults have also DEMONSTRATED ASSOCIATIONS between Vitamin D status and asthma Control (table 3).']	[('FUTURE_WORK', 47), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 120), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 279), ('INCOMPLETE_EVIDENCE', 283), ('IMPORTANT_CONSIDERATION', 294), ('IMPORTANT_CONSIDERATION', 333), ('INCOMPLETE_EVIDENCE', 361), ('SUPERFICIAL_RELATIONSHIP', 365), ('INCOMPLETE_EVIDENCE', 409), ('INCOMPLETE_EVIDENCE', 460), ('INCOMPLETE_EVIDENCE', 514), ('SUPERFICIAL_RELATIONSHIP', 527)]	14	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0007023', 'adult organism', 13, 'Adults'), ('UBERON_0007023', 'adult organism', 35, 'adults'), ('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('CHEBI_33290', 'food', 160, 'foods'), ('CHEBI_27300', 'vitamin D', 184, 'vitamin D'), ('UBERON_0007023', 'adult organism', 221, 'adult'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 383, 'vitamin D'), ('UBERON_0007023', 'adult organism', 497, 'adults'), ('CHEBI_27300', 'vitamin D', 548, 'vitamin D'), ('GO_0065007', 'biological regulation', 576, 'control')]	0	['vitamin adults asthma\nin adults, dietary intake  ranges 600 800 iu daily.47however, foods supplemented proportion adult population  deficient,77,78perhaps sun exposure obesity decreased  bioavailability.79similar school age children, cross-sectional adults  status asthma  (table 3).']
S11-PMC3458940	PMC3458940	9/2012	S11-PMC3458940	['introduction\nAll- Trans Retinoic Acid (Tra) is the primary Bioactive form of endogenous Retinoids derived from dietary Vitamin A and plays IMPORTANT ROLES in Regulating a myriad of physiological events[1].']	[('IMPORTANT_CONSIDERATION', 139), ('SUPERFICIAL_RELATIONSHIP', 149)]	2	[('CHEBI_80638', '3-Oxovalproic acid', 13, 'All- trans retinoic acid'), ('CHEBI_37972', 'phosphorus-32 atom', 39, 'tRA'), ('CHEBI_51870', 'boryl group', 59, 'bioactive'), ('CHEBI_26537', 'retinoid', 88, 'retinoids'), ('CHEBI_27300', 'vitamin D', 119, 'vitamin A'), ('GO_0065007', 'biological regulation', 158, 'regulating')]	0	['introduction\nall- trans retinoic acid (tra) bioactive form endogenous retinoids dietary  plays  physiological events[1].']
S29-PMC3465343	PMC3465343	10/2012	S29-PMC3465343	['ra signaling is tightly Controlled by the opposing actions of Retinaldehyde dehydrogenases (raldhs), which are ESSENTIAL for the generation of Embryonic ra from Vitamin A, and cyp26 members, which Catabolize ra[18].']	[('IMPORTANT_CONSIDERATION', 111)]	1	[('GO_0065007', 'biological regulation', 24, 'controlled'), ('CHEBI_17173', 'D-ribulose', 62, 'retinaldehyde'), ('UBERON_0000922', 'embryo', 143, 'embryonic'), ('CHEBI_27300', 'vitamin D', 161, 'vitamin A'), ('GO_0009953', 'dorsal/ventral pattern formation', 197, 'catabolize')]	0	['ra signaling tightly  retinaldehyde dehydrogenases (raldhs), generation embryonic ra cyp26 members, catabolize ra[18].']
S142-PMC3465343	PMC3465343	10/2012	S142-PMC3465343	['vitamin a supplies MUST BE Regulated to avoid Teratogenic consequences from deficiency or over-Intake and adequate maternal Vitamin A level is IMPORTANT for newborn.']	[('IMPORTANT_CONSIDERATION', 19), ('IMPORTANT_CONSIDERATION', 143)]	2	[('GO_0065007', 'biological regulation', 27, 'regulated'), ('CHEBI_50905', 'teratogenic agent', 46, 'teratogenic'), ('GO_0031649', 'heat generation', 46, 'teratogenic'), ('GO_0007631', 'feeding behavior', 95, 'intake'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin A')]	0	['vitamin supplies  teratogenic over-intake maternal  newborn.']
S52-PMC3472720	PMC3472720	8/2012	S52-PMC3472720	['among the current CANDIDATES, we can cite mir-22 that is induced by Vitamin D and acts as an antiproliferative and antimigratory agent in cancer cells [21] or mir-125B that Regulates the Expression of Human Vitamin D receptor and abolishes the anti-proliferative action of Calcitriol [22].']	[('INCOMPLETE_EVIDENCE', 18)]	1	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('PR_000000035', 'BMP receptor type-1A', 162, '-125b'), ('GO_0065007', 'biological regulation', 173, 'regulates'), ('GO_0010467', 'gene expression', 187, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 201, 'human'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 215, 'D'), ('CHEBI_17823', 'calcitriol', 273, 'calcitriol')]	0	['among candidates, mir-22 induced  antiproliferative antimigratory agent cancer cells [21] mir-125b  expression human  receptor abolishes anti-proliferative calcitriol [22].']
S2-PMC3476426	PMC3476426	8/2012	S2-PMC3476426	['immunomodulatory EFFECTS of Vitamin D MAY act NOT ONLY through Modulation of T-Helper Cell function, BUT ALSO through induction of Cd4+Cd25Highregulatory T-Cells.']	[('SUPERFICIAL_RELATIONSHIP', 17), ('INCOMPLETE_EVIDENCE', 38), ('ANOMALY_CURIOUS_FINDING', 46), ('ANOMALY_CURIOUS_FINDING', 101)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0065007', 'biological regulation', 63, 'modulation'), ('CL_0000912', 'helper T cell', 77, 'T-helper cell'), ('PR_000001204', 'C-C chemokine receptor type 8', 131, 'CD4'), ('PR_000005166', 'CMRF35-like molecule 7', 135, 'CD25highregulatory'), ('CL_0000084', 'T cell', 154, 'T-cells')]	0	['immunomodulatory   t-helper cell function, induction cd4+cd25highregulatory t-cells.']
S20-PMC3476426	PMC3476426	8/2012	S20-PMC3476426	['it has since been RECOGNIZED that the active form of Vitamin D has direct AFFECTS on Naïve and Activated Helper T Cells, Regulatory T Cells, Activated B Cells, and Dendritic Cells.']	[('PROBABLE_UNDERSTANDING', 18), ('SUPERFICIAL_RELATIONSHIP', 74)]	2	[('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('CL_0000540', 'neuron', 85, 'naïve ...'), ('CL_0002131', 'regular ventricular cardiac myocyte', 95, 'activated helper T cells'), ('CL_0000815', 'regulatory T cell', 121, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 121, 'regulatory'), ('CL_0002063', 'type II pneumocyte', 141, 'activated B cells'), ('CL_0000451', 'dendritic cell', 164, 'dendritic cells')]	0	['form  activated helper cells,  cells, activated b cells, dendritic cells.']
S128-PMC3476426	PMC3476426	8/2012	S128-PMC3476426	['Vitamin D deficiency HAS BEEN IMPLICATED as a POTENTIAL environmental FACTOR triggering SOME Autoimmune disorders SUGGESTING that Vitamin D MIGHT play a ROLE in Regulating auto-Antibody production [5,6].']	[('INCOMPLETE_EVIDENCE', 21), ('SUPERFICIAL_RELATIONSHIP', 30), ('INCOMPLETE_EVIDENCE', 46), ('SUPERFICIAL_RELATIONSHIP', 70), ('INCOMPLETE_EVIDENCE', 88), ('INCOMPLETE_EVIDENCE', 114), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 153)]	8	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0001442', 'skeleton of manus', 93, 'autoimmune'), ('CHEBI_27300', 'vitamin D', 130, 'vitamin D'), ('GO_0065007', 'biological regulation', 161, 'regulating'), ('GO_0042571', 'immunoglobulin complex, circulating', 177, 'antibody')]	0	['vitamin environmental autoimmune disorders  play  auto-antibody production [5,6].']
S134-PMC3476426	PMC3476426	8/2012	S134-PMC3476426	['immunomodulatory effect of Vitamin D MAY act NOT ONLY through Modulation of Helper T Cell function, BUT ALSO through induction of Cd4+Cd25Highregulatory T-Cells (Tregs) [44].']	[('INCOMPLETE_EVIDENCE', 37), ('ANOMALY_CURIOUS_FINDING', 45), ('ANOMALY_CURIOUS_FINDING', 100)]	3	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0065007', 'biological regulation', 62, 'modulation'), ('CL_0000912', 'helper T cell', 76, 'helper T cell'), ('PR_000001204', 'C-C chemokine receptor type 8', 130, 'CD4'), ('PR_000005166', 'CMRF35-like molecule 7', 134, 'CD25highregulatory'), ('CL_0000084', 'T cell', 153, 'T-cells'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 162, 'Tregs')]	0	['immunomodulatory   helper cell function, induction cd4+cd25highregulatory t-cells (tregs) [44].']
S22-PMC3501517	PMC3501517	11/2012	S22-PMC3501517	['these data SUGGEST that Vitamin D levels MAY Modulate Pulmonary Inflammatory Responses and/or resolution of inflammation in response to infectious stimuli.']	[('INCOMPLETE_EVIDENCE', 11), ('INCOMPLETE_EVIDENCE', 41)]	2	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0065007', 'biological regulation', 45, 'modulate'), ('GO_0006925', 'inflammatory cell apoptotic process', 54, 'pulmonary inflammatory responses'), ('UBERON_0002048', 'lung', 54, 'pulmonary')]	0	[' levels  pulmonary inflammatory responses and/or resolution inflammation response infectious stimuli.']
S178-PMC3501517	PMC3501517	11/2012	S178-PMC3501517	['TOGETHER, these data SUGGEST that Vitamin D does not affect Neutrophil Chemotaxis to Kc/Cxcl1 through Modulation of Cxcr2 Expression.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21)]	2	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CL_0000775', 'neutrophil', 60, 'neutrophil'), ('GO_0007567', 'parturition', 60, 'neutrophil'), ('GO_0006935', 'chemotaxis', 71, 'chemotaxis'), ('PR_000009255', 'potassium voltage-gated channel subfamily E member 1', 85, 'KC'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 88, 'CXCL1'), ('GO_0065007', 'biological regulation', 102, 'modulation'), ('PR_000001209', 'C-X-C chemokine receptor type 5', 116, 'CXCR2'), ('GO_0010467', 'gene expression', 122, 'expression')]	0	['together,  neutrophil chemotaxis kc/cxcl1  cxcr2 expression.']
S217-PMC3501517	PMC3501517	11/2012	S217-PMC3501517	['THEREFORE, WHILE Vitamin D MAY not play a ROLE in the acute inflammatory Response or resolution of inflammation, it MAY STILL be IMPORTANT in Controlling infections in the Lung.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 11), ('INCOMPLETE_EVIDENCE', 27), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 116), ('IMPORTANT_CONSIDERATION', 120), ('IMPORTANT_CONSIDERATION', 129)]	7	[('CHEBI_27300', 'vitamin D', 17, 'vitamin D'), ('GO_0060033', 'anatomical structure regression', 73, 'response'), ('GO_0065007', 'biological regulation', 142, 'controlling'), ('UBERON_0002048', 'lung', 172, 'lung')]	0	['therefore,  play acute inflammatory response resolution inflammation,  infections lung.']
S218-PMC3501517	PMC3501517	11/2012	S218-PMC3501517	['WHETHER Vitamin D Modulates Neutrophil function with infectious pneumonia REMAINS UNKNOWN.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('EXPLICIT_QUESTION', 0), ('FULL_UNKNOWN', 74)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('GO_0065007', 'biological regulation', 18, 'modulates'), ('CL_0000775', 'neutrophil', 28, 'neutrophil')]	0	['whether   neutrophil infectious pneumonia unknown.']
S10-PMC3582478	PMC3582478	2/2013	S10-PMC3582478	['changes in Fatty Acid composition during Pregnancy quickly return to the normal range following Parturition HOWEVER, an increase in the Omega-6/3 ratio increases the risk of Ppd11,12low maternal Omega-3 Polyunsaturated Fatty Acid Intake is SUGGESTED to CONTRIBUTE to decreased maternal and fetal health, INTERACTING with the Serotonin transporter Alleles to CONTRIBUTE TO ppd.13\ndecreased Pregnancy Vitamin D ASSOCIATES with many RISK FACTORS for ppd, including Preeclampsia,14SUGGESTING that it will indirectly Modulate ppd susceptibility.']	[('ANOMALY_CURIOUS_FINDING', 108), ('INCOMPLETE_EVIDENCE', 240), ('SUPERFICIAL_RELATIONSHIP', 253), ('SUPERFICIAL_RELATIONSHIP', 304), ('SUPERFICIAL_RELATIONSHIP', 358), ('SUPERFICIAL_RELATIONSHIP', 409), ('SUPERFICIAL_RELATIONSHIP', 430), ('INCOMPLETE_EVIDENCE', 475)]	8	[('CHEBI_35366', 'fatty acid', 11, 'fatty acid'), ('GO_0007565', 'female pregnancy', 41, 'pregnancy'), ('GO_0019230', 'proprioception', 96, 'parturition'), ('CHEBI_30823', 'oleate', 136, 'omega'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 174, 'PPD11'), ('CHEBI_79370', 'ibho#10', 195, 'omega-3'), ('GO_0033576', 'protein glycosylation in cytosol', 203, 'polyunsaturated fatty acid intake'), ('CHEBI_35366', 'fatty acid', 219, 'fatty acid'), ('CHEBI_28790', 'serotonin', 325, 'serotonin'), ('SO_0001023', 'allele', 347, 'alleles'), ('GO_0007565', 'female pregnancy', 389, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 399, 'vitamin D'), ('GO_0007128', 'meiotic prophase I', 462, 'preeclampsia'), ('GO_0065007', 'biological regulation', 512, 'modulate')]	0	['changes fatty acid composition pregnancy quickly return normal following parturition however, increase omega-6/3 ratio ppd11,12low maternal omega-3 polyunsaturated fatty acid intake decreased maternal fetal health, serotonin transporter alleles ppd.13\ndecreased pregnancy  ppd, preeclampsia,14suggesting  ppd susceptibility.']
S208-PMC3613945	PMC3613945	2/2013	S208-PMC3613945	['the UNDERLYING mechanism by which Vitamin D status AFFECTS cancer RISK is UNKNOWN, HOWEVER, 1,25(Oh)2D3Has BEEN SHOWN to Modulate Cell Proliferation and Differentiation Of both normal and malignant Cells.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 51), ('IMPORTANT_CONSIDERATION', 66), ('FULL_UNKNOWN', 74), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 83), ('ANOMALY_CURIOUS_FINDING', 83), ('INCOMPLETE_EVIDENCE', 107)]	7	[('CHEBI_27300', 'vitamin D', 34, 'vitamin D'), ('CHEBI_76957', 'N-2-hydroxytetracosenoylsphingosine', 92, '1,25(OH)2D3has'), ('GO_0065007', 'biological regulation', 121, 'modulate'), ('GO_0008283', 'cell proliferation', 130, 'cell proliferation'), ('GO_0030154', 'cell differentiation', 153, 'differentiation of ... cells')]	0	[' status cancer unknown, however, 1,25(oh)2d3has  cell proliferation normal malignant cells.']
S243-PMC3641012	PMC3641012	4/2013	S243-PMC3641012	['third, a positive ASSOCIATION between adj-ca and 25(Oh)D was apparent in the range of 25(Oh)D below 100\xa0nmol/l BUT not above 100\xa0nmol/l; evidence of POSSIBLE harm would be more CONSISTENT with the OPPOSITE FINDING of a Serum calcium that was tightly Controlled (i.e., unassociated with 25(Oh)D) within the lower range of 25(Oh)D, but deflected upward at higher 25(Oh)D. all maternal uncorrected and adj-ca values were below the threshold for hypercalcemia used by the iom in the 1997 Vitamin D dris (2.75\xa0mmol/l) [10] and the 2010 revision (2.63\xa0mmol/l) [7].']	[('SUPERFICIAL_RELATIONSHIP', 18), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 111), ('INCOMPLETE_EVIDENCE', 149), ('INCOMPLETE_EVIDENCE', 177), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 197), ('INCOMPLETE_EVIDENCE', 206)]	6	[('CHEBI_71657', 'versiconol acetate', 49, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 86, '25(OH)D'), ('UBERON_0001977', 'blood serum', 219, 'serum'), ('GO_0065007', 'biological regulation', 250, 'controlled'), ('CHEBI_71657', 'versiconol acetate', 286, '25(OH)D'), ('CHEBI_71657', 'versiconol acetate', 321, '25(OH)D'), ('CHEBI_72805', '2-alkyl-sn-glycero-3-phosphocholine', 364, 'OH)D'), ('CHEBI_27300', 'vitamin D', 484, 'vitamin D')]	0	['third, positive adj-ca 25(oh)d 25(oh)d 100\xa0nmol/l 100\xa0nmol/l; harm serum calcium tightly  (i.e., unassociated 25(oh)d) 25(oh)d, deflected upward higher 25(oh)d. maternal uncorrected adj-ca values hypercalcemia iom 1997  dris (2.75\xa0mmol/l) [10] 2010 revision (2.63\xa0mmol/l) [7].']
S24-PMC3651971	PMC3651971	5/2013	S24-PMC3651971	['introduction\nrisk for Cognitive and motor impairment begins in the Womb, where nutritional restrictions on Embryofetal Tissue growth, differentiation, development and Maturation MAY disturb growth, maturation and function of the Central Nervous System.1neural myelination and Synaptogenesis are underway before 24\u2005weeks’ Gestational age, Neural Tube Formation and Cell Migration are complete before the third Trimester of Pregnancy, and basic structures of the Brain formed before Birth.2as complex structures and functions extend as a cascade, disruptions to nascent systems by nutritional and OTHER insults CAN be amplified with age.3\nEmbryofetal Development is sensitive to Gestational deficiency in Vitamin A,4most EVIDENT in Animals by gross anomalies in Organ and Tissue Morphogenesis, development, structure and function.5–7Retinoic Acid, the oxidised Metabolite and transcriptional ligand of Vitamin A, Regulates the Expression of hox Genes that are essential in Neural Tube Formation,8the Development Of Neurons, and in Synaptic Signalling that UNDERLIES Learning and Memory.9–13developing neural Tissue in the Mouse is ESPECIALLY sensitive to variation in Retinoic Acid exposure near Parturition, a time analogous to the second Trimester of Human Gestation, when deficiency can induce behavioural problems and mild structural damage within the Limbic Cortex.14\nchronic dietary Vitamin A deficiency is common among Pregnant women in poor countries,1516leading TO concern that it MAY have adverse consequences for Cognitive and Motor Development Of the Fetus.']	[('INCOMPLETE_EVIDENCE', 178), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 595), ('INCOMPLETE_EVIDENCE', 609), ('PROBABLE_UNDERSTANDING', 719), ('SUPERFICIAL_RELATIONSHIP', 1054), ('ANOMALY_CURIOUS_FINDING', 1129), ('QUESTION_ANSWERED_BY_THIS_WORK', 1469), ('INCOMPLETE_EVIDENCE', 1488)]	8	[('GO_0050890', 'cognition', 22, 'cognitive'), ('UBERON_0002396', 'vomer', 67, 'womb'), ('UBERON_0000922', 'embryo', 107, 'embryofetal'), ('UBERON_0000479', 'tissue', 119, 'tissue'), ('GO_0007618', 'mating', 167, 'maturation'), ('UBERON_0001017', 'central nervous system', 229, 'central nervous system'), ('GO_0007416', 'synapse assembly', 276, 'synaptogenesis'), ('GO_0007565', 'female pregnancy', 321, 'gestational'), ('GO_0042136', 'neurotransmitter biosynthetic process', 338, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 338, 'neural tube'), ('GO_0016477', 'cell migration', 364, 'cell migration'), ('GO_0009294', 'DNA mediated transformation', 409, 'trimester'), ('GO_0007565', 'female pregnancy', 422, 'pregnancy'), ('UBERON_0000955', 'brain', 461, 'brain'), ('GO_0007567', 'parturition', 481, 'birth'), ('GO_0009790', 'embryo development', 637, 'Embryofetal development'), ('UBERON_0000922', 'embryo', 637, 'Embryofetal'), ('GO_0007565', 'female pregnancy', 677, 'gestational'), ('CHEBI_27300', 'vitamin D', 703, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 730, 'animals'), ('UBERON_0000062', 'organ', 760, 'organ'), ('GO_0048729', 'tissue morphogenesis', 770, 'tissue morphogenesis'), ('UBERON_0000479', 'tissue', 770, 'tissue'), ('CHEBI_52071', 'dextran', 828, '5'), ('CHEBI_24115', 'fuconate', 830, '7Retinoic acid'), ('CHEBI_39382', 'flufenoxuron', 859, 'metabolite'), ('CHEBI_27300', 'vitamin D', 900, 'vitamin A'), ('GO_0065007', 'biological regulation', 911, 'regulates'), ('GO_0010467', 'gene expression', 925, 'expression'), ('SO_0000704', 'gene', 943, 'genes'), ('GO_0042136', 'neurotransmitter biosynthetic process', 971, 'neural tube formation'), ('UBERON_0001049', 'neural tube', 971, 'neural tube'), ('GO_0046697', 'decidualization', 998, 'development of neurons'), ('CL_0000540', 'neuron', 1013, 'neurons'), ('GO_0045202', 'synapse', 1029, 'synaptic'), ('GO_0099536', 'synaptic signaling', 1029, 'synaptic signalling'), ('GO_0007612', 'learning', 1064, 'learning'), ('GO_0007613', 'memory', 1077, 'memory'), ('UBERON_0000479', 'tissue', 1106, 'tissue'), ('NCBITaxon_10088', 'Mus <genus>', 1120, 'mouse'), ('CHEBI_26536', 'retinoic acid', 1166, 'retinoic acid'), ('GO_0019230', 'proprioception', 1194, 'parturition'), ('GO_0009294', 'DNA mediated transformation', 1238, 'trimester'), ('NCBITaxon_9606', 'Homo sapiens', 1251, 'human'), ('GO_0007565', 'female pregnancy', 1257, 'gestation'), ('UBERON_0016542', 'limbic cortex', 1354, 'limbic cortex'), ('CHEBI_27300', 'vitamin D', 1387, 'vitamin A'), ('GO_0007565', 'female pregnancy', 1424, 'pregnant'), ('GO_0050890', 'cognition', 1522, 'cognitive ...'), ('GO_0048870', 'cell motility', 1536, 'motor development of ... fetus')]	0	['introduction\nrisk cognitive motor impairment begins womb, nutritional embryofetal tissue growth, differentiation, maturation disturb growth, maturation central nervous system.1neural myelination synaptogenesis 24\u2005weeks’ gestational age, neural tube formation cell migration third trimester pregnancy, structures brain formed birth.2as structures functions cascade, nascent systems nutritional insults amplified age.3\nembryofetal sensitive gestational ,4most animals anomalies organ tissue morphogenesis, development, structure function.5–7retinoic acid, oxidised metabolite transcriptional ligand  expression hox genes neural tube formation,8the neurons, synaptic signalling learning memory.9–13developing neural tissue mouse sensitive retinoic acid exposure parturition, trimester human gestation, behavioural structural limbic cortex.14\nchronic dietary  among pregnant women countries,1516leading cognitive motor fetus.']
S161-PMC3659910	PMC3659910	1/2013	S161-PMC3659910	['[44] ALTHOUGH 1,25(Oh) 2D is the active circulating form of Vitamin D, measuring this level is NOT HELPFUL BECAUSE it is quickly and tightly Regulated by the Kidney.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 5), ('DIFFICULT_TASK', 95), ('PROBLEM_COMPLICATION', 107)]	3	[('CHEBI_37983', 'sulfur-35 atom', 14, '1'), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 16, '25(OH) 2D'), ('CHEBI_27300', 'vitamin D', 60, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 68, 'D'), ('GO_0065007', 'biological regulation', 141, 'regulated'), ('UBERON_0002113', 'kidney', 158, 'kidney')]	0	['[44] 1,25(oh) 2d circulating form measuring helpful quickly tightly  kidney.']
S66-PMC3695234	PMC3695234	7/2013	S66-PMC3695234	['another prospective Birth cohort study investigated Vitamin D deficiency and Food sensitization, and genotyped 11 Genes INVOLVED in Regulating Ige and 25(Oh)D3Concentration.']	[('SUPERFICIAL_RELATIONSHIP', 120)]	1	[('GO_0007567', 'parturition', 20, 'birth'), ('CHEBI_27300', 'vitamin D', 52, 'vitamin D'), ('CHEBI_33290', 'food', 77, 'food'), ('SO_0000704', 'gene', 114, 'genes'), ('GO_0065007', 'biological regulation', 132, 'regulating'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 143, 'IgE'), ('CHEBI_74304', '(6Z,9Z,12Z,15Z,18Z,21Z)-3-oxotetracosahexaenoyl-CoA(4-)', 151, '25(OH)D3concentration'), ('PR_000010888', 'deubiquitinase MYSM1', 151, '25 ... OH ... D3concentration')]	0	['another birth  food sensitization, genotyped 11 genes  ige 25(oh)d3concentration.']
S10-PMC3702245	PMC3702245	6/2013	S10-PMC3702245	['a second hydroxylation takes place in the Kidney, which converts 25(Oh)D to the most biologically active Metabolite, 1,25-Dihydroxyvitamin D, the major classical physiologic function of which is to increase calcium and Phosphorus absorption from the Gut in order to maintain Calcium Homeostasis and promote mineralization of Osteoid bone.9\nalthough the Renal 1-alpha hydroxylase (Cytochrome P450 [Cyp]27B1) enzyme is a MAJOR DETERMINANT of Synthesis of 1,25-Dihydroxyvitamin D, IT IS KNOWN that Cyp27B1 is Expressed in Nonrenal Tissues to produce 1,25 Dihydroxyvitamin D.6,19in addition, Vitamin D receptors are also Expressed in a variety of Organs, Tissues, and cells (seefigure 1).20the 1,25-Dihydroxyvitamin D locally produced in Extrarenal Tissues, such as immune cells, Pancreatic Beta Cells, the Intestine, Prostate, Breast, and other Organs, Controls multiple Vitamin D-responsive Genes, and THUS plays an important physiologic ROLE in Cardiovascular health,21,22the Adaptive and Innate Immune Responses,23,24insulin secretion,25,26regulation of Cell Proliferation, Differentiation, and Apoptosis, and inhibition of Angiogenesis.27\n\nVitamin D Homeostasis and functions during Pregnancy\nthe classical function of Vitamin D is to maintain calcium Homeostasis.']	[('IMPORTANT_CONSIDERATION', 419), ('SUPERFICIAL_RELATIONSHIP', 425), ('INCOMPLETE_EVIDENCE', 478), ('PROBABLE_UNDERSTANDING', 900), ('SUPERFICIAL_RELATIONSHIP', 936)]	5	[('UBERON_0002113', 'kidney', 42, 'kidney'), ('CHEBI_71657', 'versiconol acetate', 65, '25(OH)D'), ('CHEBI_39382', 'flufenoxuron', 105, 'metabolite'), ('CHEBI_67472', '15-epi-lupulin B', 117, '1,25-dihydroxyvitamin D'), ('CHEBI_35885', 'secondary phosphine', 219, 'phosphorus'), ('UBERON_0001555', 'digestive tract', 250, 'gut'), ('GO_0055073', 'cadmium ion homeostasis', 275, 'calcium homeostasis'), ('UBERON_0008883', 'osteoid', 325, 'osteoid'), ('UBERON_0002113', 'kidney', 353, 'renal'), ('CHEBI_4056', 'cytochrome', 380, 'cytochrome'), ('PR_000006100', 'aromatase', 380, 'cytochrome P450'), ('PR_000006138', 'cytochrome P450 4F11', 397, 'CYP ... 27B1'), ('GO_0009057', 'macromolecule catabolic process', 440, 'synthesis'), ('CHEBI_67472', '15-epi-lupulin B', 453, '1,25-dihydroxyvitamin D'), ('PR_000006101', 'cytochrome P450 1A1', 495, 'CYP27B1'), ('GO_0010467', 'gene expression', 506, 'expressed'), ('UBERON_0002481', 'bone tissue', 519, 'nonrenal tissues'), ('CHEBI_67469', '15-hydroxyajubractin C', 547, '1,25 dihydroxyvitamin D'), ('CHEBI_27300', 'vitamin D', 588, 'vitamin D'), ('GO_0010467', 'gene expression', 617, 'expressed'), ('UBERON_0000062', 'organ', 643, 'organs'), ('UBERON_0000479', 'tissue', 651, 'tissues'), ('CHEBI_67472', '15-epi-lupulin B', 690, '1,25-dihydroxyvitamin D'), ('UBERON_0005292', 'extraembryonic tissue', 734, 'extrarenal tissues'), ('CL_0000169', 'type B pancreatic cell', 776, 'pancreatic beta cells'), ('UBERON_0001264', 'pancreas', 776, 'pancreatic'), ('UBERON_0000160', 'intestine', 803, 'intestine'), ('UBERON_0002367', 'prostate gland', 814, 'prostate'), ('UBERON_0000310', 'breast', 824, 'breast'), ('UBERON_0000062', 'organ', 842, 'organs'), ('GO_0065007', 'biological regulation', 850, 'controls'), ('CHEBI_27300', 'vitamin D', 868, 'vitamin D'), ('SO_0000704', 'gene', 889, 'genes'), ('UBERON_0004535', 'cardiovascular system', 944, 'cardiovascular'), ('GO_0051886', 'negative regulation of timing of anagen', 975, 'adaptive ...'), ('GO_0044419', 'biological process involved in interspecies interaction between organisms', 988, 'innate immune responses'), ('UBERON_0002405', 'immune system', 995, 'immune'), ('GO_0030154', 'cell differentiation', 1054, 'cell proliferation ... differentiation'), ('GO_0006915', 'apoptotic process', 1095, 'apoptosis'), ('GO_0001525', 'angiogenesis', 1124, 'angiogenesis'), ('CHEBI_28384', 'vitamin K', 1141, 'Vitamin D'), ('GO_0042592', 'homeostatic process', 1151, 'homeostasis'), ('GO_0007565', 'female pregnancy', 1184, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1220, 'vitamin D'), ('GO_0042592', 'homeostatic process', 1253, 'homeostasis')]	0	['hydroxylation takes place kidney, converts 25(oh)d biologically metabolite, 1,25-dihydroxyvitamin d, physiologic increase calcium phosphorus absorption gut maintain calcium homeostasis mineralization osteoid bone.9\nalthough renal 1-alpha hydroxylase (cytochrome p450 [cyp]27b1) enzyme synthesis 1,25-dihydroxyvitamin d, cyp27b1 expressed nonrenal tissues produce 1,25 dihydroxyvitamin d.6,19in addition,  receptors expressed organs, tissues, cells (seefigure 1).20the 1,25-dihydroxyvitamin locally extrarenal tissues, immune cells, pancreatic beta cells, intestine, prostate, breast, organs,  -responsive genes, plays physiologic cardiovascular health,21,22the adaptive innate immune responses,23,24insulin secretion,25,26regulation cell proliferation, differentiation, apoptosis, inhibition angiogenesis.27\n\nvitamin homeostasis functions pregnancy\nthe  maintain calcium homeostasis.']
S30-PMC3705146	PMC3705146	5/2013	S30-PMC3705146	['mcgrath and welham (1999) have PROPOSED that Vitamin D availability MAY Modulate the eventual development of schizophrenia, and kinney et al.']	[('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 68)]	2	[('CHEBI_27300', 'vitamin D', 45, 'vitamin D'), ('GO_0065007', 'biological regulation', 72, 'modulate')]	0	['mcgrath welham (1999)  availability  eventual schizophrenia, kinney et al.']
S208-PMC3705146	PMC3705146	5/2013	S208-PMC3705146	['with respect to the POSSIBLE ROLE of sunlight intensity in behavioral phenotypes, it HAS BEEN PROPOSED that cutaneous Vitamin D generation MAY BE INVOLVED in Gestational EFFECTS that Modulate the eventual development of schizophrenia (mcgrath and welham,1999).']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 29), ('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 139), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 170)]	7	[('CHEBI_27300', 'vitamin D', 118, 'vitamin D'), ('GO_0007565', 'female pregnancy', 158, 'gestational'), ('GO_0065007', 'biological regulation', 183, 'modulate')]	0	['respect sunlight intensity behavioral phenotypes, cutaneous  generation gestational  eventual schizophrenia (mcgrath welham,1999).']
S262-PMC3705146	PMC3705146	5/2013	S262-PMC3705146	['the need for Vitamin D MAY have AFFECTED NOT ONLY Gene frequencies of relevance to schizophrenia BUT MAY ALSO have Modulated Gene-environment INTERACTIONS that CAN occur in differing light regimes.']	[('INCOMPLETE_EVIDENCE', 23), ('SUPERFICIAL_RELATIONSHIP', 32), ('ANOMALY_CURIOUS_FINDING', 41), ('ANOMALY_CURIOUS_FINDING', 97), ('INCOMPLETE_EVIDENCE', 101), ('ANOMALY_CURIOUS_FINDING', 105), ('SUPERFICIAL_RELATIONSHIP', 142), ('INCOMPLETE_EVIDENCE', 160)]	8	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('SO_0000704', 'gene', 50, 'gene'), ('GO_0065007', 'biological regulation', 115, 'modulated'), ('SO_0000704', 'gene', 125, 'gene')]	0	[' gene frequencies schizophrenia  gene-environment occur regimes.']
S139-PMC3713405	PMC3713405	7/2013	S139-PMC3713405	['this Complex binds to Vitamin D response elements (vdre) in the Promoters of a number of Genes; to Regulate their transcription (christakos et al., 2003).']	[('DIFFICULT_TASK', 5)]	1	[('GO_0032991', 'protein-containing complex', 5, 'complex'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('SO_0000167', 'promoter', 64, 'promoters'), ('SO_0000704', 'gene', 89, 'genes'), ('GO_0065007', 'biological regulation', 99, 'regulate')]	0	['binds  response elements (vdre) promoters genes;  transcription (christakos et al., 2003).']
S171-PMC3713405	PMC3713405	7/2013	S171-PMC3713405	['moreover, EVIDENCE continues to accumulate INDICATING Vitamin D positively Regulates Gdnf levels in the developing Mesencephalon (orme et al., 2013).']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 43)]	2	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0065007', 'biological regulation', 75, 'regulates'), ('PR_000007939', 'glial fibrillary acidic protein', 85, 'GDNF'), ('UBERON_0001891', 'midbrain', 115, 'mesencephalon')]	0	['moreover, accumulate  positively  gdnf levels mesencephalon (orme et al., 2013).']
S20-PMC3717170	PMC3717170	5/2013	S20-PMC3717170	['the mechanism of 1,25(Oh)2D3Suppression of Il-17 was found to be transcriptional and to involve blocking of Nuclear factor for Activated T Cells (Nfat, which is IMPORTANT for T Cell receptor–mediated transcriptional Regulation of Il-17), recruitment of Histone deacetylase to the Il-17 Promoter, and Sequestration of Runt-Related Transcription Factor 1 (runx1) by the vdr.31,25(Oh)2D3Was also FOUND to have a direct EFFECT on the induction of Foxp3, a transcription factor that ASSOCIATES with Nfat and runx1 for transcriptional repression.3THESE results DESCRIBE NOVEL mechanisms and new CONCEPTS with regard to Vitamin D and the Immune System and SUGGEST THERAPEUTIC TARGETS for the Control of Autoimmune diseases.']	[('IMPORTANT_CONSIDERATION', 161), ('ANOMALY_CURIOUS_FINDING', 393), ('SUPERFICIAL_RELATIONSHIP', 416), ('SUPERFICIAL_RELATIONSHIP', 478), ('INCOMPLETE_EVIDENCE', 540), ('INCOMPLETE_EVIDENCE', 555), ('FULL_UNKNOWN', 564), ('INCOMPLETE_EVIDENCE', 589), ('FUTURE_WORK', 649), ('INCOMPLETE_EVIDENCE', 649), ('FUTURE_WORK', 657), ('FUTURE_WORK', 669)]	12	[('CHEBI_42976', 'L-glycero-alpha-D-manno-heptopyranose', 17, '1,25(OH)2D3suppression'), ('PR_000001470', 'interleukin-28B', 43, 'IL-17'), ('GO_0005634', 'nucleus', 108, 'nuclear'), ('CL_0002129', 'regular atrial cardiac myocyte', 127, 'activated T cells'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 146, 'NFAT'), ('CL_0000084', 'T cell', 175, 'T cell'), ('GO_0065007', 'biological regulation', 216, 'regulation'), ('PR_000001470', 'interleukin-28B', 230, 'IL-17'), ('CHEBI_15358', 'histone', 253, 'histone'), ('PR_000043452', 'core histone', 253, 'histone'), ('PR_000001470', 'interleukin-28B', 280, 'IL-17'), ('SO_0000167', 'promoter', 286, 'promoter'), ('GO_0051235', 'maintenance of location', 300, 'sequestration'), ('PR_000014373', 'retinoic acid receptor RXR-beta', 317, 'Runt-related transcription factor 1'), ('CHEBI_73386', 'Ala-Val-Asp-Ser', 375, '25(OH)2D3was'), ('PR_000007655', 'GSK-3-binding protein FRAT2', 443, 'Foxp3'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 494, 'NFAT'), ('CHEBI_27300', 'vitamin D', 613, 'vitamin D'), ('UBERON_0002405', 'immune system', 631, 'immune system'), ('GO_0065007', 'biological regulation', 685, 'control'), ('UBERON_0001442', 'skeleton of manus', 696, 'autoimmune')]	0	['1,25(oh)2d3suppression il-17 transcriptional blocking nuclear activated cells (nfat, cell receptor–mediated transcriptional  il-17), recruitment histone deacetylase il-17 promoter, sequestration runt-related transcription (runx1) vdr.31,25(oh)2d3was induction foxp3, transcription nfat runx1 transcriptional repression.3these results mechanisms regard  immune system  autoimmune diseases.']
S50-PMC3717170	PMC3717170	5/2013	S50-PMC3717170	['WHILE the Heart and Vasculature have ONLY RECENTLY been identified as POTENTIAL targets of Vitamin D action, a GROWING body of EVIDENCE SUGGESTS that the activated vdr plays an IMPORTANT ROLE in Regulating Cardiovascular function.8first, the vdr and the ligand-generating 25-Hydroxyvitamin D31-α-hydroxylase HAVE BEEN SHOWN to be present in Cardiac Myocytes, Cardiac Fibroblasts, Vascular Smooth Muscle Cells, and Vascular Endothelial Cells.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 37), ('INCOMPLETE_EVIDENCE', 42), ('INCOMPLETE_EVIDENCE', 70), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 136), ('IMPORTANT_CONSIDERATION', 177), ('SUPERFICIAL_RELATIONSHIP', 187), ('INCOMPLETE_EVIDENCE', 308)]	9	[('UBERON_0000948', 'heart', 10, 'heart'), ('UBERON_0002049', 'vasculature', 20, 'vasculature'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0065007', 'biological regulation', 195, 'regulating'), ('UBERON_0004535', 'cardiovascular system', 206, 'cardiovascular'), ('CHEBI_67376', 'dihydrooroxylin A', 272, '25-hydroxyvitamin'), ('PR_000002019', 'MHC class II histocompatibility antigen beta chain DRB1', 290, 'D31'), ('CL_0000746', 'cardiac muscle cell', 341, 'cardiac myocytes'), ('UBERON_0000948', 'heart', 341, 'cardiac'), ('CL_0002548', 'fibroblast of cardiac tissue', 359, 'cardiac fibroblasts'), ('UBERON_0000948', 'heart', 359, 'cardiac'), ('CL_0000359', 'vascular associated smooth muscle cell', 380, 'vascular smooth muscle cells'), ('UBERON_0001135', 'smooth muscle tissue', 389, 'smooth muscle'), ('CL_0000071', 'blood vessel endothelial cell', 414, 'vascular endothelial cells'), ('UBERON_0001986', 'endothelium', 423, 'endothelial')]	0	['vasculature  action, activated vdr plays  cardiovascular function.8first, vdr ligand-generating 25-hydroxyvitamin d31-α-hydroxylase cardiac myocytes, cardiac fibroblasts, vascular smooth muscle cells, vascular endothelial cells.']
S66-PMC3717170	PMC3717170	5/2013	S66-PMC3717170	['collectively, these data DEMONSTRATE that the Vitamin D system—specifically, the ligand-bound vdr—plays an IMPORTANT ROLE in the maintenance of Cardiovascular health and SUGGEST that Vitamin D repletion MAY have IMPORTANT PUBLIC HEALTH IMPLICATIONS in Controlling the prevalence of, and morbidity ASSOCIATED with, Cardiovascular disease.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 25), ('IMPORTANT_CONSIDERATION', 107), ('SUPERFICIAL_RELATIONSHIP', 117), ('INCOMPLETE_EVIDENCE', 170), ('INCOMPLETE_EVIDENCE', 203), ('IMPORTANT_CONSIDERATION', 212), ('IMPORTANT_CONSIDERATION', 222), ('SUPERFICIAL_RELATIONSHIP', 297)]	8	[('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('UBERON_0004535', 'cardiovascular system', 144, 'cardiovascular'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('GO_0065007', 'biological regulation', 252, 'controlling'), ('UBERON_0004535', 'cardiovascular system', 314, 'cardiovascular')]	0	['collectively,  system—specifically, ligand-bound vdr—plays maintenance cardiovascular  repletion  of, morbidity with, cardiovascular disease.']
S82-PMC3717170	PMC3717170	5/2013	S82-PMC3717170	['the EFFECTS of the hormonal form of Vitamin D, 1,25(Oh)2D3, on Apoptotic Cell Death are MEDIATED via multiple signaling pathways that involve common regulators and Effectors CONVERGING on cellular Ca2+.19,21sergeev and colleagues HAVE SHOWN that the CRITICAL characteristic of the apoptotic Ca2+signal is a sustained increase in the concentration of Intracellular Ca2+, reaching elevated BUT NOT cytotoxic levels.22HOWEVER, 1,25(Oh)2D3-Regulated, Ca2+-dependent apoptotic molecular targets HAVE NOT BEEN IDENTIFIED in Adipose Tissue.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('SUPERFICIAL_RELATIONSHIP', 88), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 174), ('INCOMPLETE_EVIDENCE', 230), ('IMPORTANT_CONSIDERATION', 250), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 388), ('ANOMALY_CURIOUS_FINDING', 392), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 413), ('FULL_UNKNOWN', 490)]	9	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('CHEBI_72779', '11-trans-LTE4', 47, '1,25(OH)2D3'), ('CL_0000445', 'apoptosis fated cell', 63, 'apoptotic cell'), ('GO_0006915', 'apoptotic process', 63, 'apoptotic cell death'), ('CHEBI_35224', 'effector', 164, 'effectors'), ('CHEBI_29108', 'calcium(2+)', 197, 'Ca2+.'), ('CHEBI_29108', 'calcium(2+)', 291, 'Ca2+'), ('GO_0005622', 'intracellular anatomical structure', 350, 'intracellular'), ('CHEBI_3312', 'calcium dichloride', 364, 'Ca2+,'), ('CHEBI_17996', 'chloride', 425, ','), ('CHEBI_73394', 'Ala-Ser', 426, '25(OH)2D3'), ('GO_0065007', 'biological regulation', 436, 'regulated'), ('CHEBI_81233', 'Schizonepetoside B', 447, 'Ca2+-'), ('UBERON_0001013', 'adipose tissue', 518, 'adipose tissue')]	0	['hormonal form 1,25(oh)2d3, apoptotic cell death via signaling effectors cellular ca2+.19,21sergeev colleagues apoptotic ca2+signal sustained increase concentration intracellular ca2+, reaching elevated cytotoxic levels.22however, 1,25(oh)2d3-, ca2+-dependent apoptotic molecular adipose tissue.']
S135-PMC3717170	PMC3717170	5/2013	S135-PMC3717170	['the EFFECT of Vitamin D MAY BE direct, as SUPPORTED by the Expression of the vdr and the local Production Of 1,25(Oh)2D3In Pancreatic Β Cells, OR indirect via its ROLE in Regulating Calcium Homeostasis and calcium Flux through Cell Membranes.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 24), ('INCOMPLETE_EVIDENCE', 42), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 143), ('SUPERFICIAL_RELATIONSHIP', 163)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0010467', 'gene expression', 59, 'expression'), ('GO_0008283', 'cell proliferation', 95, 'production of ...'), ('CHEBI_84175', '2-methylhexadecanoate', 109, '1,25(OH)2D3in'), ('GO_0006306', 'DNA methylation', 117, '2D3in'), ('UBERON_0001264', 'pancreas', 123, 'pancreatic'), ('CL_0000015', 'male germ cell', 134, 'β cells'), ('GO_0065007', 'biological regulation', 171, 'regulating'), ('GO_0055073', 'cadmium ion homeostasis', 182, 'calcium homeostasis'), ('GO_0006457', 'protein folding', 214, 'flux'), ('GO_0005886', 'plasma membrane', 227, 'cell membranes'), ('GO_0007613', 'memory', 232, 'membranes')]	0	[' direct, expression vdr local production 1,25(oh)2d3in pancreatic β cells, via  calcium homeostasis calcium flux cell membranes.']
S155-PMC3717170	PMC3717170	5/2013	S155-PMC3717170	['alterations in these mechanisms during Vitamin D deficiency states MAY account for Skeletal muscle weakness, in VIEW of the KEY ROLE that Ca2+plays in the Regulation of Contractility.']	[('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 112), ('IMPORTANT_CONSIDERATION', 124), ('SUPERFICIAL_RELATIONSHIP', 128)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('UBERON_0004288', 'skeleton', 83, 'skeletal'), ('CHEBI_29108', 'calcium(2+)', 138, 'Ca2+'), ('GO_0065007', 'biological regulation', 155, 'regulation'), ('GO_0006936', 'muscle contraction', 169, 'contractility')]	0	['alterations mechanisms  skeletal muscle weakness, ca2+plays  contractility.']
S103-PMC3773018	PMC3773018	4/2013	S103-PMC3773018	['FUTURE laboratory STUDIES also SHOULD BE SERIOUSLY CONSIDERED to help BETTER UNDERSTAND the molecular basis UNDERLYING HOW the immunomodulatory EFFECT of Vitamin D and Regulatory EFFECT of the Il4 Gene on Ige Production JOINTLY INFLUENCE the risk of fs.']	[('FUTURE_WORK', 0), ('FUTURE_WORK', 31), ('IMPORTANT_CONSIDERATION', 41), ('FUTURE_WORK', 51), ('IMPORTANT_CONSIDERATION', 51), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 108), ('EXPLICIT_QUESTION', 119), ('SUPERFICIAL_RELATIONSHIP', 144), ('SUPERFICIAL_RELATIONSHIP', 179), ('SUPERFICIAL_RELATIONSHIP', 220), ('SUPERFICIAL_RELATIONSHIP', 228)]	12	[('CHEBI_27300', 'vitamin D', 154, 'vitamin D'), ('GO_0065007', 'biological regulation', 168, 'regulatory'), ('PR_000008989', 'interleukin-1 family member 7', 193, 'IL4'), ('SO_0000704', 'gene', 197, 'gene'), ('GO_0032631', 'interleukin-27 production', 205, 'IgE production'), ('GO_0071743', 'IgE immunoglobulin complex, circulating', 205, 'IgE')]	0	['future laboratory molecular immunomodulatory   il4 gene ige production fs.']
S70-PMC3798907	PMC3798907	8/2013	S70-PMC3798907	['HOWEVER, just as for cbmc, there was a TREND for GENERALLY enhanced secretion of the Regulatory cytokine Tgf-Β when pbmc were supplemented with Vitamin E, and these increases were significant in the cultures responding to con a (13 of 17 cultures exhibiting an increase) or hdm, (13 of 17 cultures exhibiting an increase) (figure 2andtable 1).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 39), ('PROBABLE_UNDERSTANDING', 49)]	3	[('GO_0065007', 'biological regulation', 85, 'regulatory'), ('PR_000000046', 'TGF-beta', 105, 'TGF-β'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin E')]	0	['however, cbmc, secretion  cytokine tgf-β pbmc supplemented cultures responding con (13 17 cultures increase) hdm, (13 17 cultures increase) (figure 2andtable 1).']
S93-PMC3798907	PMC3798907	8/2013	S93-PMC3798907	['it can be seen that the EFFECTS of Vitamin E supplementation on cbmc responses to these Allergens were GENERALLY inhibitory, with the NOTABLE EXCEPTIONS of stronger Proliferation to tg and increased secretion of the Regulatory cytokine Tgf-Β in cultures stimulated with either hdm or tg.']	[('SUPERFICIAL_RELATIONSHIP', 24), ('PROBABLE_UNDERSTANDING', 103), ('ANOMALY_CURIOUS_FINDING', 134), ('ANOMALY_CURIOUS_FINDING', 142)]	4	[('CHEBI_27300', 'vitamin D', 35, 'vitamin E'), ('CHEBI_33663', 'cyclic hydrocarbon', 88, 'allergens'), ('GO_0008283', 'cell proliferation', 165, 'proliferation'), ('GO_0065007', 'biological regulation', 216, 'regulatory'), ('PR_000000046', 'TGF-beta', 236, 'TGF-β')]	0	[' supplementation cbmc responses allergens inhibitory, proliferation tg secretion  cytokine tgf-β cultures tg.']
S94-PMC3798907	PMC3798907	8/2013	S94-PMC3798907	['IN CONTRAST, the pattern of EFFECTS of Vitamin E supplementation on pbmc responses was typified by increases in both th Effector and Regulatory cytokine responses.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('SUPERFICIAL_RELATIONSHIP', 28)]	2	[('CHEBI_27300', 'vitamin D', 39, 'vitamin E'), ('CHEBI_35224', 'effector', 120, 'effector'), ('GO_0065007', 'biological regulation', 133, 'regulatory')]	0	['contrast,  supplementation pbmc responses typified th effector  cytokine responses.']
S102-PMC3798907	PMC3798907	8/2013	S102-PMC3798907	['before embarking on a Vitamin E intervention study during Pregnancy we wanted TO TEST WHETHER in vitro Vitamin E supplementation COULD Modulate Neonatal Immune Responses, REASONING that the demonstration of a direct EFFECT would justify Vitamin E supplementation, WHEREAS FAILURE to demonstrate a direct EFFECT would justify ALTERNATIVE dietary STRATEGIES to increase Vitamin E intake.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 78), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 86), ('INCOMPLETE_EVIDENCE', 129), ('PROBABLE_UNDERSTANDING', 171), ('PROBABLE_UNDERSTANDING', 171), ('SUPERFICIAL_RELATIONSHIP', 216), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 264), ('PROBLEM_COMPLICATION', 272), ('SUPERFICIAL_RELATIONSHIP', 304), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 325), ('FUTURE_WORK', 345)]	11	[('CHEBI_27300', 'vitamin D', 22, 'vitamin E'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 103, 'vitamin E'), ('GO_0065007', 'biological regulation', 135, 'modulate'), ('GO_0007567', 'parturition', 144, 'neonatal'), ('GO_0006955', 'immune response', 153, 'immune responses'), ('UBERON_0002405', 'immune system', 153, 'immune'), ('CHEBI_27300', 'vitamin D', 237, 'vitamin E'), ('CHEBI_27300', 'vitamin D', 368, 'vitamin E')]	0	['embarking  pregnancy  supplementation  neonatal immune responses,  supplementation, dietary increase  intake.']
S104-PMC3798907	PMC3798907	8/2013	S104-PMC3798907	['PREVIOUS work HAS REPORTED low maternal Vitamin E intake to be ASSOCIATED with increased Cbmc Proliferation to hdm and tg [13,16], encouraging the belief that the Nutrient has a direct EFFECT in Modulating neonatal T-Cell Responses.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 63), ('SUPERFICIAL_RELATIONSHIP', 185)]	4	[('CHEBI_27300', 'vitamin D', 40, 'vitamin E'), ('CL_0002062', 'type I pneumocyte', 89, 'CBMC'), ('GO_0070343', 'white fat cell proliferation', 89, 'CBMC proliferation'), ('CHEBI_33284', 'nutrient', 163, 'nutrient'), ('GO_0065007', 'biological regulation', 195, 'modulating'), ('CL_0000084', 'T cell', 215, 'T-cell'), ('GO_0001914', 'regulation of T cell mediated cytotoxicity', 215, 'T-cell responses')]	0	['previous maternal  intake cbmc proliferation hdm tg [13,16], nutrient  neonatal t-cell responses.']
S19-PMC3827489	PMC3827489	10/2013	S19-PMC3827489	['the vdr HAS also BEEN FOUND in Hematolymphopoietic Cells, and Vitamin D HAS BEEN SHOWN to Regulate Cell Differentiation and the production of interleukins and cytokines1,2).']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 22), ('INCOMPLETE_EVIDENCE', 72)]	3	[('CL_0000988', 'hematopoietic cell', 31, 'hematolymphopoietic cells'), ('GO_0030097', 'hemopoiesis', 31, 'hematolymphopoietic'), ('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0065007', 'biological regulation', 90, 'regulate'), ('GO_0030154', 'cell differentiation', 99, 'cell differentiation')]	0	['vdr hematolymphopoietic cells,   cell production interleukins cytokines1,2).']
S73-PMC3827489	PMC3827489	10/2013	S73-PMC3827489	['another RECENT STUDY SHOWED that lower Vitamin D levels in 86 children with SEVERE, therapy-resistant asthma in the united kingdom were ASSOCIATED with worsened asthma Control and Lung function49).']	[('INCOMPLETE_EVIDENCE', 8), ('INCOMPLETE_EVIDENCE', 21), ('IMPORTANT_CONSIDERATION', 76), ('SUPERFICIAL_RELATIONSHIP', 136)]	4	[('CHEBI_27300', 'vitamin D', 39, 'vitamin D'), ('GO_0065007', 'biological regulation', 168, 'control'), ('UBERON_0002048', 'lung', 180, 'lung')]	0	['another  levels 86 children severe, therapy-resistant asthma united kingdom worsened asthma  lung function49).']
S83-PMC3827489	PMC3827489	10/2013	S83-PMC3827489	['studies have SUGGESTED that Vitamin D MAY directly Regulate Insulin secretion by binding to Pancreatic Β-Cell vdrs59), and MAY indirectly AFFECT Pancreatic Β-Cell function by Regulating Extracellular calcium concentrations59); these data SUGGEST that low Vitamin D levels MAY BE ASSOCIATED with Insulin resistance.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 38), ('INCOMPLETE_EVIDENCE', 123), ('SUPERFICIAL_RELATIONSHIP', 138), ('INCOMPLETE_EVIDENCE', 238), ('INCOMPLETE_EVIDENCE', 272), ('SUPERFICIAL_RELATIONSHIP', 279)]	7	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('GO_0065007', 'biological regulation', 51, 'regulate'), ('PR_000045358', 'insulin family protein', 60, 'insulin'), ('CL_0000173', 'pancreatic D cell', 92, 'pancreatic β-cell'), ('UBERON_0001069', 'head of pancreas', 92, 'pancreatic β-'), ('CL_0000173', 'pancreatic D cell', 145, 'pancreatic β-cell'), ('UBERON_0001069', 'head of pancreas', 145, 'pancreatic β-'), ('GO_0065007', 'biological regulation', 175, 'regulating'), ('GO_0005576', 'extracellular region', 186, 'extracellular'), ('CHEBI_27300', 'vitamin D', 255, 'vitamin D'), ('PR_000045358', 'insulin family protein', 295, 'insulin')]	0	['studies   insulin secretion binding pancreatic β-cell vdrs59), pancreatic β-cell  extracellular calcium concentrations59);  levels insulin resistance.']
S148-PMC3926113	PMC3926113	1/2014	S148-PMC3926113	['Prenatal vitc deficiency in the guinea pig foetal Brain does not Modulate levels of Vitamin E, nt or Hne Protein modifications or Caspase-3 HOWEVER, increases sod activity as compensation ALTHOUGH this is not adequate to prevent increased Lipid peroxidation at the investigated time points.']	[('ANOMALY_CURIOUS_FINDING', 140), ('ANOMALY_CURIOUS_FINDING', 188)]	2	[('GO_0007565', 'female pregnancy', 0, 'Prenatal'), ('UBERON_0000955', 'brain', 50, 'brain'), ('GO_0065007', 'biological regulation', 65, 'modulate'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin E'), ('PR_000008653', 'hepatocyte nuclear factor 1-beta', 101, 'HNE'), ('GO_0000239', 'pachytene', 105, 'protein'), ('PR_000002319', 'catenin beta-1 isoform 1', 130, 'caspase-3'), ('CHEBI_18059', 'lipid', 239, 'lipid')]	0	['prenatal vitc guinea pig foetal brain  levels nt hne protein modifications caspase-3 however, sod activity compensation lipid peroxidation points.']
S193-PMC4045304	PMC4045304	2/2014	S193-PMC4045304	['OTHER mechanisms which MAY EXPLAIN the EFFECT of Vitamin D on autism symptoms are that Vitamin D MAY reduce the severity of autism through its anti-inflammatory actions, increasing T-Regulatory Cells, antiautoimmune effects, and upregulating Glutathione, a scavenger of oxidative byproducts [81–84].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 23), ('PROBABLE_UNDERSTANDING', 27), ('SUPERFICIAL_RELATIONSHIP', 39), ('INCOMPLETE_EVIDENCE', 97)]	5	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 87, 'vitamin D'), ('CL_0000901', 'Tr1 cell', 181, 'T-regulatory cells'), ('GO_0065007', 'biological regulation', 183, 'regulatory'), ('CHEBI_16856', 'glutathione', 242, 'glutathione')]	0	['mechanisms  autism symptoms  autism anti-inflammatory actions, t- cells, antiautoimmune effects, upregulating glutathione, scavenger oxidative byproducts [81–84].']
S274-PMC4045304	PMC4045304	2/2014	S274-PMC4045304	['PLAUSIBLE mechanisms HAVE BEEN put FORWARD to EXPLAIN the palliative ROLE of Vitamin D in children with autism via Dna Repair, anti-inflammatory actions, Autoimmune activities, and increase in Regulatory T Cells or stimulation antioxidant pathways.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 21), ('FUTURE_WORK', 35), ('PROBABLE_UNDERSTANDING', 46), ('SUPERFICIAL_RELATIONSHIP', 69)]	5	[('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('GO_0006281', 'DNA repair', 115, 'DNA repair'), ('UBERON_0001442', 'skeleton of manus', 154, 'autoimmune'), ('CL_0000815', 'regulatory T cell', 193, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 193, 'regulatory')]	0	['plausible mechanisms palliative  children autism via dna repair, anti-inflammatory actions, autoimmune activities, increase  cells stimulation antioxidant pathways.']
S22-PMC4072587	PMC4072587	6/2014	S22-PMC4072587	['more RECENTLY, maternal Vitamin D deficiency HAS BEEN ASSOCIATED with impaired infant Language Development in school-aged children[24], and HAS BEEN SUGGESTED as a possible environmental risk FACTOR for autism spectrum disorder, HIGHLIGHTING the IMPORTANT ROLE of Vitamin D in Brain Development, Neuronal function and Gene Regulation[10],[25],[26].']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 45), ('SUPERFICIAL_RELATIONSHIP', 54), ('INCOMPLETE_EVIDENCE', 140), ('SUPERFICIAL_RELATIONSHIP', 192), ('INCOMPLETE_EVIDENCE', 229), ('IMPORTANT_CONSIDERATION', 246), ('SUPERFICIAL_RELATIONSHIP', 256)]	8	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0060132', 'prolactin secreting cell development', 86, 'language development'), ('CHEBI_27300', 'vitamin D', 264, 'vitamin D'), ('GO_0007420', 'brain development', 277, 'brain development'), ('UBERON_0000955', 'brain', 277, 'brain'), ('CL_0000540', 'neuron', 296, 'neuronal'), ('SO_0000704', 'gene', 318, 'gene'), ('GO_0065007', 'biological regulation', 323, 'regulation')]	0	['recently, maternal  infant language school-aged children[24], environmental autism spectrum disorder,  brain development, neuronal gene [10],[25],[26].']
S122-PMC4072587	PMC4072587	6/2014	S122-PMC4072587	['the OBSERVED ASSOCIATION between Antenatal Vitamin D concentration and infant development is PLAUSIBLE AS Vitamin D has an IMPORTANT ROLE in Neurodevelopment through Cell Differentiation, cytokine Regulation, neurotransmitter synthesis and anti-oxidant activity, and it is HAS BEEN SUGGESTED that in utero exposure to Vitamin D deficiency during the second and third trimesters MAY AFFECT the development of the perisylvian structures, which are responsible for Language in children[24],[39].']	[('INCOMPLETE_EVIDENCE', 4), ('SUPERFICIAL_RELATIONSHIP', 13), ('INCOMPLETE_EVIDENCE', 93), ('PROBABLE_UNDERSTANDING', 103), ('IMPORTANT_CONSIDERATION', 123), ('SUPERFICIAL_RELATIONSHIP', 133), ('INCOMPLETE_EVIDENCE', 273), ('INCOMPLETE_EVIDENCE', 378), ('SUPERFICIAL_RELATIONSHIP', 382)]	9	[('GO_0007567', 'parturition', 33, 'antenatal'), ('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 106, 'vitamin D'), ('GO_0007399', 'nervous system development', 141, 'neurodevelopment'), ('GO_0030154', 'cell differentiation', 166, 'cell differentiation'), ('GO_0065007', 'biological regulation', 197, 'regulation'), ('CHEBI_27300', 'vitamin D', 318, 'vitamin D'), ('GO_0006266', 'DNA ligation', 462, 'language')]	0	['antenatal  concentration infant  neurodevelopment cell differentiation, cytokine neurotransmitter synthesis anti-oxidant activity, utero exposure  third trimesters perisylvian structures, language children[24],[39].']
S124-PMC4072587	PMC4072587	6/2014	S124-PMC4072587	['RECENT RESEARCH SUGGESTS that Vitamin D deficiency during Pregnancy or early childhood MAY BE an environmental TRIGGER for autism spectrum disorder in infants Genetically predisposed to autism, EITHER through its EFFECT on Neuronal function and Brain Development, or through Gene interaction and Regulation.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 111), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 194), ('SUPERFICIAL_RELATIONSHIP', 213)]	6	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0007565', 'female pregnancy', 58, 'pregnancy'), ('SO_0000704', 'gene', 159, 'genetically'), ('CL_0000540', 'neuron', 223, 'neuronal'), ('GO_0007420', 'brain development', 245, 'brain development'), ('UBERON_0000955', 'brain', 245, 'brain'), ('SO_0000704', 'gene', 275, 'gene'), ('GO_0065007', 'biological regulation', 296, 'regulation')]	0	['recent  pregnancy childhood environmental autism spectrum disorder infants genetically autism, neuronal brain development, gene .']
S36-PMC4106226	PMC4106226	7/2014	S36-PMC4106226	['OF INTEREST, asthmatic children had less exposure to sunlight and ate a diet less rich in Vitamin D. this MAY INDICATE that asthma Control MAY benefit from a healthier Life-style and a Vitamin D supplementation.']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 106), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 139)]	4	[('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('GO_0065007', 'biological regulation', 131, 'control'), ('UBERON_0000104', 'life cycle', 168, 'life'), ('CHEBI_27300', 'vitamin D', 185, 'vitamin D')]	0	['interest, asthmatic children exposure sunlight ate diet rich . asthma  healthier life-style  supplementation.']
S39-PMC4106226	PMC4106226	7/2014	S39-PMC4106226	['RECENT STUDIES SUGGEST that Vitamin D deficiency MAY increase the RISK of developing Autoimmune diseases including type 1 diabetes (t1dm), by Modulating the Immune and inflammatory reactions.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 49), ('IMPORTANT_CONSIDERATION', 66)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0001442', 'skeleton of manus', 85, 'autoimmune'), ('GO_0065007', 'biological regulation', 142, 'modulating'), ('UBERON_0002405', 'immune system', 157, 'immune')]	0	['recent  increase autoimmune diseases type diabetes (t1dm),  immune inflammatory reactions.']
S214-PMC4113768	PMC4113768	7/2014	S214-PMC4113768	['we THEREFORE AIMED TO DETERMINE WHETHER seasonal Vitamin D deficiency occurs in two healthy young Adult populations with moderate or dark skin pigmentation in cape town, WHETHER this had an EFFECT on the number and function of Circulating Blood Cells, their ability to Control to hiv-1 infection and WHETHER Vitamin D supplementation modifies the investigated responses.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 32), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 170), ('SUPERFICIAL_RELATIONSHIP', 190), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 300)]	7	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('UBERON_0007023', 'adult organism', 98, 'adult'), ('CL_0000080', 'circulating cell', 227, 'circulating'), ('CL_0000081', 'blood cell', 239, 'blood cells'), ('UBERON_0000178', 'blood', 239, 'blood'), ('GO_0065007', 'biological regulation', 269, 'control'), ('CHEBI_27300', 'vitamin D', 308, 'vitamin D')]	0	['seasonal  occurs healthy young adult populations dark skin pigmentation cape town, circulating blood cells, ability  hiv-1 infection  supplementation modifies responses.']
S377-PMC4113768	PMC4113768	7/2014	S377-PMC4113768	['background: INTERACTIONS between dietary Calcium and Vitamin D MAY have IMPLICATIONS for the Regulation of Serum 25-Hydroxy Vitamin D (25(Oh)D) and its Catabolism, and CONSEQUENTLY for the dietary REQUIREMENT for Vitamin D ((iom) institute of medicine.']	[('SUPERFICIAL_RELATIONSHIP', 12), ('INCOMPLETE_EVIDENCE', 63), ('IMPORTANT_CONSIDERATION', 72), ('SUPERFICIAL_RELATIONSHIP', 93), ('PROBABLE_UNDERSTANDING', 168), ('IMPORTANT_CONSIDERATION', 197)]	6	[('CHEBI_22313', 'alkaline earth metal atom', 41, 'calcium'), ('CHEBI_27300', 'vitamin D', 53, 'vitamin D'), ('GO_0065007', 'biological regulation', 93, 'regulation'), ('UBERON_0001977', 'blood serum', 107, 'serum'), ('CHEBI_43141', '3-hydroxypropoxy group', 113, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 124, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 135, '25(OH)D'), ('GO_0009056', 'catabolic process', 152, 'catabolism'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D')]	0	['background: dietary calcium   serum 25-hydroxy  (25(oh)d) catabolism, dietary  ((iom) institute medicine.']
S807-PMC4113768	PMC4113768	7/2014	S807-PMC4113768	['these transporters contain putative Vitamin D receptor response elements within their Promoters, SUGGESTING that amino acid transporters MAY BE Modulated by maternal Vitamin D status, a measure previously shown to RELATE to adiposity and bone health of the offspring.']	[('INCOMPLETE_EVIDENCE', 97), ('INCOMPLETE_EVIDENCE', 137), ('SUPERFICIAL_RELATIONSHIP', 214)]	3	[('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('SO_0000167', 'promoter', 86, 'promoters'), ('GO_0065007', 'biological regulation', 144, 'modulated'), ('CHEBI_27300', 'vitamin D', 166, 'vitamin D')]	0	['transporters contain  receptor response elements promoters, amino acid transporters  maternal  status, measure adiposity bone offspring.']
S1710-PMC4113768	PMC4113768	7/2014	S1710-PMC4113768	['we THEREFORE CONDUCTED a study TO DETERMINE the prevalence of Vitamin D deficiency in a cohort of Adults with asthma who were screened for participation in a clinical trial in london, uk, and TO IDENTIFY CORRELATES of poor asthma Control and low Vitamin D status in this population.']	[('PROBABLE_UNDERSTANDING', 3), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 31), ('QUESTION_ANSWERED_BY_THIS_WORK', 192), ('SUPERFICIAL_RELATIONSHIP', 204)]	5	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('UBERON_0007023', 'adult organism', 98, 'adults'), ('GO_0065007', 'biological regulation', 230, 'control'), ('CHEBI_27300', 'vitamin D', 246, 'vitamin D')]	0	[' adults asthma screened participation london, uk, asthma   status population.']
S1713-PMC4113768	PMC4113768	7/2014	S1713-PMC4113768	['multivariate logistic regression was performed TO IDENTIFY POTENTIAL DETERMINANTS of Vitamin D status and of six clinical MARKERS of asthma Control (asthma Control test score, british Thoracic society treatment step, number of exacerbations in preceding 12 months, % predicted fev1, exhaled Nitric Oxide concentration and degree of reversibility of Airway obstruction following administration of inhaled Salbutamol).']	[('QUESTION_ANSWERED_BY_THIS_WORK', 47), ('INCOMPLETE_EVIDENCE', 59), ('SUPERFICIAL_RELATIONSHIP', 69), ('SUPERFICIAL_RELATIONSHIP', 122)]	4	[('CHEBI_27300', 'vitamin D', 85, 'vitamin D'), ('GO_0065007', 'biological regulation', 140, 'control'), ('GO_0065007', 'biological regulation', 156, 'Control'), ('UBERON_0000915', 'thoracic segment of trunk', 184, 'Thoracic'), ('CHEBI_16480', 'nitric oxide', 291, 'nitric oxide'), ('UBERON_0001005', 'respiratory airway', 349, 'airway'), ('CHEBI_66163', 'samaderine Y', 404, 'salbutamol')]	0	['multivariate logistic regression  status six asthma  (asthma  score, british thoracic society treatment step, exacerbations preceding 12 months, % fev1, exhaled nitric oxide concentration degree reversibility airway obstruction following administration inhaled salbutamol).']
S2051-PMC4113768	PMC4113768	7/2014	S2051-PMC4113768	['evaluation of Vitamin D status in RELATION to Immune Response in children with Lower Respiratory Tract infections\n\ngori, m.; vierucci, f.; fanos, m.; del pistoia, m.; erba, p.; saggese, g.\nbackground: in addition to its KNOWN Skeletal EFFECTS, Vitamin D plays a ROLE in the Regulation of Immune Response.']	[('SUPERFICIAL_RELATIONSHIP', 34), ('INCOMPLETE_EVIDENCE', 220), ('SUPERFICIAL_RELATIONSHIP', 235), ('SUPERFICIAL_RELATIONSHIP', 262)]	4	[('CHEBI_28384', 'vitamin K', 14, 'Vitamin D'), ('GO_0006955', 'immune response', 46, 'Immune Response'), ('UBERON_0009567', 'nail of pedal digit', 79, 'Lower'), ('UBERON_0000061', 'anatomical structure', 85, 'Respiratory Tract'), ('UBERON_0004288', 'skeleton', 226, 'skeletal'), ('CHEBI_27300', 'vitamin D', 244, 'vitamin D'), ('GO_0065007', 'biological regulation', 274, 'regulation'), ('GO_0006955', 'immune response', 288, 'immune response'), ('UBERON_0002405', 'immune system', 288, 'immune')]	0	['evaluation vitamin status immune response children respiratory tract infections\n\ngori, m.; vierucci, f.; fanos, m.; del pistoia, m.; erba, p.; saggese, g.\nbackground: addition skeletal effects,  plays  immune response.']
S2543-PMC4113768	PMC4113768	7/2014	S2543-PMC4113768	['background: AS Vitamin D is ESSENTIAL to calcium Regulation, the concern HAS BEEN RAISED that high levels of Vitamin D MAY lead TO hypercalcemia (Plasma levels exceeding 2.6 mmol/l) that, in turn, MAY increase the RISK of adverse health events such as Cardiac arrest, Renal failure, and Hepatic injuries.']	[('PROBABLE_UNDERSTANDING', 12), ('IMPORTANT_CONSIDERATION', 28), ('SUPERFICIAL_RELATIONSHIP', 49), ('INCOMPLETE_EVIDENCE', 73), ('EXPLICIT_QUESTION', 82), ('INCOMPLETE_EVIDENCE', 119), ('QUESTION_ANSWERED_BY_THIS_WORK', 128), ('INCOMPLETE_EVIDENCE', 197), ('IMPORTANT_CONSIDERATION', 214)]	9	[('CHEBI_27300', 'vitamin D', 15, 'vitamin D'), ('GO_0065007', 'biological regulation', 49, 'regulation'), ('CHEBI_28384', 'vitamin K', 109, 'Vitamin D'), ('UBERON_0001969', 'blood plasma', 146, 'plasma'), ('UBERON_0000948', 'heart', 252, 'cardiac'), ('UBERON_0002113', 'kidney', 268, 'renal'), ('UBERON_0002107', 'liver', 287, 'hepatic')]	0	['background:  calcium levels vitamin hypercalcemia (plasma levels exceeding 2.6 mmol/l) that, turn, increase events cardiac arrest, renal failure, hepatic injuries.']
S3209-PMC4113768	PMC4113768	7/2014	S3209-PMC4113768	['25-Hydroxy Vitamin D3(25(Oh)D3) Modulates Innate Immunity and RECENT EVIDENCE HIGHLIGHTS ASSOCIATIONS between Vitamin D deficiency and several Respiratory illnesses.']	[('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 78), ('SUPERFICIAL_RELATIONSHIP', 89)]	3	[('CHEBI_43141', '3-hydroxypropoxy group', 0, '25-hydroxy'), ('CHEBI_33279', 'vitamin D5', 11, 'vitamin D3'), ('PR_000017299', 'VIP peptides', 11, 'vitamin D3'), ('CHEBI_62946', 'ammonium sulfate', 22, '25(OH)D3'), ('GO_0065007', 'biological regulation', 32, 'modulates'), ('GO_0045087', 'innate immune response', 42, 'innate immunity'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 143, 'respiratory')]	0	['25-hydroxy vitamin d3(25(oh)d3)  innate immunity  respiratory illnesses.']
S217-PMC4161853	PMC4161853	8/2014	S217-PMC4161853	['moreover, Gestational Vitamin A deficiency in Animal models HAS BEEN SHOWN to reduce the Intestinal Immune Response by decreasing the number of Immune Cells in Rat offspring [119] and Controlling the size of Secondary Lymph Organ and the efficiency of Immune Responses in the Adult Mouse offspring [120].']	[('INCOMPLETE_EVIDENCE', 60)]	1	[('GO_0007565', 'female pregnancy', 10, 'gestational'), ('CHEBI_27300', 'vitamin D', 22, 'vitamin A'), ('NCBITaxon_33208', 'Metazoa', 46, 'animal'), ('UBERON_0000160', 'intestine', 89, 'intestinal'), ('GO_0006955', 'immune response', 100, 'immune response'), ('UBERON_0002405', 'immune system', 100, 'immune'), ('CL_0000738', 'leukocyte', 144, 'immune cells'), ('UBERON_0002405', 'immune system', 144, 'immune'), ('NCBITaxon_9986', 'Oryctolagus cuniculus', 160, 'rat'), ('GO_0065007', 'biological regulation', 184, 'controlling'), ('UBERON_0005174', 'dorsal region element', 208, 'secondary lymph organ'), ('GO_0006955', 'immune response', 252, 'immune responses'), ('UBERON_0002405', 'immune system', 252, 'immune'), ('UBERON_0007023', 'adult organism', 276, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 282, 'mouse')]	0	['moreover, gestational  animal intestinal immune response decreasing immune cells rat offspring [119]  secondary lymph organ efficiency immune responses adult mouse offspring [120].']
S148-PMC4161944	PMC4161944	9/2014	S148-PMC4161944	['full reviews on Micronutrient malnutrition and immunity can be found elsewhere (114–116) and ONLY select Micronutrients (Selenium, zinc, and Vitamin A) known to Modulate Immunity are highlighted HERE.']	[('INCOMPLETE_EVIDENCE', 93), ('QUESTION_ANSWERED_BY_THIS_WORK', 195)]	2	[('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 16, 'micronutrient'), ('CHEBI_33839', 'macromolecule', 105, 'micronutrients'), ('CHEBI_27568', 'selenium atom', 121, 'selenium'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin A'), ('GO_0065007', 'biological regulation', 161, 'modulate'), ('GO_0007566', 'embryo implantation', 170, 'immunity')]	0	['full micronutrient malnutrition immunity (114–116) select micronutrients (selenium, zinc,  immunity here.']
S101-PMC4251419	PMC4251419	12/2014	S101-PMC4251419	['ALTERNATIVELY, microbiome changes, like those induced following the use of Probiotics, MAY Regulate the responsiveness of Immune Cells to Vitamin D by enhancing the Expression of the Vitamin D receptor (vdr) THUS reducing Tissue inflammation.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 87), ('PROBABLE_UNDERSTANDING', 208)]	3	[('CHEBI_26346', 'prostaglandins J', 75, 'probiotics'), ('GO_0065007', 'biological regulation', 91, 'regulate'), ('CL_0000738', 'leukocyte', 122, 'immune cells'), ('UBERON_0002405', 'immune system', 122, 'immune'), ('GO_0007567', 'parturition', 129, 'cells'), ('CHEBI_27300', 'vitamin D', 138, 'vitamin D'), ('GO_0010467', 'gene expression', 165, 'expression'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D'), ('UBERON_0000479', 'tissue', 222, 'tissue')]	0	['alternatively, microbiome changes, induced following probiotics,  responsiveness immune cells  expression  receptor (vdr) reducing tissue inflammation.']
S110-PMC4251419	PMC4251419	12/2014	S110-PMC4251419	['collectively, these studies SUGGEST that Vitamin D is instrumental in Regulating the microbiome of the Lungs and Gut, and is ENTWINED with the maintenance of Immune tolerance.']	[('INCOMPLETE_EVIDENCE', 28), ('SUPERFICIAL_RELATIONSHIP', 125)]	2	[('CHEBI_27300', 'vitamin D', 41, 'vitamin D'), ('GO_0065007', 'biological regulation', 70, 'regulating'), ('UBERON_0002048', 'lung', 103, 'lungs'), ('UBERON_0001555', 'digestive tract', 113, 'gut'), ('UBERON_0002405', 'immune system', 158, 'immune')]	0	['collectively,   microbiome lungs gut, maintenance immune tolerance.']
S116-PMC4251419	PMC4251419	12/2014	S116-PMC4251419	['we ANTICIPATE that a deeper understanding of HOW Vitamin D Modulates the microbiomes of the skin and other Tissues will come through ONGOING Vitamin D supplementation trials [74].']	[('IMPORTANT_CONSIDERATION', 3), ('IMPORTANT_CONSIDERATION', 3), ('EXPLICIT_QUESTION', 45), ('IMPORTANT_CONSIDERATION', 133)]	4	[('CHEBI_27300', 'vitamin D', 49, 'vitamin D'), ('GO_0065007', 'biological regulation', 59, 'modulates'), ('UBERON_0000479', 'tissue', 107, 'tissues'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D')]	0	['deeper   microbiomes skin tissues come  supplementation [74].']
S117-PMC4251419	PMC4251419	12/2014	S117-PMC4251419	['other studies SUGGEST that the microbiome MAY modify the capacity of Tissue Regulation by Vitamin D. in Rodent MODELS, Probiotics CAN upregulate Expression of the vdr in the Colon, reducing inflammation and delaying the transition to dysplasia and cancer [75].']	[('INCOMPLETE_EVIDENCE', 14), ('INCOMPLETE_EVIDENCE', 42), ('SUPERFICIAL_RELATIONSHIP', 76), ('INCOMPLETE_EVIDENCE', 111), ('INCOMPLETE_EVIDENCE', 130)]	5	[('UBERON_0000479', 'tissue', 69, 'tissue'), ('GO_0065007', 'biological regulation', 76, 'regulation'), ('CHEBI_27300', 'vitamin D', 90, 'vitamin D'), ('NCBITaxon_33208', 'Metazoa', 104, 'rodent'), ('CHEBI_26346', 'prostaglandins J', 119, 'probiotics'), ('GO_0010467', 'gene expression', 145, 'expression'), ('UBERON_0001155', 'colon', 174, 'colon')]	0	['microbiome capacity tissue  . rodent models, probiotics upregulate expression vdr colon, reducing inflammation delaying transition dysplasia cancer [75].']
S120-PMC4251419	PMC4251419	12/2014	S120-PMC4251419	['these data SUGGEST that NOT ONLY can Vitamin D Modulate Tissue inflammation through modifications to the microbiome, BUT the reverse is also POSSIBLE—the microbiome and inflammation can change the responsiveness of Tissues to Vitamin D through Regulation of the vdr.']	[('INCOMPLETE_EVIDENCE', 11), ('ANOMALY_CURIOUS_FINDING', 24), ('INCOMPLETE_EVIDENCE', 141)]	3	[('CHEBI_27300', 'vitamin D', 37, 'vitamin D'), ('GO_0065007', 'biological regulation', 47, 'modulate'), ('UBERON_0000479', 'tissue', 56, 'tissue'), ('UBERON_0000479', 'tissue', 215, 'tissues'), ('CHEBI_27300', 'vitamin D', 226, 'vitamin D'), ('GO_0065007', 'biological regulation', 244, 'regulation')]	0	['  tissue inflammation modifications microbiome, possible—the microbiome inflammation responsiveness tissues   vdr.']
S296-PMC4258799	PMC4258799	11/2014	S296-PMC4258799	['rcts and prospective studies CONCUR that oral supplementation of Vitamin E reduces Lipid Peroxidation damage [102,150], improves Sperm Motility [102,103] and function [101] as well as improve Fertilization [150] and Pregnancy rates [102,103].']	[('INCOMPLETE_EVIDENCE', 29)]	1	[('CHEBI_27300', 'vitamin D', 65, 'vitamin E'), ('CHEBI_18059', 'lipid', 83, 'lipid'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 89, 'peroxidation'), ('CL_0000019', 'sperm', 129, 'sperm'), ('GO_0065007', 'biological regulation', 135, 'motility'), ('GO_0009566', 'fertilization', 192, 'fertilization'), ('GO_0007565', 'female pregnancy', 216, 'pregnancy')]	0	['rcts oral supplementation  reduces lipid peroxidation [102,150], sperm  [102,103] [101] fertilization [150] pregnancy rates [102,103].']
S299-PMC4258799	PMC4258799	11/2014	S299-PMC4258799	['in women with unexplained infertility, oral Vitamin E intake improved the Endometrial response, POSSIBLY DUE TO its antioxidant and anticoagulant EFFECTS as well as by Modulating the anti-Estrogenic EFFECT of Clomiphene Citrate.']	[('INCOMPLETE_EVIDENCE', 96), ('PROBABLE_UNDERSTANDING', 105), ('SUPERFICIAL_RELATIONSHIP', 146), ('SUPERFICIAL_RELATIONSHIP', 199)]	4	[('CHEBI_27300', 'vitamin D', 44, 'vitamin E'), ('UBERON_0001983', 'crypt of Lieberkuhn', 74, 'endometrial'), ('GO_0065007', 'biological regulation', 168, 'modulating'), ('CHEBI_59715', 'sodium squarate', 188, 'estrogenic'), ('CHEBI_3753', 'clomiphene citrate', 209, 'clomiphene citrate')]	0	['women infertility, oral  intake endometrial response, antioxidant anticoagulant  anti-estrogenic clomiphene citrate.']
S185-PMC4277121	PMC4277121	12/2015	S185-PMC4277121	['antioxidants\noxidative stress and Mitochondrial dysfunction are both CONSIDERED hallmarks of ds Tissues and CONTRIBUTORS to Neurological phenotypes across the ds Lifespan.1,91cortical Neurons derived from ds fetal Brains show elevated levels of Reactive Oxygen Species, and survival is enhanced by treatment with Antioxidants.92several Hsa21 Genes, among them Sod1 , Bach1 , ets2 , and S100B , are KNOWN to CONTRIBUTE to the Regulation of oxidative stress when Overexpressed.9CONSISTENT with these OBSERVATIONS, it was SHOWN that levels of oxidative stress are elevated in the Brains of Adult ts65dn, and when male ts65dn Mice were Fed a diet high in Vitamin E (0.4 g per kg) from the age of 4 months to ~8 months and 10 months, the levels of oxidative stress were decreased.93performance in the Wram was improved at 8 months, and at 10 months; loss of the Trka receptor in the Bfcn had been PREVENTED.']	[('INCOMPLETE_EVIDENCE', 69), ('SUPERFICIAL_RELATIONSHIP', 108), ('INCOMPLETE_EVIDENCE', 398), ('SUPERFICIAL_RELATIONSHIP', 407), ('SUPERFICIAL_RELATIONSHIP', 425), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('ANOMALY_CURIOUS_FINDING', 475), ('INCOMPLETE_EVIDENCE', 498), ('INCOMPLETE_EVIDENCE', 519), ('SUPERFICIAL_RELATIONSHIP', 892)]	11	[('GO_0005739', 'mitochondrion', 34, 'mitochondrial'), ('UBERON_0000479', 'tissue', 96, 'tissues'), ('UBERON_0001016', 'nervous system', 124, 'neurological'), ('UBERON_0000104', 'life cycle', 162, 'lifespan'), ('CL_0000540', 'neuron', 184, 'neurons'), ('UBERON_0000955', 'brain', 214, 'brains'), ('CHEBI_26523', 'reactive oxygen species', 245, 'reactive oxygen species'), ('CHEBI_60641', 'methyl 5-aminolevulinate hydrochloride', 313, 'antioxidants'), ('PR_000008820', 'heat shock protein beta-8', 336, 'Hsa21'), ('SO_0000704', 'gene', 342, 'genes'), ('PR_000015399', 'superoxide dismutase [Cu-Zn]', 360, 'SOD1'), ('PR_000004633', 'brain-specific angiogenesis inhibitor 1-associated protein 2-like protein 1', 367, 'BACH1'), ('PR_000014404', 'protein S100-A11', 386, 'S100B'), ('GO_0065007', 'biological regulation', 425, 'regulation'), ('GO_0003054', 'circadian regulation of systemic arterial blood pressure by the suprachiasmatic nucleus', 461, 'overexpressed'), ('UBERON_0000955', 'brain', 577, 'brains'), ('UBERON_0007023', 'adult organism', 587, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 622, 'mice'), ('GO_0007631', 'feeding behavior', 632, 'fed'), ('CHEBI_27300', 'vitamin D', 651, 'vitamin E'), ('PR_000001067', 'transient receptor potential cation channel TRPV1 isoform 1', 796, 'WRAM'), ('PR_000000123', 'ribosomal protein S6 kinase beta-1', 857, 'TRKA'), ('UBERON_0001943', 'midbrain tegmentum', 878, 'BFCN')]	0	['antioxidants\noxidative mitochondrial dysfunction hallmarks ds tissues neurological phenotypes ds lifespan.1,91cortical neurons ds fetal brains elevated levels reactive oxygen species, survival treatment antioxidants.92several hsa21 genes, among sod1 bach1 ets2 s100b  oxidative overexpressed.9consistent observations, levels oxidative elevated brains adult ts65dn, male ts65dn mice fed diet  (0.4 g kg) age 4 months ~8 months 10 months, levels oxidative decreased.93performance wram 8 months, 10 months; loss trka receptor bfcn prevented.']
S175-PMC4302429	PMC4302429	1/2015	S175-PMC4302429	['we THEREFORE ASKED WHETHER Vitamin D MIGHT Modulate the course of and survival from infection after bacterial meningoencephalitis and WHETHER Vitamin D COULD POTENTIALLY be used therapeutically to alleviate Cns pathology.']	[('PROBABLE_UNDERSTANDING', 3), ('EXPLICIT_QUESTION', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 19), ('INCOMPLETE_EVIDENCE', 37), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 134), ('EXPLICIT_QUESTION', 134), ('INCOMPLETE_EVIDENCE', 152), ('INCOMPLETE_EVIDENCE', 158)]	9	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0065007', 'biological regulation', 43, 'modulate'), ('CHEBI_27300', 'vitamin D', 142, 'vitamin D'), ('UBERON_0001017', 'central nervous system', 207, 'CNS')]	0	['  course survival infection bacterial meningoencephalitis  therapeutically alleviate cns pathology.']
S193-PMC4302429	PMC4302429	1/2015	S193-PMC4302429	['OTHER mechanisms COULD BE the Regulation of Anti- and proinflammatory Compounds by Vitamin D. for this PURPOSE, we INVESTIGATED the pattern of cytokine and Chemokine Production, a central feature in the development of Neuroinflammation, neurodegeneration, and demyelination in the Cns [46,47].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 30), ('QUESTION_ANSWERED_BY_THIS_WORK', 103), ('QUESTION_ANSWERED_BY_THIS_WORK', 115)]	5	[('GO_0065007', 'biological regulation', 30, 'regulation'), ('CHEBI_67437', 'Euparin', 44, 'anti-'), ('CHEBI_36357', 'polyatomic entity', 70, 'compounds'), ('CHEBI_27300', 'vitamin D', 83, 'vitamin D'), ('GO_0032602', 'chemokine production', 156, 'chemokine production'), ('GO_0007009', 'plasma membrane organization', 218, 'neuroinflammation'), ('UBERON_0001017', 'central nervous system', 281, 'CNS')]	0	['mechanisms  anti- proinflammatory compounds . purpose, cytokine chemokine production, central neuroinflammation, neurodegeneration, demyelination cns [46,47].']
S210-PMC4302429	PMC4302429	1/2015	S210-PMC4302429	['high-dose Vitamin D MAY BE able to Modulate the inflammatory response to Cns infections.']	[('INCOMPLETE_EVIDENCE', 20)]	1	[('CHEBI_27300', 'vitamin D', 10, 'vitamin D'), ('GO_0065007', 'biological regulation', 35, 'modulate'), ('UBERON_0001017', 'central nervous system', 73, 'CNS')]	0	['high-dose  able  inflammatory response cns infections.']
S2-PMC4303849	PMC4303849	1/2015	S2-PMC4303849	['THEREFORE, factors that Regulate Vitamin D Metabolism are of main IMPORTANCE, especially during Pregnancy.']	[('PROBABLE_UNDERSTANDING', 0), ('IMPORTANT_CONSIDERATION', 66)]	2	[('GO_0065007', 'biological regulation', 24, 'regulate'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 33, 'vitamin D metabolism'), ('GO_0007565', 'female pregnancy', 96, 'pregnancy')]	0	['therefore,   metabolism main importance, pregnancy.']
S133-PMC4303849	PMC4303849	1/2015	S133-PMC4303849	['25Ohd values lesser than 50 nmol/l MAY sustain long-term adverse health consequences and are classified as “deficiency.” the 75 nmol/l cut-off is the point above which there is no upper stimulation of pth [102] and was thereafter designated as “sufficient.” HOWEVER, heaney POINTED out that 25Ohd concentrations < 80 nmol/l are ASSOCIATED with reduced calcium absorption and osteoporosis risk [103]; therefore, values lesser than 75 nmol/l are considered AS “insufficient.” the conversion factor between 25Ohd nmol/l and ng/ml is 2.5 (table 2).nutrients-07-00443-t001_table 1\n\ncaption (table-wrap): table 1\n\ntargets Modulated by Calcitriol in the Human Placenta (+ = stimulation; − = inhibition).targetbiological networkregulationbioeffectcell typereferenceplacental Lactogencell Life and death+growth controltrophoblast[97]Tnf-Αimmune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Il-6Immune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]Csf2 (Colony Stimulating Factor 2)immune function−immunosupressiondecidual Cells[89]hctdimmune function+restraining infectiontrophoblast[90]Decidual Cells[89]Cyp24A1Bone and Mineral Metabolism+Calcitriol Catabolismtrophoblast[12]Decidual Cells[104]Cyp27B1Bone and Mineral Metabolism−Calcitriol synthesistrophoblast[12]Il-10 (Interleukin 10)immune function−reducing risk of infectiontrophoblast[105]Kcnh1 (potassium voltage-Gated channel)Cell Life and Death−unknowntrophoblast[106]Calbindin-D 28 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61,62]Calbindin-D 9 kdabone and Mineral Metabolism+Calcium transfertrophoblast[61]hcg (Human Chorionic Gonadotrophin)Cell Life and Death+, −maintenance of Pregnancytrophoblast[96]3β-hsd (3Β-Hydroxysteroid dehydrogenase) *Cell Life and Death+Progesterone Synthesistrophoblast[95]Cyp19 (aromatase) *Cell Life and Death+Estradiol Synthesistrophoblast[95]Prolactincell Life and Death+Establishment Of Pregnancydecidual Cells[107]Vdrbone and Mineral Metabolism+allowing Calcitriol actionstrophoblast[62]Platelet-Activating factor acetylhydrolasecell life and Death−inactivation of Platelet-Activating factordecidual Macrophages[108]Hoxa10 (Homeobox A10)Cell Life and Death+Embryo Implantationdecidual cells[109]Osteopontinbone and Mineral Metabolism+Embryo Implantationdecidual Cells[104]Hbd2Immune function+restraining infectiontrophoblast[93]Hbd3Immune function+restraining infectiontrophoblast[93]\n* only observed at the enzyme activity level.nutrients-07-00443-t002_table 2\n\ncaption (table-wrap): table 2\n\ncut-offs in Vitamin D status according to the Endocrine society [110].Vitamin D status25ohd (nmol/l)25Ohd (ng/ml)severe deficiency<25<10deficiency<50<20insufficiency<75<30sufficiency75–11030–44toxicity>250>100\ntable 2shows the criteria for vd status as PROPOSED by the Endocrine society.']	[('INCOMPLETE_EVIDENCE', 35), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 258), ('INCOMPLETE_EVIDENCE', 274), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBABLE_UNDERSTANDING', 455), ('INCOMPLETE_EVIDENCE', 2831)]	6	[('CHEBI_72652', '7,2*-dihydroxy-4*-methoxyisoflavan-4-ylium cation', 0, '25OHD'), ('CHEBI_72652', '7,2*-dihydroxy-4*-methoxyisoflavan-4-ylium cation', 291, '25OHD'), ('CHEBI_72652', '7,2*-dihydroxy-4*-methoxyisoflavan-4-ylium cation', 504, '25OHD'), ('GO_0065007', 'biological regulation', 616, 'modulated'), ('CHEBI_17823', 'calcitriol', 629, 'calcitriol'), ('NCBITaxon_9606', 'Homo sapiens', 647, 'human'), ('UBERON_0001987', 'placenta', 653, 'placenta'), ('CHEBI_35417', 'alpha-amino-acid residue radical', 767, 'lactogenCell'), ('PR_000009797', 'LIM/homeobox protein Lhx9', 767, 'lactogenCell'), ('UBERON_0000104', 'life cycle', 780, 'life'), ('PR_000000045', 'S-phase kinase-associated protein 1A', 824, 'TNF-αImmune'), ('PR_000008988', 'interleukin-1 family member 5', 922, 'IL-6Immune'), ('PR_000005890', 'crooked neck-like protein 1', 1019, 'CSF2'), ('PR_000005528', 'chloride channel protein, skeletal muscle', 1025, 'colony stimulating factor 2'), ('CL_0000573', 'retinal cone cell', 1094, 'cells'), ('CL_0000635', 'Deiter*s cell', 1159, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1177, 'CYP24A1Bone'), ('CHEBI_46662', 'mineral', 1193, 'mineral'), ('GO_0008152', 'metabolic process', 1201, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1212, 'Calcitriol'), ('GO_0019065', 'receptor-mediated endocytosis of virus by host cell', 1212, 'Calcitriol catabolismTrophoblast'), ('CL_0000635', 'Deiter*s cell', 1248, 'Decidual cells'), ('PR_000006081', 'NADH-cytochrome b5 reductase 2', 1267, 'CYP27B1Bone'), ('CHEBI_46662', 'mineral', 1283, 'mineral'), ('GO_0008152', 'metabolic process', 1291, 'metabolism'), ('CHEBI_17823', 'calcitriol', 1302, 'Calcitriol'), ('PR_000001470', 'interleukin-28B', 1337, 'IL-10'), ('PR_000001470', 'interleukin-28B', 1344, 'Interleukin 10'), ('PR_000000793', 'voltage-gated potassium channel KCNH4', 1417, 'KCNH1'), ('PR_000004587', 'beta-1,3-galactosyltransferase 6', 1441, '-gated'), ('GO_0008219', 'cell death', 1456, 'Cell life ... death'), ('PR_000004968', 'calretinin', 1499, 'Calbindin-D 28'), ('CHEBI_46662', 'mineral', 1526, 'mineral'), ('GO_0008152', 'metabolic process', 1534, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1545, 'Calcium'), ('PR_000004998', 'calmodulin-regulated spectrin-associated protein 1', 1579, 'Calbindin-D'), ('CHEBI_46662', 'mineral', 1605, 'mineral'), ('GO_0008152', 'metabolic process', 1613, 'metabolism'), ('CHEBI_31341', 'calcium dihydroxide', 1624, 'Calcium'), ('NCBITaxon_9606', 'Homo sapiens', 1660, 'human'), ('PR_000005170', 'CD37 molecule', 1666, 'chorionic gonadotrophin'), ('UBERON_0003124', 'chorion', 1666, 'chorionic'), ('GO_0008219', 'cell death', 1690, 'Cell life ... death'), ('GO_0006412', 'translation', 1728, 'pregnancyTrophoblast'), ('CHEBI_36864', '25-hydroxy steroid', 1760, '3β-hydroxysteroid'), ('GO_0008219', 'cell death', 1794, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1799, 'life'), ('CHEBI_17026', 'progesterone', 1814, 'Progesterone'), ('GO_0072598', 'protein localization to chloroplast', 1814, 'Progesterone synthesisTrophoblast'), ('PR_000006100', 'aromatase', 1851, 'CYP19'), ('GO_0008219', 'cell death', 1870, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 1875, 'life'), ('CHEBI_4856', 'esmolol', 1890, 'Estradiol'), ('GO_0072596', 'establishment of protein localization to chloroplast', 1890, 'Estradiol synthesisTrophoblast'), ('PR_000013039', 'POU domain, class 3, transcription factor 2', 1924, 'ProlactinCell'), ('GO_0006266', 'DNA ligation', 1938, 'life ... death'), ('GO_0006884', 'cell volume homeostasis', 1953, 'Establishment of pregnancyDecidual cells'), ('CL_0000573', 'retinal cone cell', 1988, 'cells'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 1998, 'VDRBone'), ('CHEBI_46662', 'mineral', 2010, 'mineral'), ('GO_0008152', 'metabolic process', 2018, 'metabolism'), ('CHEBI_17823', 'calcitriol', 2038, 'calcitriol'), ('CL_0000233', 'platelet', 2071, 'Platelet'), ('GO_0030168', 'platelet activation', 2071, 'Platelet-activating'), ('GO_0007608', 'sensory perception of smell', 2127, '... death'), ('CL_0000233', 'platelet', 2149, 'platelet'), ('GO_0030168', 'platelet activation', 2149, 'platelet-activating'), ('CL_0000235', 'macrophage', 2184, 'macrophages'), ('PR_000008689', 'homeobox protein Hox-A13', 2200, 'HOXA10'), ('PR_000008469', 'holocytochrome c-type synthase', 2208, 'Homeobox A10'), ('GO_0008219', 'cell death', 2221, 'Cell life ... death'), ('UBERON_0000104', 'life cycle', 2226, 'life'), ('GO_0007601', 'visual perception', 2241, 'Embryo'), ('UBERON_0000922', 'embryo', 2241, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2248, 'implantationDecidual'), ('PR_000021995', 'dual specificity mitogen-activated protein kinase kinase 4 phosphorylated form', 2279, 'OsteopontinBone'), ('CHEBI_46662', 'mineral', 2299, 'mineral'), ('GO_0008152', 'metabolic process', 2307, 'metabolism'), ('UBERON_0000922', 'embryo', 2318, 'Embryo'), ('GO_0007446', 'imaginal disc growth', 2325, 'implantationDecidual'), ('CL_0000573', 'retinal cone cell', 2346, 'cells'), ('PR_000000035', 'BMP receptor type-1A', 2356, 'HBD2Immune'), ('PR_000000035', 'BMP receptor type-1A', 2412, 'HBD3Immune'), ('CHEBI_27300', 'vitamin D', 2590, 'vitamin D'), ('UBERON_0005063', 'left ventricular compact myocardium', 2624, 'Endocrine'), ('CHEBI_28384', 'vitamin K', 2648, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 2648, 'Vitamin'), ('CHEBI_72652', '7,2*-dihydroxy-4*-methoxyisoflavan-4-ylium cation', 2678, '25OHD'), ('UBERON_0005063', 'left ventricular compact myocardium', 2847, 'Endocrine')]	0	['25ohd values lesser 50 nmol/l sustain long-term “deficiency.” 75 nmol/l cut-off upper stimulation pth [102] thereafter designated “sufficient.” however, heaney 25ohd concentrations 80 nmol/l calcium absorption osteoporosis [103]; therefore, values lesser 75 nmol/l “insufficient.” conversion 25ohd nmol/l ng/ml 2.5 (table 2).nutrients-07-00443-t001_table 1\n\ncaption (table-wrap): table 1\n\ntargets  calcitriol human placenta (+ = stimulation; − = inhibition).targetbiological networkregulationbioeffectcell typereferenceplacental lactogencell life death+growth controltrophoblast[97]tnf-αimmune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]il-6immune function−restraining inflammationtrophoblast[91,92]−immunosupressiondecidual cells[89]csf2 (colony 2)immune function−immunosupressiondecidual cells[89]hctdimmune function+restraining infectiontrophoblast[90]decidual cells[89]cyp24a1bone mineral metabolism+calcitriol catabolismtrophoblast[12]decidual cells[104]cyp27b1bone mineral metabolism−calcitriol synthesistrophoblast[12]il-10 (interleukin 10)immune function−reducing infectiontrophoblast[105]kcnh1 (potassium voltage-gated channel)cell life death−unknowntrophoblast[106]calbindin-d 28 kdabone mineral metabolism+calcium transfertrophoblast[61,62]calbindin-d 9 kdabone mineral metabolism+calcium transfertrophoblast[61]hcg (human chorionic gonadotrophin)cell life death+, −maintenance pregnancytrophoblast[96]3β-hsd (3β-hydroxysteroid dehydrogenase) *cell life death+progesterone synthesistrophoblast[95]cyp19 (aromatase) *cell life death+estradiol synthesistrophoblast[95]prolactincell life death+establishment pregnancydecidual cells[107]vdrbone mineral metabolism+allowing calcitriol actionstrophoblast[62]platelet-activating acetylhydrolasecell life death−inactivation platelet-activating factordecidual macrophages[108]hoxa10 (homeobox a10)cell life death+embryo implantationdecidual cells[109]osteopontinbone mineral metabolism+embryo implantationdecidual cells[104]hbd2immune function+restraining infectiontrophoblast[93]hbd3immune function+restraining infectiontrophoblast[93]\n* enzyme activity level.nutrients-07-00443-t002_table 2\n\ncaption (table-wrap): table 2\n\ncut-offs  status endocrine society [110].vitamin status25ohd (nmol/l)25ohd (ng/ml)severe deficiency<25<10deficiency<50<20insufficiency<75<30sufficiency75–11030–44toxicity>250>100\ntable criteria vd status endocrine society.']
S8-PMC4329404	PMC4329404	10/2014	S8-PMC4329404	['conclusion\nperi-natal Vitamin D deficiency ALONE has immunomodulatory EFFECTS including th2 skewing and reduced Il-10-Secreting T Regulatory Cells, exaggerated with additional Allergen exposure.']	[('ANOMALY_CURIOUS_FINDING', 43), ('SUPERFICIAL_RELATIONSHIP', 70)]	2	[('CHEBI_27300', 'vitamin D', 22, 'vitamin D'), ('PR_000001470', 'interleukin-28B', 112, 'IL-10'), ('CL_0000595', 'enucleate erythrocyte', 118, 'secreting'), ('GO_0046903', 'secretion', 118, 'secreting'), ('CL_0000902', 'induced T-regulatory cell', 128, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 130, 'regulatory'), ('CHEBI_50904', 'allergen', 176, 'allergen')]	0	['conclusion\nperi-natal  immunomodulatory th2 skewing il-10-secreting  cells, allergen exposure.']
S26-PMC4329404	PMC4329404	10/2014	S26-PMC4329404	['the ROLE of Vitamin D as an immunomodulator is BETTER DEFINED, with Vitamin D skewing the Immune System towards Regulation.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('INCOMPLETE_EVIDENCE', 47)]	2	[('CHEBI_27300', 'vitamin D', 12, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('UBERON_0002405', 'immune system', 90, 'immune system'), ('GO_0065007', 'biological regulation', 112, 'regulation')]	0	[' immunomodulator defined,  skewing immune system .']
S28-PMC4329404	PMC4329404	10/2014	S28-PMC4329404	['MULTIPLE STUDIES HAVE REPORTED a positive CORRELATION between Serum Vitamin D and Foxp3+Regulatory T-Cell numbers in both the periphery and Airways of Adults (24) and children (25,26).']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 42)]	3	[('UBERON_0001977', 'blood serum', 62, 'serum'), ('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('PR_000017653', 'zinc finger protein ZFPM2', 82, 'FoxP3'), ('CL_0000815', 'regulatory T cell', 88, 'regulatory T-cell'), ('GO_0065007', 'biological regulation', 88, 'regulatory'), ('GO_0005854', 'nascent polypeptide-associated complex', 100, '-'), ('UBERON_0001005', 'respiratory airway', 140, 'airways'), ('UBERON_0007023', 'adult organism', 151, 'adults')]	0	['multiple positive serum  foxp3+ t-cell periphery airways adults (24) children (25,26).']
S32-PMC4329404	PMC4329404	10/2014	S32-PMC4329404	['we HYPOTHESIZED that pups experiencing in utero and early-Life Vitamin D deficiency would develop more SEVERE hdm-induced Airway hyper-responsiveness (ahr), Eosinophilic inflammation and remodelling due to a reduction in Regulatory T Cells in the Lung.']	[('INCOMPLETE_EVIDENCE', 3), ('IMPORTANT_CONSIDERATION', 103)]	2	[('UBERON_0000104', 'life cycle', 58, 'life'), ('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 122, 'airway'), ('CL_0000771', 'eosinophil', 157, 'eosinophilic'), ('CL_0000815', 'regulatory T cell', 221, 'regulatory T cells'), ('GO_0065007', 'biological regulation', 221, 'regulatory'), ('UBERON_0002048', 'lung', 247, 'lung')]	0	['pups experiencing utero early-life  hdm-induced airway hyper-responsiveness (ahr), eosinophilic inflammation remodelling reduction  cells lung.']
S87-PMC4329404	PMC4329404	10/2014	S87-PMC4329404	['Vitamin D insufficiency in utero and in early Life promotes Pulmonary th2 skewing and reduced Il-10+T Regulatory Cells\nto DETERMINE the ROLE of Vitamin D in T-Cell Differentiation, we analysed Th2 Cells and Il-10+T Regulatory Cells in the Lungs of pups.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 122), ('SUPERFICIAL_RELATIONSHIP', 136)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('UBERON_0000104', 'life cycle', 46, 'life'), ('UBERON_0002048', 'lung', 60, 'pulmonary'), ('PR_000001470', 'interleukin-28B', 94, 'IL-10'), ('CL_0000902', 'induced T-regulatory cell', 100, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 102, 'regulatory'), ('CHEBI_27300', 'vitamin D', 144, 'vitamin D'), ('CL_0000084', 'T cell', 157, 'T-cell'), ('GO_0030217', 'T cell differentiation', 157, 'T-cell differentiation'), ('CL_0000546', 'T-helper 2 cell', 193, 'Th2 cells'), ('PR_000001470', 'interleukin-28B', 207, 'IL-10'), ('CL_0000902', 'induced T-regulatory cell', 213, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 215, 'regulatory'), ('UBERON_0002048', 'lung', 239, 'lungs')]	0	['vitamin utero life pulmonary th2 skewing il-10+t  cells\nto  t-cell differentiation, th2 cells il-10+t  cells lungs pups.']
S133-PMC4329404	PMC4329404	10/2014	S133-PMC4329404	['discussion\nwe HAVE SHOWN that Adult female Mice given a Vitamin D-deficient diet for 4\xa0weeks (from day-16 Gestation until 3\xa0weeks Postpartum) developed a th2-skewed Pulmonary Immune phenotype, concomitant with reduced Cd4+Il-10+Regulatory Cells.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('UBERON_0007023', 'adult organism', 30, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 43, 'mice'), ('CHEBI_27300', 'vitamin D', 56, 'vitamin D'), ('GO_0007565', 'female pregnancy', 106, 'gestation'), ('GO_0007565', 'female pregnancy', 130, 'postpartum'), ('UBERON_0002048', 'lung', 165, 'pulmonary'), ('UBERON_0002405', 'immune system', 175, 'immune'), ('PR_000001204', 'C-C chemokine receptor type 8', 218, 'CD4'), ('PR_000001470', 'interleukin-28B', 222, 'IL-10'), ('CL_0000232', 'erythrocyte', 228, 'regulatory cells'), ('GO_0065007', 'biological regulation', 228, 'regulatory')]	0	['discussion\nwe adult female mice 4\xa0weeks (from day-16 gestation 3\xa0weeks postpartum) th2-skewed pulmonary immune phenotype, cd4+il-10+ cells.']
S178-PMC4329404	PMC4329404	10/2014	S178-PMC4329404	['in addition, an Adult Murine MODEL of Vitamin D supplementation in ovalbumin-induced allergic Airways disease DEMONSTRATED an increase in Circulating T Regulatory Cells after Vitamin D supplementation, but levels of Pulmonary Tregs were NOT REPORTED (31).']	[('INCOMPLETE_EVIDENCE', 29), ('INCOMPLETE_EVIDENCE', 110), ('INCOMPLETE_EVIDENCE', 237)]	3	[('UBERON_0007023', 'adult organism', 16, 'adult'), ('NCBITaxon_39107', 'Murinae', 22, 'murine'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin D'), ('UBERON_0001005', 'respiratory airway', 94, 'airways'), ('CL_0000080', 'circulating cell', 138, 'circulating'), ('CL_0000902', 'induced T-regulatory cell', 150, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 152, 'regulatory'), ('CHEBI_27300', 'vitamin D', 175, 'vitamin D'), ('UBERON_0002048', 'lung', 216, 'pulmonary'), ('CL_0000909', 'CD8-positive, alpha-beta memory T cell', 226, 'Tregs')]	0	['addition, adult  supplementation ovalbumin-induced allergic airways disease increase circulating  cells  supplementation, levels pulmonary tregs (31).']
S180-PMC4329404	PMC4329404	10/2014	S180-PMC4329404	['it MAY BE that ONLY alterations in circulating T Regulatory Cells are apparent following supplementation with Vitamin D.\nwe have PREVIOUSLY SHOWN that transfer of T Regulatory Cells prevented Development Of Airway Remodelling in an Adult Mouse MODEL of aad (40).']	[('INCOMPLETE_EVIDENCE', 3), ('ANOMALY_CURIOUS_FINDING', 15), ('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 129), ('INCOMPLETE_EVIDENCE', 244)]	5	[('CL_0000902', 'induced T-regulatory cell', 47, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 49, 'regulatory'), ('CHEBI_27300', 'vitamin D', 110, 'vitamin D'), ('CL_0000902', 'induced T-regulatory cell', 163, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 165, 'regulatory'), ('GO_0032498', 'detection of muramyl dipeptide', 192, 'development of airway remodelling'), ('UBERON_0001005', 'respiratory airway', 207, 'airway'), ('UBERON_0007023', 'adult organism', 232, 'adult'), ('NCBITaxon_10088', 'Mus <genus>', 238, 'mouse')]	0	['alterations circulating  cells following supplementation .\nwe transfer  cells airway remodelling adult mouse aad (40).']
S182-PMC4329404	PMC4329404	10/2014	S182-PMC4329404	['IN SUMMARY, we report for the FIRST TIME that in utero and Postnatal Vitamin D deficiency, with concomitant inhaled Allergen exposure in the Neonatal Period, results in increased Airway Eosinophilia and Th2 Cells and reduced Cd4+Il-10+T Regulatory Cells.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 30)]	2	[('GO_0007567', 'parturition', 59, 'postnatal'), ('CHEBI_27300', 'vitamin D', 69, 'vitamin D'), ('CHEBI_50904', 'allergen', 116, 'allergen'), ('UBERON_0007221', 'neonate stage', 141, 'neonatal period'), ('UBERON_0001005', 'respiratory airway', 179, 'airway'), ('CL_0000771', 'eosinophil', 186, 'eosinophilia'), ('CL_0000546', 'T-helper 2 cell', 203, 'Th2 cells'), ('PR_000001204', 'C-C chemokine receptor type 8', 225, 'CD4'), ('PR_000001470', 'interleukin-28B', 229, 'IL-10'), ('CL_0000902', 'induced T-regulatory cell', 235, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 237, 'regulatory')]	0	['summary, utero postnatal  deficiency, inhaled allergen exposure neonatal period, results airway eosinophilia th2 cells cd4+il-10+t  cells.']
S68-PMC4377888	PMC4377888	3/2015	S68-PMC4377888	['the mechanism UNDERLYING this abnormal Kidney phenotype is MOST LIKELY the fact the Vitamin A is a key ligand for the cret receptor, which Controls the earliest processes of Kidney Development (seesection 2for full details).']	[('SUPERFICIAL_RELATIONSHIP', 14), ('PROBABLE_UNDERSTANDING', 59), ('SUPERFICIAL_RELATIONSHIP', 139)]	3	[('UBERON_0002113', 'kidney', 39, 'kidney'), ('CHEBI_27300', 'vitamin D', 84, 'vitamin A'), ('GO_0065007', 'biological regulation', 139, 'controls'), ('GO_0001822', 'kidney development', 174, 'kidney development'), ('UBERON_0002113', 'kidney', 174, 'kidney')]	0	['abnormal kidney phenotype  ligand cret receptor,  processes kidney (seesection 2for details).']
S41-PMC4383226	PMC4383226	2/2015	S41-PMC4383226	['WHILE Vitamin A did not APPEAR to Modulate the risk of parasitemia in a clinical trial study of ghanaian children (binka et al., 1995) and tanzanian children previously hospitalized with pneumonia (villamor et al., 2003), a cluster randomized intervention trial for breastfeeding in uganda OBSERVED a sixfold decrease in the adjusted risk of malaria infection among children receiving Vitamin A (nankabirwa et al., 2011).']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 24), ('INCOMPLETE_EVIDENCE', 290)]	3	[('CHEBI_27300', 'vitamin D', 6, 'vitamin A'), ('GO_0065007', 'biological regulation', 34, 'modulate'), ('CHEBI_27300', 'vitamin D', 385, 'vitamin A')]	0	[' ghanaian children (binka et al., 1995) tanzanian children hospitalized pneumonia (villamor et al., 2003), cluster breastfeeding uganda sixfold decrease adjusted malaria infection among children receiving  (nankabirwa et al., 2011).']
S99-PMC4383226	PMC4383226	2/2015	S99-PMC4383226	['Vitamin A, dtp and gender\nOUR STUDY EXTENDS PREVIOUS randomized clinical TRIAL EVIDENCE from burkina faso (zeba et al., 2008), papua new guinea (shankar et al., 1999), tanzania (villamor et al., 2002), and uganda (nankabirwa et al., 2011) SHOWING consistent reductions in malaria-induced morbidity and Mortality from Vitamin A.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 26), ('SUPERFICIAL_RELATIONSHIP', 36), ('INCOMPLETE_EVIDENCE', 44), ('INCOMPLETE_EVIDENCE', 73), ('INCOMPLETE_EVIDENCE', 79), ('INCOMPLETE_EVIDENCE', 239)]	6	[('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin A'), ('GO_0065007', 'biological regulation', 302, 'mortality'), ('CHEBI_27300', 'vitamin D', 317, 'vitamin A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 325, 'A')]	0	['vitamin a, dtp gender\nour burkina faso (zeba et al., 2008), papua guinea (shankar et al., 1999), tanzania (villamor et al., 2002), uganda (nankabirwa et al., 2011) reductions malaria-induced morbidity  .']
S22-PMC4396835	PMC4396835	1/2015	S22-PMC4396835	['FURTHER research HAS SHOWN that Vitamin D has a ROLE in Brain Development and function, including Neuronal differentiation, Axonal connectivity, Dopamine ontogeny, immunological modulation and transcriptional Control over a large number of Genes [18–21].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 17), ('SUPERFICIAL_RELATIONSHIP', 48)]	3	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0007420', 'brain development', 56, 'brain development'), ('UBERON_0000955', 'brain', 56, 'brain'), ('CL_0000540', 'neuron', 98, 'neuronal'), ('GO_0030424', 'axon', 124, 'axonal'), ('CHEBI_18243', 'dopamine', 145, 'dopamine'), ('GO_0065007', 'biological regulation', 209, 'control'), ('SO_0000704', 'gene', 240, 'genes')]	0	[' brain function, neuronal differentiation, axonal connectivity, dopamine ontogeny, immunological transcriptional  genes [18–21].']
S106-PMC4417995	PMC4417995	4/2015	S106-PMC4417995	['[50] DEMONSTRATED an inverse ASSOCIATION between Cord Plasma Vitamin D levels and T-Regulatory Cells number.']	[('INCOMPLETE_EVIDENCE', 5), ('SUPERFICIAL_RELATIONSHIP', 29)]	2	[('UBERON_0002240', 'spinal cord', 49, 'cord'), ('UBERON_0001969', 'blood plasma', 54, 'plasma'), ('CHEBI_27300', 'vitamin D', 61, 'vitamin D'), ('CL_0000901', 'Tr1 cell', 82, 'T-regulatory cells'), ('GO_0065007', 'biological regulation', 84, 'regulatory')]	0	['[50] cord plasma  levels t- cells number.']
S20-PMC4427001	PMC4427001	4/2015	S20-PMC4427001	['Vitamin D—via its binding to the Vitamin D receptor (vdr)—Regulates Expression of hundreds of Genes (directly OR indirectly) including those that Control key processes AFFECTING cell fate [8].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 110), ('SUPERFICIAL_RELATIONSHIP', 168)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0065007', 'biological regulation', 58, 'regulates'), ('GO_0010467', 'gene expression', 68, 'expression'), ('SO_0000704', 'gene', 94, 'genes'), ('GO_0065007', 'biological regulation', 146, 'control')]	0	['vitamin d—via binding  receptor (vdr)— expression hundreds genes (directly indirectly)  processes cell fate [8].']
S24-PMC4427001	PMC4427001	4/2015	S24-PMC4427001	['furthermore, Vitamin D has a strong immunomodulatory EFFECT; it inhibits Angiogenesis [8] and is also INVOLVED in the Regulation of Insulin secretion and POSSIBLY Insulin action [11,12].']	[('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 102), ('INCOMPLETE_EVIDENCE', 154)]	3	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0001525', 'angiogenesis', 73, 'angiogenesis'), ('GO_0065007', 'biological regulation', 118, 'regulation'), ('PR_000045358', 'insulin family protein', 132, 'insulin'), ('PR_000045358', 'insulin family protein', 163, 'insulin')]	0	['furthermore,  immunomodulatory effect; inhibits angiogenesis [8]  insulin secretion insulin [11,12].']
S153-PMC4427001	PMC4427001	4/2015	S153-PMC4427001	['POTENTIALLY beneficial EFFECT of Vitamin D supplementation and the PLAUSIBLE pathogenic ROLE of 25(Oh)D deficiency in the subsequent development of diabetes mellitus type 2 in women with gdm history HAS to be FURTHER explored considering the ROLE of Vitamin D in Modulating Insulin sensitivity and Glucose Metabolism.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 23), ('INCOMPLETE_EVIDENCE', 67), ('SUPERFICIAL_RELATIONSHIP', 88), ('IMPORTANT_CONSIDERATION', 199), ('FUTURE_WORK', 209), ('SUPERFICIAL_RELATIONSHIP', 242)]	7	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 96, '25(OH)D'), ('CHEBI_27300', 'vitamin D', 250, 'vitamin D'), ('GO_0065007', 'biological regulation', 263, 'modulating'), ('PR_000045358', 'insulin family protein', 274, 'insulin'), ('CHEBI_17234', 'glucose', 298, 'glucose'), ('GO_0006006', 'glucose metabolic process', 298, 'glucose metabolism')]	0	['potentially  supplementation pathogenic 25(oh)d diabetes mellitus type 2 women gdm   insulin sensitivity glucose metabolism.']
S273-PMC4448820	PMC4448820	5/2015	S273-PMC4448820	['for the PURPOSE of this overview, the general molecular actions of 4 Micronutrients (Vitamins A and d, zinc, Folic Acid) will be the primary focus, including their specific points of convergence on the Regulation of 2 major regulators of inflammation: Nf-Κb activity and the induction, and maintenance, of Treg cells.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 8), ('SUPERFICIAL_RELATIONSHIP', 202)]	2	[('CHEBI_33839', 'macromolecule', 69, 'micronutrients'), ('CHEBI_27300', 'vitamin D', 85, 'vitamins A'), ('CHEBI_30751', 'formic acid', 109, 'folic acid'), ('GO_0065007', 'biological regulation', 202, 'regulation'), ('GO_0005883', 'neurofilament', 252, 'NF-'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 252, 'NF-κB'), ('CL_0000901', 'Tr1 cell', 306, 'Treg')]	0	['overview, molecular 4 micronutrients d, zinc, folic acid) focus,  2 inflammation: nf-κb activity induction, maintenance, treg cells.']
S274-PMC4448820	PMC4448820	5/2015	S274-PMC4448820	['caption (boxed-text): text box 9\u2003\npotential pathways of intersection for Micronutrients\n\n● Myelomonocytic Cell Differentiation (Vitamins A and D)\n● Macrophage polarization (Vitamins a and d, zinc, Folic Acid)\n● B and T Cell Proliferation (zinc, Iron, Folic Acid, others)\n● T Cell Apoptosis (zinc, iron, Vitamin A, Vitamin E, others)\n● Regulation of Nf-Κb activity (Vitamins A, d, and e; zinc; iron; many others)\n● induction, and maintenance, of Treg Cells (Vitamins A and D, zinc, Folic Acid)\n● Regulation Of Gene Expression and/or activity of Protein Kinase C, cyclins, and cyclin-dependent kinases (e.g., as seen with iron): such defects in one or more of these factors MAY AFFECT or Modulate Lymphocyte Responses to stimuli\n\niv.']	[('INCOMPLETE_EVIDENCE', 672), ('SUPERFICIAL_RELATIONSHIP', 676)]	2	[('CHEBI_33839', 'macromolecule', 73, 'micronutrients'), ('CL_0000763', 'myeloid cell', 91, 'Myelomonocytic cell'), ('GO_0002270', 'plasmacytoid dendritic cell activation', 91, 'Myelomonocytic'), ('GO_0030154', 'cell differentiation', 106, 'cell differentiation'), ('CHEBI_27300', 'vitamin D', 128, 'vitamins A'), ('PR_000004370', 'asialoglycoprotein receptor 2', 137, 'A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 143, 'D'), ('PR_000006444', 'diacylglycerol kinase delta', 143, 'D'), ('CL_0000235', 'macrophage', 148, 'Macrophage'), ('CHEBI_33277', 'gamma-tocotrienol', 173, 'vitamins'), ('CHEBI_30751', 'formic acid', 197, 'folic acid'), ('CL_0000969', 'regulatory B cell', 211, 'B ...'), ('CL_0000084', 'T cell', 217, 'T cell'), ('GO_0008283', 'cell proliferation', 219, 'cell proliferation'), ('CHEBI_24870', 'ion', 245, 'iron'), ('CHEBI_30751', 'formic acid', 251, 'folic acid'), ('CL_0000084', 'T cell', 273, 'T cell'), ('GO_0006915', 'apoptotic process', 275, 'cell apoptosis'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin A'), ('CHEBI_27300', 'vitamin D', 314, 'vitamin E'), ('GO_0065007', 'biological regulation', 335, 'Regulation'), ('GO_0035773', 'insulin secretion involved in cellular response to glucose stimulus', 349, 'NF-κB'), ('GO_0071159', 'NF-kappaB complex', 349, 'NF-κB'), ('PR_000011111', 'N-terminal EF-hand calcium-binding protein 3', 349, 'NF-κB'), ('CHEBI_27300', 'vitamin D', 365, 'vitamins A'), ('CL_0000960', 'T3 B cell', 445, 'Treg cells'), ('CHEBI_27300', 'vitamin D', 457, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 472, 'D'), ('CHEBI_30751', 'formic acid', 481, 'folic acid'), ('GO_0010468', 'regulation of gene expression', 495, 'Regulation of gene expression'), ('SO_0000704', 'gene', 509, 'gene'), ('PR_000013390', '26S proteasome non-ATPase regulatory subunit 8', 544, 'protein kinase C'), ('GO_0065007', 'biological regulation', 686, 'modulate'), ('CL_0000542', 'lymphocyte', 695, 'lymphocyte'), ('GO_0060033', 'anatomical structure regression', 706, 'responses')]	0	['caption (boxed-text): text box 9\u2003\npotential intersection micronutrients\n\n● myelomonocytic cell d)\n● macrophage polarization (vitamins d, zinc, folic acid)\n● b cell proliferation (zinc, iron, folic acid, others)\n● cell apoptosis (zinc, iron, , others)\n●  nf-κb activity (, d, e; zinc; iron; others)\n● induction, maintenance, treg cells d, zinc, folic acid)\n● gene expression and/or activity protein kinase c, cyclins, cyclin-dependent kinases (e.g., iron): defects  lymphocyte responses stimuli\n\niv.']
S297-PMC4448820	PMC4448820	5/2015	S297-PMC4448820	['because Vitamins A and D share a Nuclear receptor (rxr), compete for coactivators and corepressors, and reciprocally Regulate the Expression of their receptors, a wide variety of combined EFFECTS on Gene Regulation LIKELY occurs (190–192).']	[('SUPERFICIAL_RELATIONSHIP', 188), ('PROBABLE_UNDERSTANDING', 215)]	2	[('CHEBI_27300', 'vitamin D', 8, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 23, 'D'), ('GO_0005634', 'nucleus', 33, 'nuclear'), ('GO_0065007', 'biological regulation', 117, 'regulate'), ('GO_0010467', 'gene expression', 130, 'expression'), ('SO_0000704', 'gene', 199, 'gene'), ('GO_0065007', 'biological regulation', 204, 'regulation')]	0	[' nuclear receptor (rxr), compete coactivators corepressors, reciprocally  expression receptors, combined gene  occurs (190–192).']
S347-PMC4448820	PMC4448820	5/2015	S347-PMC4448820	['cell culture MODELS and a very SMALL NUMBER OF Human clinical STUDIES INDICATE that nutritional factors including Vitamins A and D AFFECT numerous Genes INVOLVED in Chromatin Remodeling or processes that are INVOLVED in epigenetic Regulation.']	[('INCOMPLETE_EVIDENCE', 13), ('INCOMPLETE_EVIDENCE', 31), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 70), ('SUPERFICIAL_RELATIONSHIP', 131), ('SUPERFICIAL_RELATIONSHIP', 153), ('SUPERFICIAL_RELATIONSHIP', 208)]	7	[('NCBITaxon_9606', 'Homo sapiens', 47, 'human'), ('CHEBI_27300', 'vitamin D', 114, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 129, 'D'), ('SO_0000704', 'gene', 147, 'genes'), ('GO_0000785', 'chromatin', 165, 'chromatin'), ('GO_0006338', 'chromatin remodeling', 165, 'chromatin remodeling'), ('GO_0065007', 'biological regulation', 231, 'regulation')]	0	['cell culture human nutritional  genes chromatin remodeling processes epigenetic .']
S351-PMC4448820	PMC4448820	5/2015	S351-PMC4448820	['because this mechanism has the POTENTIAL to alter the global abundance of Methyl Donors, and because Vitamin A has general actions on Cell Differentiation, it is UNKNOWN whether these EFFECTS are indirect OR WHETHER specific Genes are targeted for epigenetic Regulation by Vitamin A in vivo.']	[('INCOMPLETE_EVIDENCE', 31), ('FULL_UNKNOWN', 162), ('SUPERFICIAL_RELATIONSHIP', 184), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 205), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 208)]	5	[('CHEBI_6842', 'methoxychlor', 74, 'methyl donors'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin A'), ('GO_0030154', 'cell differentiation', 134, 'cell differentiation'), ('SO_0000704', 'gene', 225, 'genes'), ('GO_0065007', 'biological regulation', 259, 'regulation'), ('CHEBI_27300', 'vitamin D', 273, 'vitamin A')]	0	['alter abundance methyl donors,  cell differentiation, genes epigenetic   vivo.']
S375-PMC4448820	PMC4448820	5/2015	S375-PMC4448820	['Kdm6B/Jmjd3 Histone demethylase is induced by Vitamin D, but NOT Atra, in Human Colon cancer cells (217) and HAS BEEN IMPLICATED in the Regulation of Cyclin-Dependent Kinase Inhibitor 1A ( Cdkn1A ) /P21Cip1 by 1,25(Oh)2D in normal Prostate cells (218).']	[('ANOMALY_CURIOUS_FINDING', 61), ('INCOMPLETE_EVIDENCE', 109), ('SUPERFICIAL_RELATIONSHIP', 118)]	3	[('PR_000009209', 'juxtaposed with another zinc finger protein 1', 0, 'KDM6B'), ('PR_000009211', 'lysine-specific demethylase 3A', 6, 'JMJD3'), ('CHEBI_15358', 'histone', 12, 'histone'), ('PR_000043452', 'core histone', 12, 'histone'), ('CHEBI_27300', 'vitamin D', 46, 'vitamin D'), ('CHEBI_17033', 'biliverdin', 65, 'ATRA'), ('NCBITaxon_9606', 'Homo sapiens', 74, 'human'), ('UBERON_0001155', 'colon', 80, 'colon'), ('GO_0065007', 'biological regulation', 136, 'regulation'), ('PR_000004910', 'complement component C8 gamma chain', 150, 'cyclin-dependent kinase inhibitor 1A'), ('CHEBI_35222', 'inhibitor', 174, 'inhibitor'), ('PR_000005259', 'cyclin-dependent kinase 5 activator 1', 189, 'CDKN1A'), ('PR_000014700', 'serpin B9', 199, 'p21CIP1'), ('CHEBI_37983', 'sulfur-35 atom', 210, '1'), ('CHEBI_17996', 'chloride', 211, ','), ('CHEBI_66212', '5,7,3*,4*-tetrahydroxy-2*-(3,3-dimethylallyl)isoflavone', 212, '25(OH)2D'), ('CL_0002249', 'primitive cardiac myocyte', 231, 'prostate'), ('UBERON_0002367', 'prostate gland', 231, 'prostate')]	0	['kdm6b/jmjd3 histone demethylase induced atra, human colon cancer cells (217)  cyclin-dependent kinase inhibitor 1a cdkn1a /p21cip1 1,25(oh)2d normal prostate cells (218).']
S378-PMC4448820	PMC4448820	5/2015	S378-PMC4448820	['Plasma Mirna profiles HAVE BEEN determined in subjects given high-dose Vitamin D, BUT the within-subject heterogeneity and SMALL number of subjects PRECLUDED any determination of definitive Vitamin D–Regulated Mirna (220).']	[('INCOMPLETE_EVIDENCE', 22), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 123), ('INCOMPLETE_EVIDENCE', 148)]	4	[('UBERON_0001969', 'blood plasma', 0, 'Plasma'), ('SO_0000276', 'miRNA', 7, 'miRNA'), ('CHEBI_27300', 'vitamin D', 71, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('GO_0065007', 'biological regulation', 200, 'regulated'), ('SO_0000276', 'miRNA', 210, 'miRNA')]	0	['plasma mirna subjects high-dose within-subject subjects determination mirna (220).']
S379-PMC4448820	PMC4448820	5/2015	S379-PMC4448820	['the ESSENTIALITY of Vitamin D in Regulating invariant invariant Nk T Cell Development in Mice IS THOUGHT TO be via epigenetic mechanisms (173).']	[('IMPORTANT_CONSIDERATION', 4), ('INCOMPLETE_EVIDENCE', 94), ('INCOMPLETE_EVIDENCE', 97)]	3	[('CHEBI_27300', 'vitamin D', 20, 'vitamin D'), ('GO_0065007', 'biological regulation', 33, 'regulating'), ('CL_0000213', 'lining cell', 64, 'NK T cell'), ('GO_0001822', 'kidney development', 64, 'NK T cell development'), ('GO_0005634', 'nucleus', 64, 'NK'), ('NCBITaxon_10088', 'Mus <genus>', 89, 'mice')]	0	['  invariant invariant nk cell mice via epigenetic mechanisms (173).']
S39-PMC4488777	PMC4488777	5/2015	S39-PMC4488777	['the EFFECT of Vitamin D on Ovarian Granulosa Cells RESPONSIBLE for Steroidogenesis, as well as on Immune System Regulation, was ESTABLISHED after FINDING 1-α-hydroxylase and vdr receptors in Deciduae, Placentas, Ovaries, Endometriums and Pituitary Glands, and was CONFIRMED in vitro by DEMONSTRATING active Metabolites of Vitamin D such as 1,25[Oh]2D and 24,25[Oh]2D in mentioned Tissues [14,15,16,17,18].']	[('SUPERFICIAL_RELATIONSHIP', 4), ('PROBABLE_UNDERSTANDING', 51), ('INCOMPLETE_EVIDENCE', 128), ('INCOMPLETE_EVIDENCE', 146), ('INCOMPLETE_EVIDENCE', 264), ('INCOMPLETE_EVIDENCE', 286)]	6	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('CL_0000477', 'ovarian follicle cell', 27, 'ovarian granulosa cells'), ('UBERON_0000992', 'ovary', 27, 'ovarian'), ('GO_0001501', 'skeletal system development', 67, 'steroidogenesis'), ('UBERON_0002405', 'immune system', 98, 'immune system'), ('GO_0065007', 'biological regulation', 112, 'regulation'), ('UBERON_0002450', 'decidua', 191, 'deciduae'), ('UBERON_0001987', 'placenta', 201, 'placentas'), ('UBERON_0000992', 'ovary', 212, 'ovaries'), ('UBERON_0001852', 'endolymph', 221, 'endometriums'), ('UBERON_0000007', 'pituitary gland', 238, 'pituitary glands'), ('CHEBI_25212', 'metabolite', 307, 'metabolites'), ('CHEBI_27300', 'vitamin D', 322, 'vitamin D'), ('CHEBI_82784', 'PVP38-Ag NP', 342, '25[OH]2D'), ('CHEBI_82784', 'PVP38-Ag NP', 358, '25[OH]2D'), ('UBERON_0000479', 'tissue', 380, 'tissues')]	0	[' ovarian granulosa cells steroidogenesis, immune system 1-α-hydroxylase vdr receptors deciduae, placentas, ovaries, endometriums pituitary glands, metabolites  1,25[oh]2d 24,25[oh]2d tissues [14,15,16,17,18].']
S161-PMC4488777	PMC4488777	5/2015	S161-PMC4488777	['as STATED by the authors, the results of their study PROVE an increased Production Of active form Of Vitamin D in the first trimester Decidua, which Modulates reactions in a Paracrine manner between the mother’s and the Embryo’s Immune System during the Implantation.']	[('INCOMPLETE_EVIDENCE', 3), ('PROBABLE_UNDERSTANDING', 53)]	2	[('GO_0040007', 'growth', 72, 'production of ... of vitamin D'), ('CHEBI_27300', 'vitamin D', 101, 'vitamin D'), ('UBERON_0002450', 'decidua', 134, 'decidua'), ('GO_0065007', 'biological regulation', 149, 'modulates'), ('GO_0038001', 'paracrine signaling', 174, 'paracrine'), ('UBERON_0000922', 'embryo', 220, 'embryo'), ('UBERON_0002405', 'immune system', 229, 'immune system'), ('GO_0007566', 'embryo implantation', 254, 'implantation')]	0	['authors, production form  trimester decidua,  reactions paracrine manner mother’s embryo’s immune system implantation.']
S48-PMC4499946	PMC4499946	7/2015	S48-PMC4499946	['clinical, biochemical, and microbiological Surveillance of enrolled mother-infant pairs will enable a range of secondary objectives to be addressed, including (1) estimation of the EFFECT of maternal Vitamin D supplementation on the incidence of acute Respiratory infections (aris) during early infancy; (2) exploration of the ROLES of specific hormones, Nutrients, environmental Contaminants, and inflammatory markers in the mediation or modification of the EFFECT of Vitamin D on fetal and infant growth, with particular emphasis on the ROLE of the Parathyroid hormone (pth) system; and (3) investigation of the ROLE of epigenetic modification of Genes involved in Perinatal Vitamin D Metabolism in infant stunting.']	[('SUPERFICIAL_RELATIONSHIP', 181), ('SUPERFICIAL_RELATIONSHIP', 327), ('SUPERFICIAL_RELATIONSHIP', 459), ('SUPERFICIAL_RELATIONSHIP', 539), ('SUPERFICIAL_RELATIONSHIP', 614)]	5	[('GO_0065007', 'biological regulation', 43, 'surveillance'), ('CHEBI_27300', 'vitamin D', 200, 'vitamin D'), ('UBERON_0001004', 'respiratory system', 252, 'respiratory'), ('CHEBI_33284', 'nutrient', 355, 'nutrients'), ('CHEBI_60688', 'EC 4.2.1.20 (tryptophan synthase) inhibitor', 380, 'contaminants'), ('CHEBI_27300', 'vitamin D', 469, 'vitamin D'), ('UBERON_0001132', 'parathyroid gland', 551, 'parathyroid'), ('SO_0000704', 'gene', 649, 'genes'), ('GO_0036268', 'swimming', 667, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 667, 'perinatal'), ('CHEBI_27300', 'vitamin D', 677, 'vitamin D'), ('GO_0008152', 'metabolic process', 687, 'metabolism')]	0	['clinical, biochemical, microbiological  enrolled mother-infant pairs secondary addressed, (1) maternal  supplementation acute respiratory infections (aris) infancy; (2) hormones, nutrients, environmental contaminants, inflammatory  fetal infant growth, parathyroid hormone (pth) system; (3) epigenetic genes perinatal  metabolism infant stunting.']
S74-PMC4514967	PMC4514967	12/2014	S74-PMC4514967	['first, ra can synergize with the activity of Tgf-Β to promote development of induced Foxp3+Tregcells,55,59–61ALTHOUGH it should be NOTED that neither the frequency nor number of Tregcells are reduced in Vitamin A–deficient Mice.62second, ra is REQUIRED to mount protective Immune Responses to infection by Organisms such as toxoplasma gondii .62third, Vitamin A–deficient Mice lack th17 cells63,64and display IMPAIRED th1 and th17 responses to t. gondii infection and oral administration of escherichia coli heat-labile enterotoxin.62vitamin A is also required for conditioning of Dcs and promoting the stereotypical phenotypic features of Intestinal Cd103+Dcs,58highlighting the fact that multiple cell types are Modulated by Vitamin A and underscoring the IMPORTANT ROLE it plays in Immunity.']	[('ANOMALY_CURIOUS_FINDING', 107), ('ANOMALY_CURIOUS_FINDING', 131), ('IMPORTANT_CONSIDERATION', 244), ('IMPORTANT_CONSIDERATION', 409), ('IMPORTANT_CONSIDERATION', 758), ('SUPERFICIAL_RELATIONSHIP', 768)]	6	[('PR_000000046', 'TGF-beta', 45, 'TGF-β'), ('PR_000017653', 'zinc finger protein ZFPM2', 85, 'FoxP3'), ('CL_0000960', 'T3 B cell', 91, 'Tregcells'), ('CL_0000960', 'T3 B cell', 178, 'Tregcells'), ('CHEBI_27300', 'vitamin D', 203, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 223, 'mice'), ('GO_0006955', 'immune response', 273, 'immune responses'), ('UBERON_0002405', 'immune system', 273, 'immune'), ('NCBITaxon_1', 'root', 306, 'organisms'), ('CHEBI_27300', 'vitamin D', 352, 'vitamin A'), ('NCBITaxon_10088', 'Mus <genus>', 372, 'mice'), ('PR_000004370', 'asialoglycoprotein receptor 2', 542, 'A'), ('CL_0000990', 'conventional dendritic cell', 581, 'DCs'), ('UBERON_0000160', 'intestine', 640, 'intestinal'), ('PR_000002060', 'lysosome-associated membrane glycoprotein 1', 651, 'CD103'), ('CL_0000990', 'conventional dendritic cell', 657, 'DCs'), ('GO_0065007', 'biological regulation', 714, 'modulated'), ('CHEBI_27300', 'vitamin D', 727, 'vitamin A'), ('GO_0007566', 'embryo implantation', 785, 'immunity')]	0	['first, ra synergize activity tgf-β induced foxp3+tregcells,55,59–61although frequency tregcells –deficient mice.62second, ra mount immune responses infection organisms toxoplasma gondii .62third, –deficient mice th17 cells63,64and display th1 th17 responses t. gondii infection oral administration escherichia coli heat-labile enterotoxin.62vitamin conditioning dcs promoting stereotypical phenotypic intestinal cd103+dcs,58highlighting cell   plays immunity.']
S52-PMC4516377	PMC4516377	6/2015	S52-PMC4516377	['moreover, Calcitriol inhibit s the Expression of Uncoupling Protein-2 (INVOLVED in the Regulation Of Metabolism, diet-induced Thermogenesis and body weight Control) through the classic Nuclear Vitamin D receptors in Adipocytes, thereby increasing energy efficiency.24,25additionally, the Regulation by Calcitriol of the Uncoupling Protein-2 and the levels of Intracellular calcium SEEMS to have an EFFECT on energy Metabolism by AFFECTING Adipocyte Apoptosis.24\n\n\ncaption (fig): figure 2.']	[('SUPERFICIAL_RELATIONSHIP', 71), ('ANOMALY_CURIOUS_FINDING', 381), ('SUPERFICIAL_RELATIONSHIP', 398), ('SUPERFICIAL_RELATIONSHIP', 429)]	4	[('CHEBI_17823', 'calcitriol', 10, 'calcitriol'), ('GO_0010467', 'gene expression', 35, 'expression'), ('PR_000017016', 'E3 ubiquitin-protein ligase UBR5', 49, 'uncoupling protein-2'), ('GO_0009894', 'regulation of catabolic process', 87, 'regulation of metabolism'), ('GO_0031649', 'heat generation', 126, 'thermogenesis'), ('GO_0065007', 'biological regulation', 156, 'control'), ('GO_0005634', 'nucleus', 185, 'nuclear'), ('CHEBI_27300', 'vitamin D', 193, 'vitamin D'), ('CL_0000136', 'fat cell', 216, 'adipocytes'), ('GO_0065007', 'biological regulation', 288, 'regulation'), ('CHEBI_17823', 'calcitriol', 302, 'calcitriol'), ('PR_000017016', 'E3 ubiquitin-protein ligase UBR5', 320, 'uncoupling protein-2'), ('GO_0005622', 'intracellular anatomical structure', 359, 'intracellular'), ('GO_0008152', 'metabolic process', 415, 'metabolism'), ('CL_0000136', 'fat cell', 439, 'adipocyte'), ('GO_0006915', 'apoptotic process', 449, 'apoptosis')]	0	['moreover, calcitriol inhibit expression uncoupling protein-2 (involved metabolism, diet-induced thermogenesis nuclear  receptors adipocytes, energy efficiency.24,25additionally,  calcitriol uncoupling protein-2 levels intracellular calcium energy metabolism adipocyte apoptosis.24\n\n\ncaption (fig): figure 2.']
S76-PMC4516377	PMC4516377	6/2015	S76-PMC4516377	['that reduces its bioavailability and triggers the Hypothalamus to generate a cascade of reactions that leads to increased feelings of hunger and decreased energy expenditure, to compensate for the lack of the vitamin.37among these reactions is the increase in Parathyroid hormone (pth) levels, which promotes Lipogenesis38,39and CAN Modulate Adipogenesis by suppressing the Vitamin D receptor, which inhibits Compounds INVOLVED in Adipocyte differentiation and maturation.39,40in general, it can be OBSERVED that the increase in Bf can aggravate Vitamin D deficiency which, in turn, can further increase the accumulation of fat, creating a cycle (fig.']	[('INCOMPLETE_EVIDENCE', 329), ('SUPERFICIAL_RELATIONSHIP', 419), ('INCOMPLETE_EVIDENCE', 499)]	3	[('UBERON_0001898', 'hypothalamus', 50, 'hypothalamus'), ('UBERON_0001132', 'parathyroid gland', 260, 'parathyroid'), ('GO_0007129', 'homologous chromosome pairing at meiosis', 309, 'lipogenesis38'), ('GO_0065007', 'biological regulation', 333, 'modulate'), ('GO_0060612', 'adipose tissue development', 342, 'adipogenesis'), ('CHEBI_27300', 'vitamin D', 374, 'vitamin D'), ('CHEBI_36357', 'polyatomic entity', 409, 'compounds'), ('CL_0000136', 'fat cell', 431, 'adipocyte'), ('UBERON_0002061', 'truncus arteriosus', 529, 'BF'), ('CHEBI_27300', 'vitamin D', 546, 'vitamin D')]	0	['reduces bioavailability hypothalamus generate cascade reactions feelings decreased energy expenditure, compensate vitamin.37among reactions increase parathyroid hormone (pth) levels, lipogenesis38,39and  adipogenesis suppressing  receptor, inhibits compounds adipocyte maturation.39,40in general, increase bf  which, turn, increase accumulation fat, creating cycle (fig.']
S9-PMC4595656	PMC4595656	10/2015	S9-PMC4595656	['introduction\nuntil a little over 30 years ago, the ROLE of hormonal Vitamin D was classically ASSOCIATED with Calcium Homeostasis, bone formation and maintenance, its up-Regulation by Parathyroid hormone being KNOWN for MANY YEARS.']	[('SUPERFICIAL_RELATIONSHIP', 51), ('SUPERFICIAL_RELATIONSHIP', 94), ('SUPERFICIAL_RELATIONSHIP', 170), ('INCOMPLETE_EVIDENCE', 210), ('INCOMPLETE_EVIDENCE', 220)]	5	[('CHEBI_27300', 'vitamin D', 68, 'vitamin D'), ('GO_0055073', 'cadmium ion homeostasis', 110, 'calcium homeostasis'), ('GO_0065007', 'biological regulation', 170, 'regulation'), ('UBERON_0001132', 'parathyroid gland', 184, 'parathyroid')]	0	['introduction\nuntil 30 ago, hormonal  calcium homeostasis, bone formation maintenance, up- parathyroid hormone years.']
S110-PMC4595656	PMC4595656	10/2015	S110-PMC4595656	['they FOUND an increase in the number of Neurospheres formed in culture from the Subventricular Zone (Svz), which was unaffected by subsequent supplementation with Vitamin D. the authors CONCLUDED that Vitamin D CAN Regulate Cellular Proliferation in the developing Brain.']	[('INCOMPLETE_EVIDENCE', 5), ('INCOMPLETE_EVIDENCE', 186), ('INCOMPLETE_EVIDENCE', 211)]	3	[('CL_0000855', 'sensory hair cell', 40, 'neurospheres'), ('UBERON_0004922', 'postnatal subventricular zone', 80, 'subventricular zone'), ('UBERON_0004922', 'postnatal subventricular zone', 101, 'SVZ'), ('CHEBI_27300', 'vitamin D', 163, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 201, 'vitamin D'), ('GO_0065007', 'biological regulation', 215, 'regulate'), ('GO_0008283', 'cell proliferation', 224, 'cellular proliferation'), ('UBERON_0000955', 'brain', 265, 'brain')]	0	['increase neurospheres formed culture subventricular zone (svz), unaffected supplementation . authors   cellular proliferation brain.']
S26-PMC4600246	PMC4600246	10/2015	S26-PMC4600246	['gla-containing proteins (Mgp and Osteocalcin) Regulate many Anticalcification and Bone-Forming processes in the body, which are DEPENDENT on Vitamin K in order to be produced.']	[('SUPERFICIAL_RELATIONSHIP', 128)]	1	[('PR_000010430', 'MAP kinase-interacting serine/threonine-protein kinase 2', 25, 'MGP'), ('PR_000011634', 'oxidized low-density lipoprotein receptor 1', 33, 'osteocalcin'), ('GO_0065007', 'biological regulation', 46, 'regulate'), ('GO_0009948', 'anterior/posterior axis specification', 60, 'anticalcification'), ('GO_0071714', 'icosanoid transmembrane transporter activity', 82, 'bone-forming'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin K')]	0	['gla-containing proteins (mgp osteocalcin)  anticalcification bone-forming processes body,  produced.']
S145-PMC4670104	PMC4670104	12/2015	S145-PMC4670104	['about half of the proteins negatively CORRELATED with agp (i.e., that decline in relative abundance with inflammation) are also CONSIDERED Hepatic proteins released into the Bloodstream, but more INVOLVED in Transport and Metabolism Of Nutrients and Small Molecules (e.g., Rbp4 and ttr for Vitamin A; Apolipoproteins A1/A2/h/m for Lipid or Cholesterol Transport and Metabolism; and ahsg for Calcium And Phosphate Metabolism), sex Hormone and growth factor binding (e.g., Shbg and Igfals) or serine endopeptidase or proteinase inhibition in Regulating Blood Coagulation and complement cascades, among other ROLES.']	[('SUPERFICIAL_RELATIONSHIP', 38), ('INCOMPLETE_EVIDENCE', 128), ('SUPERFICIAL_RELATIONSHIP', 196), ('SUPERFICIAL_RELATIONSHIP', 606)]	4	[('UBERON_0002107', 'liver', 139, 'hepatic'), ('UBERON_0001969', 'blood plasma', 174, 'bloodstream'), ('GO_0009294', 'DNA mediated transformation', 208, 'transport ...'), ('GO_0019503', 'stachydrine biosynthetic process', 222, 'metabolism of nutrients'), ('CHEBI_33284', 'nutrient', 236, 'nutrients'), ('GO_0044403', 'biological process involved in symbiotic interaction', 250, 'small molecules'), ('CHEBI_36357', 'polyatomic entity', 256, 'molecules'), ('PR_000013819', 'retinol-binding protein 2', 273, 'RBP4'), ('CHEBI_27300', 'vitamin D', 290, 'vitamin A'), ('CHEBI_39015', 'apolipoprotein', 301, 'apolipoproteins'), ('PR_000004140', 'apolipoprotein A-I', 301, 'apolipoproteins A1'), ('PR_000004105', 'AP-3 complex subunit beta-2', 320, 'A2'), ('CHEBI_18059', 'lipid', 331, 'lipid'), ('GO_0006266', 'DNA ligation', 331, 'lipid ...'), ('CHEBI_16113', 'cholesterol', 340, 'cholesterol'), ('GO_0030204', 'chondroitin sulfate metabolic process', 340, 'cholesterol transport ... metabolism'), ('CHEBI_77635', 'calcium phosphate', 391, 'calcium and phosphate'), ('GO_0019752', 'carboxylic acid metabolic process', 391, 'calcium ... metabolism'), ('CHEBI_33280', 'molecular messenger', 430, 'hormone'), ('PR_000014843', 'protein shisa-3', 471, 'SHBG'), ('PR_000008940', 'intraflagellar transport protein 88', 480, 'IGFALS'), ('GO_0065007', 'biological regulation', 540, 'regulating'), ('GO_0007596', 'blood coagulation', 551, 'blood coagulation'), ('UBERON_0000178', 'blood', 551, 'blood')]	0	['half proteins agp (i.e., decline relative abundance inflammation) hepatic proteins released bloodstream, transport metabolism nutrients molecules (e.g., rbp4 ttr apolipoproteins a1/a2/h/m lipid cholesterol transport metabolism; ahsg calcium phosphate metabolism), sex hormone binding (e.g., shbg igfals) serine endopeptidase proteinase inhibition  blood coagulation cascades, among roles.']
S38-PMC4684854	PMC4684854	12/2015	S38-PMC4684854	['with the EMERGING EVIDENCE that Vitamin D acts epigenetically in the Regulation of over 2700 different Genes [36], there HAS BEEN much RECENT RESEARCH exploring the widespread prevalence of Vitamin D deficiency through the continuum of Life, including the Gestational and Neonatal Period.']	[('INCOMPLETE_EVIDENCE', 9), ('SUPERFICIAL_RELATIONSHIP', 69), ('INCOMPLETE_EVIDENCE', 121), ('INCOMPLETE_EVIDENCE', 135)]	4	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 69, 'regulation'), ('SO_0000704', 'gene', 103, 'genes'), ('CHEBI_27300', 'vitamin D', 190, 'vitamin D'), ('UBERON_0000104', 'life cycle', 236, 'life'), ('GO_0007565', 'female pregnancy', 256, 'gestational'), ('UBERON_0007221', 'neonate stage', 272, 'neonatal period')]	0	[' epigenetically  2700 genes [36],  continuum life, gestational neonatal period.']
S79-PMC4684854	PMC4684854	12/2015	S79-PMC4684854	['this research FOUND that lower Vitamin D levels were ASSOCIATED with Immune Dysregulation in a NUMBER OF ways, including differences in indices involving Natural Killer Cells, various cytokines, and certain Regulatory proteins, when compared to those with sufficient Vitamin D levels [50].']	[('INCOMPLETE_EVIDENCE', 14), ('SUPERFICIAL_RELATIONSHIP', 53), ('INCOMPLETE_EVIDENCE', 95)]	3	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0001774', 'microglial cell activation', 69, 'immune dysregulation'), ('UBERON_0002405', 'immune system', 69, 'immune'), ('CL_0000623', 'natural killer cell', 154, 'natural killer cells'), ('GO_0065007', 'biological regulation', 207, 'regulatory'), ('CHEBI_27300', 'vitamin D', 267, 'vitamin D')]	0	[' levels immune dysregulation ways, indices natural killer cells, cytokines,  proteins,  levels [50].']
S167-PMC4690051	PMC4690051	12/2015	S167-PMC4690051	['we RECENTLY REPORTED [57] that Dna Methylation is jointly Modulated by ancestry and Gestational Vitamin D levels, observations which SUPPORT multidimensional FACTORS.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 133), ('SUPERFICIAL_RELATIONSHIP', 158)]	4	[('GO_0006306', 'DNA methylation', 31, 'DNA methylation'), ('GO_0065007', 'biological regulation', 58, 'modulated'), ('GO_0007565', 'female pregnancy', 84, 'gestational'), ('CHEBI_27300', 'vitamin D', 96, 'vitamin D')]	0	['[57] dna methylation  ancestry gestational  levels, multidimensional factors.']
S108-PMC4765528	PMC4765528	12/2015	S108-PMC4765528	['the programming effect of an adverse in-utero environment and the role of epigenetics\nIT IS CLEAR that there is a strong Genetic predisposition to osteoporosis and although the Genes that Regulate bone mass have not been COMPLETELY established, responsible Gene variants include Vitamin D receptor polymorphisms [47], Collagen-1 Receptor [48] and Oestrogen receptor variants [49].']	[('PROBABLE_UNDERSTANDING', 86), ('PROBABLE_UNDERSTANDING', 221)]	2	[('SO_0000704', 'gene', 121, 'genetic'), ('SO_0000704', 'gene', 177, 'genes'), ('GO_0065007', 'biological regulation', 188, 'regulate'), ('SO_0000704', 'gene', 257, 'gene'), ('CHEBI_27300', 'vitamin D', 279, 'vitamin D'), ('PR_000003266', 'collagen type II alpha chain', 318, 'collagen-1 receptor'), ('CHEBI_50114', 'estrogen', 347, 'oestrogen')]	0	['programming in-utero environment epigenetics\nit genetic osteoporosis genes  bone mass established, gene variants  receptor polymorphisms [47], collagen-1 receptor [48] oestrogen receptor variants [49].']
S118-PMC4765528	PMC4765528	12/2015	S118-PMC4765528	['early work on methylation and Vitamin D Receptors and Placental calcium transporters SUGGESTS that epigenetic Regulation MIGHT explain HOW maternal Vitamin D levels AFFECT bone mineralization in the neonate [51].']	[('INCOMPLETE_EVIDENCE', 85), ('INCOMPLETE_EVIDENCE', 121), ('EXPLICIT_QUESTION', 135), ('SUPERFICIAL_RELATIONSHIP', 165)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('PR_000001708', 'sphingosine 1-phosphate receptor 3', 30, 'vitamin D receptors'), ('UBERON_0001987', 'placenta', 54, 'placental'), ('GO_0065007', 'biological regulation', 110, 'regulation'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]	0	['early methylation  receptors placental calcium transporters epigenetic  maternal  levels bone mineralization neonate [51].']
S24-PMC4785305	PMC4785305	3/2016	S24-PMC4785305	"['[""""ASSOCIATION between maternal Vitamin D level and neonatal adverse outcomes\\nlow maternal 25(Oh)D levels were RECENTLY LINKED to fetal programming, and were found TO be ASSOCIATED with adverse events in neonates, resulting in small for Gestational age (sga) at Birth,1923and also later on during childhood, leading to reduced muscle and bone mass in offspring at 4 and 9\\u2005years.2425this MAY BE EXPLAINED by the fact that maternal Vitamin D is ESSENTIAL for fetal Musculoskeletal integrity, as it Regulates neonatal bone accrual, POSSIBLY through specific proteins that are responsible for Placental Calcium Transport.26RECENTLY, data from the southampton women\'s survey (sws) SHOWED that maternal 25(Oh)D level is significantly CORRELATED with Placental Amino Acid transporters Expression, that mediate the Transport Of various Nutrients to the fetus.27furthermore, maternal Vitamin D MAY INFLUENCE the fetal muscle motor Unit size, and CONSEQUENTLY muscle mass and strength after Birth.25it is NOTEWORTHY that fetal bone development is one of the PREDICTORS of peak bone mass, Adult bone Mineral content and Hip geometry, THUS CORRELATING with fracture risk later in Life.2628\\n\\nVitamin d replacement guidelines during Pregnancy\\nthe guidelines regarding Vitamin D replacement or supplementation during Pregnancy VARY substantially.""""]']"	[('SUPERFICIAL_RELATIONSHIP', 0), ('INCOMPLETE_EVIDENCE', 108), ('SUPERFICIAL_RELATIONSHIP', 117), ('QUESTION_ANSWERED_BY_THIS_WORK', 161), ('SUPERFICIAL_RELATIONSHIP', 167), ('INCOMPLETE_EVIDENCE', 384), ('ANOMALY_CURIOUS_FINDING', 388), ('PROBABLE_UNDERSTANDING', 391), ('IMPORTANT_CONSIDERATION', 440), ('INCOMPLETE_EVIDENCE', 526), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 614), ('INCOMPLETE_EVIDENCE', 673), ('SUPERFICIAL_RELATIONSHIP', 725), ('INCOMPLETE_EVIDENCE', 882), ('SUPERFICIAL_RELATIONSHIP', 886), ('PROBABLE_UNDERSTANDING', 934), ('ANOMALY_CURIOUS_FINDING', 992), ('SUPERFICIAL_RELATIONSHIP', 1045), ('PROBABLE_UNDERSTANDING', 1120), ('SUPERFICIAL_RELATIONSHIP', 1125), ('DIFFICULT_TASK', 1309)]	21	[('CHEBI_27300', 'vitamin D', 29, 'vitamin D'), ('CHEBI_71657', 'versiconol acetate', 88, '25(OH)D'), ('GO_0007565', 'female pregnancy', 234, 'gestational'), ('GO_0007567', 'parturition', 259, 'birth'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D'), ('UBERON_0002204', 'musculoskeletal system', 460, 'musculoskeletal'), ('GO_0065007', 'biological regulation', 493, 'regulates'), ('UBERON_0001987', 'placenta', 586, 'placental'), ('GO_0006816', 'calcium ion transport', 596, 'calcium transport'), ('CHEBI_71657', 'versiconol acetate', 694, '25(OH)D'), ('UBERON_0001987', 'placenta', 741, 'placental'), ('CHEBI_82880', 'N-acyltetradecaphytosphingosine', 751, 'amino acid'), ('GO_0010467', 'gene expression', 775, 'expression'), ('GO_0006415', 'translational termination', 804, 'transport of ... nutrients'), ('CHEBI_33284', 'nutrient', 825, 'nutrients'), ('CHEBI_27300', 'vitamin D', 872, 'vitamin D'), ('UBERON_0002105', 'vestibulo-auditory system', 919, 'unit'), ('GO_0007567', 'parturition', 978, 'birth'), ('UBERON_0007023', 'adult organism', 1075, 'adult'), ('CHEBI_46662', 'mineral', 1086, 'mineral'), ('UBERON_0001464', 'hip', 1106, 'hip'), ('UBERON_0000104', 'life cycle', 1165, 'life'), ('CHEBI_33229', 'vitamin (role)', 1176, 'Vitamin'), ('GO_0007565', 'female pregnancy', 1216, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 1251, 'vitamin D'), ('GO_0007565', 'female pregnancy', 1299, 'pregnancy')]	0	"['[""""association maternn neonatal outcomes\\nlow maternal 25(oh)d levels fetal programming, events neonates, resulting gestational age (sga) birth,1923and childhood, muscle bone mass offspring 4 9\\u2005years.2425this vitamin fetal musculoskeletal integritregulates neonatal bone accrual, proteins placental calcium transport.26recently, southampton women*s survey (sws) maternal 25(oh)d placental amino acid transporters expression, transport nutrients fetus.27furthermore, vitamin fetal muscle motor unit size, muscle mass birth.25it fetal bone peak bone mass, adult bone mineral content hip geometry, fracture life.2628\\n\\nvitamin replacement pregnancy\\nthe guidelineng vitamin replacement supplementation pregnancy substantially.""""]']"
S51-PMC4800340	PMC4800340	5/2016	S51-PMC4800340	['the results of these studies SUGGEST that differential Dna Methylation in the regions of Genes RELATED to T-Cell Differentiation and balance between th1 and th2 during the critical Period Of early Life MAY BE POTENTIAL mechanisms of allergic disease development.73\n\nepigenetic Regulation by Nutrients\nALTHOUGH POSSIBLE ROLES of Prenatal Folate, N-3 Pufa, and Vitamin D in Immune programming HAVE BEEN SUGGESTED,3474only a LIMITED NUMBER OF STUDIES examined epigenetic Regulation by these Nutrients as a POTENTIAL biological pathway of allergic diseases.']	[('INCOMPLETE_EVIDENCE', 29), ('SUPERFICIAL_RELATIONSHIP', 95), ('INCOMPLETE_EVIDENCE', 202), ('INCOMPLETE_EVIDENCE', 209), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 301), ('ANOMALY_CURIOUS_FINDING', 301), ('INCOMPLETE_EVIDENCE', 310), ('SUPERFICIAL_RELATIONSHIP', 319), ('INCOMPLETE_EVIDENCE', 391), ('INCOMPLETE_EVIDENCE', 401), ('INCOMPLETE_EVIDENCE', 422), ('INCOMPLETE_EVIDENCE', 503)]	12	[('GO_0006306', 'DNA methylation', 55, 'DNA methylation'), ('SO_0000704', 'gene', 89, 'genes'), ('CL_0000084', 'T cell', 106, 'T-cell'), ('GO_0030217', 'T cell differentiation', 106, 'T-cell differentiation'), ('UBERON_0008266', 'periodontal ligament', 181, 'period of ... life'), ('GO_0065007', 'biological regulation', 277, 'regulation'), ('CHEBI_33284', 'nutrient', 291, 'nutrients'), ('GO_0007565', 'female pregnancy', 328, 'prenatal'), ('CHEBI_30863', '5-azaorotic acid', 337, 'folate'), ('CHEBI_80445', '9,10-EOT', 345, 'n-3 PUFA'), ('CHEBI_27300', 'vitamin D', 359, 'vitamin D'), ('GO_0007566', 'embryo implantation', 372, 'immune'), ('UBERON_0002405', 'immune system', 372, 'immune'), ('GO_0065007', 'biological regulation', 468, 'regulation'), ('CHEBI_33284', 'nutrient', 488, 'nutrients')]	0	['results dna methylation regions genes t-cell balance th1 th2 period life mechanisms allergic disease development.73\n\nepigenetic  nutrients\nalthough prenatal folate, n-3 pufa,  immune programming suggested,3474only epigenetic  nutrients biological allergic diseases.']
S56-PMC4800340	PMC4800340	5/2016	S56-PMC4800340	['THIS STUDY SHOWED that Prenatal Vitamin D-mediated epigenetic Regulation in Tslp increased the RISK of wheezing in children.77more Human STUDIES ARE NEEDED to substantiate the ROLE of epigenetic Regulation by Nutrients in the growing epidemic of Food allergy.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 0), ('INCOMPLETE_EVIDENCE', 11), ('SUPERFICIAL_RELATIONSHIP', 62), ('IMPORTANT_CONSIDERATION', 95), ('FUTURE_WORK', 137), ('SUPERFICIAL_RELATIONSHIP', 176)]	6	[('GO_0007565', 'female pregnancy', 23, 'prenatal'), ('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 62, 'regulation'), ('PR_000016770', 'testis-specific serine/threonine-protein kinase 1', 76, 'TSLP'), ('NCBITaxon_9606', 'Homo sapiens', 131, 'human'), ('GO_0065007', 'biological regulation', 195, 'regulation'), ('CHEBI_33284', 'nutrient', 209, 'nutrients'), ('CHEBI_33290', 'food', 246, 'food')]	0	['prenatal -mediated epigenetic  tslp wheezing children.77more human epigenetic  nutrients food allergy.']
S28-PMC4829940	PMC4829940	5/2016	S28-PMC4829940	['another STUDY explored epigenetic Regulation of Vitamin D converting enzymes[18], WHILE a third FOUND a RELATIONSHIP between methylation of the Genes Cyp24R1 and Cyp27A1 and variations in circulating 25(Oh)D levels[19].']	[('INCOMPLETE_EVIDENCE', 8), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 82), ('INCOMPLETE_EVIDENCE', 96), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('GO_0065007', 'biological regulation', 34, 'regulation'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('SO_0000704', 'gene', 144, 'genes'), ('PR_000006101', 'cytochrome P450 1A1', 150, 'CYP24R1'), ('PR_000006101', 'cytochrome P450 1A1', 162, 'CYP27A1'), ('CHEBI_71657', 'versiconol acetate', 200, '25(OH)D'), ('PR_000008838', 'serine protease HTRA1', 200, '25(OH ... D')]	0	['another epigenetic   converting enzymes[18], third methylation genes cyp24r1 cyp27a1 circulating 25(oh)d levels[19].']
S130-PMC4843009	PMC4843009	4/2016	S130-PMC4843009	['in wild type Animals, dietary Vitamin D does not necessarily INFLUENCE 1,25(Oh)2D3Concentration, AS 1Α-25-Hydroxyvitamin D hydroxylase and THUS 1,25(Oh)2D3Formation is under tight Regulation by Fgf23 and Klotho1.']	[('SUPERFICIAL_RELATIONSHIP', 61), ('PROBABLE_UNDERSTANDING', 97), ('PROBABLE_UNDERSTANDING', 139)]	3	[('NCBITaxon_33208', 'Metazoa', 13, 'animals'), ('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('CHEBI_52815', 'cresyl violet', 71, '1,25(OH)2D3concentration'), ('CHEBI_67449', 'ananolignan L', 100, '1α-25-hydroxyvitamin D'), ('CHEBI_77734', 'dexverapamil', 146, '25(OH)2D3formation'), ('GO_0065007', 'biological regulation', 180, 'regulation'), ('PR_000007483', 'fibroblast growth factor 13', 194, 'FGF23'), ('PR_000009207', 'lysine-specific demethylase 5D', 204, 'klotho1')]	0	['wild type animals, dietary  1,25(oh)2d3concentration, 1α-25-hydroxyvitamin hydroxylase 1,25(oh)2d3formation tight  fgf23 klotho1.']
S352-PMC4864049	PMC4864049	1/2016	S352-PMC4864049	['there is STRONGER EVIDENCE that Vitamin D acts to Modulate Chromatin Access through interactions with Histone acetyltransferases\xa0[162].']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 50, 'modulate'), ('GO_0000785', 'chromatin', 59, 'chromatin'), ('GO_0007623', 'circadian rhythm', 59, 'chromatin access'), ('CHEBI_15358', 'histone', 102, 'histone'), ('PR_000043452', 'core histone', 102, 'histone')]	0	['  chromatin access histone acetyltransferases\xa0[162].']
S6538-PMC4896250	PMC4896250	4/2016	S6538-PMC4896250	['conclusions: these results SUGGEST that Vitamin D MIGHT Modulate mediators INVOLVED in Immune Responses in crs.']	[('INCOMPLETE_EVIDENCE', 27), ('INCOMPLETE_EVIDENCE', 50), ('SUPERFICIAL_RELATIONSHIP', 75)]	3	[('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('GO_0065007', 'biological regulation', 56, 'modulate'), ('GO_0006955', 'immune response', 87, 'immune responses'), ('UBERON_0002405', 'immune system', 87, 'immune')]	0	['conclusions: results   immune responses crs.']
S8292-PMC4896250	PMC4896250	4/2016	S8292-PMC4896250	['objective\nwe AIMED TO INVESTIGATE WHETHER Vitamin D insufficiency in asthmatic Adults ASSOCIATES with atopy, poor asthma Control, and more frequent Respiratory Tract infections, and WHETHER these patients CAN BENEFIT from Vitamin D supplementation.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 13), ('QUESTION_ANSWERED_BY_THIS_WORK', 19), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 34), ('SUPERFICIAL_RELATIONSHIP', 86), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 182), ('INCOMPLETE_EVIDENCE', 205), ('IMPORTANT_CONSIDERATION', 209)]	7	[('CHEBI_27300', 'vitamin D', 42, 'vitamin D'), ('UBERON_0007023', 'adult organism', 79, 'adults'), ('GO_0065007', 'biological regulation', 121, 'control'), ('UBERON_0000065', 'respiratory tract', 148, 'respiratory tract'), ('CHEBI_27300', 'vitamin D', 222, 'vitamin D')]	0	['objective\nwe  asthmatic adults atopy, asthma respiratory tract infections, patients  supplementation.']
S8300-PMC4896250	PMC4896250	4/2016	S8300-PMC4896250	['these patients had poorer asthma Control as indicated by act scores, and had a significantly higher rate of allergic sensitization, compared TO the Vitamin D sufficient asthmatics.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 141)]	1	[('GO_0065007', 'biological regulation', 33, 'control'), ('CHEBI_27300', 'vitamin D', 148, 'vitamin D')]	0	['patients asthma  scores, higher rate allergic sensitization,  asthmatics.']
S19-PMC4908484	PMC4908484	6/2016	S19-PMC4908484	['it HAS BEEN HYPOTHESIZED that Vitamin D exerts these EFFECTS by Modulation of Neuronal Ca2+Homeostasis, in particular through downregulation of l‐type voltage‐sensitive ca2+channels in Hippocampal Neurons against excitotoxic insults (tetich et\xa0al.2005), ACCOMPANIED by an increase in vdr density.']	[('INCOMPLETE_EVIDENCE', 3), ('INCOMPLETE_EVIDENCE', 12), ('SUPERFICIAL_RELATIONSHIP', 53), ('SUPERFICIAL_RELATIONSHIP', 254)]	4	[('CHEBI_27300', 'vitamin D', 30, 'vitamin D'), ('GO_0065007', 'biological regulation', 64, 'modulation'), ('CL_0000540', 'neuron', 78, 'neuronal'), ('CHEBI_29108', 'calcium(2+)', 87, 'Ca2+'), ('GO_0007608', 'sensory perception of smell', 90, '... +'), ('GO_0042592', 'homeostatic process', 91, 'homeostasis'), ('CHEBI_29238', 'tritium atom', 172, '+'), ('CL_0002608', 'hippocampal neuron', 185, 'hippocampal neurons')]	0	[' exerts  neuronal ca2+homeostasis, downregulation l‐type voltage‐sensitive ca2+channels hippocampal neurons excitotoxic insults (tetich et\xa0al.2005), increase vdr density.']
S169-PMC4908484	PMC4908484	6/2016	S169-PMC4908484	['THUS, THERE IS EVIDENCE that the neuroprotective action of Vitamin D involves Neuronal calcium Regulation, Antioxidative pathway, Immunomodulation, and Detoxification.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 6)]	2	[('CHEBI_27300', 'vitamin D', 59, 'vitamin D'), ('CL_0000540', 'neuron', 78, 'neuronal'), ('GO_0065007', 'biological regulation', 95, 'regulation'), ('GO_0019286', 'glycine betaine biosynthetic process from glycine', 107, 'antioxidative'), ('GO_0050900', 'leukocyte migration', 130, 'immunomodulation'), ('GO_0098754', 'detoxification', 152, 'detoxification')]	0	['thus, neuroprotective  neuronal calcium antioxidative pathway, immunomodulation, detoxification.']
S283-PMC4910255	PMC4910255	6/2016	S283-PMC4910255	['the mechanisms of action are LIKELY to be MULTIFACTORIAL and follow-up REPORTS SUGGEST OTHER mechanisms such as the EFFECT of Vitamin A on Regulation of fetal Lung growth, branching and alveolarisation [67,68].']	[('PROBABLE_UNDERSTANDING', 29), ('DIFFICULT_TASK', 42), ('INCOMPLETE_EVIDENCE', 71), ('INCOMPLETE_EVIDENCE', 79), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 87), ('SUPERFICIAL_RELATIONSHIP', 116)]	6	[('CHEBI_27300', 'vitamin D', 126, 'vitamin A'), ('GO_0065007', 'biological regulation', 139, 'regulation'), ('UBERON_0002048', 'lung', 159, 'lung')]	0	['mechanisms follow-up mechanisms   fetal lung growth, branching alveolarisation [67,68].']
S58-PMC4934634	PMC4934634	11/2015	S58-PMC4934634	['IN AGREEMENT, epidemiological studies HAVE SHOWN that men with deficient Vitamin D levels (using either the iom cut-off of <25 nmol/l [22] or the endocrine society cut-off of <50 nmol/l [23]) have reduced Sperm Motility, progressive motility, and number of mature Spermatozoa.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 38)]	2	[('CHEBI_27300', 'vitamin D', 73, 'vitamin D'), ('CL_0000019', 'sperm', 205, 'sperm'), ('GO_0065007', 'biological regulation', 211, 'motility'), ('CL_0000019', 'sperm', 264, 'spermatozoa')]	0	['agreement, epidemiological men  levels (using iom cut-off <25 nmol/l [22] endocrine society cut-off <50 nmol/l [23]) sperm progressive motility, mature spermatozoa.']
S41-PMC4969253	PMC4969253	8/2016	S41-PMC4969253	['CONFIRMATION of this Ra-Sm Regulation in vivo was provided by EVIDENCE that restricting maternal Vitamin A dietary intake during initiation of Airway Development resulted in aberrant overly differentiated and ectopic distribution of sm in these Airways.']	[('INCOMPLETE_EVIDENCE', 0), ('SUPERFICIAL_RELATIONSHIP', 27), ('INCOMPLETE_EVIDENCE', 62)]	3	[('PR_000013779', 'histone-binding protein RBBP7', 21, 'RA-SM'), ('GO_0065007', 'biological regulation', 27, 'regulation'), ('CHEBI_27300', 'vitamin D', 97, 'vitamin A'), ('GO_0035904', 'aorta development', 143, 'airway development'), ('UBERON_0001005', 'respiratory airway', 143, 'airway'), ('UBERON_0001005', 'respiratory airway', 245, 'airways')]	0	['confirmation ra-sm  vivo restricting maternal  dietary intake initiation airway resulted aberrant ectopic distribution sm airways.']
S32-PMC4976416	PMC4976416	7/2016	S32-PMC4976416	['hailey–hailey disease\nin 1975, ayres and mihan REPORTED Control of the condition of three patients with hailey–hailey disease by oral administration of Vitamin E in the form of D-Α-Tocopheryl Acetate in doses of 800–1200 iu/l.']	[('INCOMPLETE_EVIDENCE', 47)]	1	[('GO_0065007', 'biological regulation', 56, 'control'), ('CHEBI_27300', 'vitamin D', 152, 'vitamin E'), ('CHEBI_16237', '4-chlorophenylacetate', 177, 'd-α-tocopheryl acetate')]	0	['hailey–hailey disease\nin 1975, ayres mihan  condition three patients hailey–hailey disease oral administration  form d-α-tocopheryl acetate doses 800–1200 iu/l.']
S6-PMC4979151	PMC4979151	8/2016	S6-PMC4979151	['HOWEVER, Pha stimulation significantly induced the Expression of Genes encoding th1 and th2 cytokines and down-regulated a number of Genes INVOLVED in T-Cell Development, Proliferation and Differentiation Of B Cells, signal transduction pathway, transcriptional Regulation and pattern recognition receptors (prrs) in the Vitamin D group (vitd group).']	[('ANOMALY_CURIOUS_FINDING', 0), ('SUPERFICIAL_RELATIONSHIP', 139)]	2	[('CHEBI_34926', 'Pitrazepin', 9, 'PHA'), ('GO_0010467', 'gene expression', 51, 'expression'), ('SO_0000704', 'gene', 65, 'genes'), ('SO_0000704', 'gene', 133, 'genes'), ('CL_0000084', 'T cell', 151, 'T-cell'), ('GO_0002296', 'T-helper 1 cell lineage commitment', 151, 'T-cell development'), ('GO_0007565', 'female pregnancy', 171, 'proliferation ...'), ('GO_0030154', 'cell differentiation', 189, 'differentiation of B cells'), ('CL_0000236', 'B cell', 208, 'B cells'), ('GO_0065007', 'biological regulation', 262, 'regulation'), ('CHEBI_27300', 'vitamin D', 321, 'vitamin D')]	0	['however, pha stimulation induced expression genes encoding th1 th2 cytokines down-regulated genes t-cell development, proliferation b cells, signal transduction pathway, transcriptional  receptors (prrs)  (vitd group).']
S0-PMC4992225	PMC4992225	8/2016	S0-PMC4992225	['a randomized controlled trial of Vitamin D supplementation on Perinatal depression: in iranian Pregnant mothers\n\nabstract\n\nbackground\nMood disorders in Pregnancy and Post-Partum Period are common and CONSIDERED as a PUBLIC HEALTH ISSUE.']	[('IMPORTANT_CONSIDERATION', 200), ('IMPORTANT_CONSIDERATION', 216), ('IMPORTANT_CONSIDERATION', 230)]	3	[('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('GO_0036268', 'swimming', 62, 'perinatal'), ('UBERON_0012101', 'perinatal stage', 62, 'perinatal'), ('GO_0007565', 'female pregnancy', 95, 'pregnant'), ('GO_0065007', 'biological regulation', 134, 'Mood'), ('GO_0007565', 'female pregnancy', 152, 'pregnancy'), ('GO_0007565', 'female pregnancy', 166, 'post-partum'), ('UBERON_0001699', 'sensory root of facial nerve', 171, 'partum period')]	0	[' supplementation perinatal depression: iranian pregnant mothers\n\nabstract\n\nbackground\n disorders pregnancy post-partum period issue.']
S135-PMC4997421	PMC4997421	8/2016	S135-PMC4997421	['Serum Retinol levels are also under tight Homeostatic Control and MAY not be reliable indicators of the Vitamin A status of an Individual [44].']	[('INCOMPLETE_EVIDENCE', 66)]	1	[('UBERON_0001977', 'blood serum', 0, 'Serum'), ('CHEBI_26536', 'retinoic acid', 6, 'retinol'), ('GO_0042592', 'homeostatic process', 42, 'homeostatic'), ('GO_0065007', 'biological regulation', 54, 'control'), ('CHEBI_27300', 'vitamin D', 104, 'vitamin A'), ('NCBITaxon_1', 'root', 127, 'individual')]	0	['serum retinol levels tight homeostatic   status individual [44].']
S105-PMC5024431	PMC5024431	9/2016	S105-PMC5024431	['Eating Out less/Eat at home morei want to only dine out for 1 meal a weekeat more at home\u2003evening/night time Eating (e.g., healthier and/or restricting)no Eating after 8:00pmlimit snacks at night\u2003follow\xa0canada’s Food guidefollow canada’s Food guide\u2003follow \ufeffvegetarian/vegan dietseat mostly vegan\u2003follow\xa0fad diets (not gluten free)more alkaline and less Acidic Foods\u2003gluten free (includes wheat free)follow celiac diet\u2003follow\xa0other plans (includes fodmap guidelines, Heart healthy, diabetes, optifast®, weight watchers®, dash, dietitian meal plans, weight lifting, Pregnancy diet, unspecified diet plans)following the dietitian’s plan, eat only my shakes this week, follow diet, follow diabetes diet\u2003glycemic indexkeep a low glycemic index diet\u2003clean Eating (includes unprocessed, whole, fresh, raw, natural foods)Eating cleaner, eat as much raw as possible, to eat fresh Food\u2003supplementstake 600-800 iu Vitamin D daily\u2003planning and preparing Food†cook dinner from scratch a minimum of 3 times per week, plan 4–5 smaller meals per daybetter Planning and Preparing Of Food, plan healthy meals, plan meals\u2003goals describing when Food is Eaten or not Eaten/Eating patternseat breakfast, Lunch, dinner & snack every day, not to eat in between mealseat more regularly, try not to snack so much throughout the day\u2003breakfasteating healthy breakfastincorporate cereal or smoothies more often for breakfast\u2003psychological aspects of Eatingdon’t binge, drink Water or 0 cal drink when hungry, stop emotional eatingto Control Food Intake, respect Food AS a means of nutrition and to satisfy hunger\u2003general Eating improvementseat healthy meals and snacks, eat the RECOMMENDED dv of Minerals and Vitamins, eat a variety of foodseat healthy, eat a balanced diet, eat right to avoid ibs symptoms\noverall, there were n\u2009= \u20091,986, n\u2009= \u2009614, n\u2009= \u2009233, and n\u2009= \u20091,134 daily, weekly, monthly, and one-time write your own goal statements, respectively (excluding irrelevant to health/Nonsense goals); these goals were RARELY tracked.']	[('PROBABLE_UNDERSTANDING', 1538), ('FUTURE_WORK', 1649), ('INCOMPLETE_EVIDENCE', 1993)]	3	[('GO_0006897', 'endocytosis', 0, 'Eating out'), ('GO_0018888', '3-chloroacrylic acid metabolic process', 16, 'Eat'), ('GO_0051318', 'G1 phase', 109, 'eating'), ('GO_0051318', 'G1 phase', 155, 'eating'), ('CHEBI_33290', 'food', 212, 'Food'), ('CHEBI_33290', 'food', 238, 'food'), ('CHEBI_37527', 'acid', 353, 'acidic'), ('CHEBI_33290', 'food', 360, 'foods'), ('UBERON_0000948', 'heart', 466, 'heart'), ('GO_0007565', 'female pregnancy', 564, 'pregnancy'), ('GO_0051318', 'G1 phase', 750, 'eating'), ('GO_0007568', 'aging', 813, 'Eating'), ('CHEBI_33290', 'food', 871, 'food'), ('CHEBI_27300', 'vitamin D', 903, 'vitamin D'), ('PR_000006444', 'diacylglycerol kinase delta', 911, 'D'), ('CHEBI_33290', 'food', 942, 'food'), ('GO_0006260', 'DNA replication', 1040, 'planning'), ('GO_0007565', 'female pregnancy', 1053, 'preparing of food'), ('CHEBI_33290', 'food', 1066, 'food'), ('CHEBI_33290', 'food', 1125, 'food'), ('GO_0036268', 'swimming', 1133, 'eaten'), ('GO_0036268', 'swimming', 1146, 'eaten'), ('GO_0051318', 'G1 phase', 1152, 'eating'), ('UBERON_0010164', 'collection of hairs', 1182, 'Lunch'), ('GO_0050957', 'equilibrioception', 1421, 'eatingDon'), ('CHEBI_15377', 'water', 1446, 'water'), ('GO_0065007', 'biological regulation', 1504, 'control'), ('CHEBI_33290', 'food', 1512, 'food'), ('GO_0007631', 'feeding behavior', 1512, 'food intake'), ('CHEBI_33290', 'food', 1533, 'food'), ('GO_0051318', 'G1 phase', 1592, 'eating'), ('CHEBI_46751', 'quinolizidine', 1667, 'minerals'), ('CHEBI_33277', 'gamma-tocotrienol', 1680, 'vitamins'), ('GO_0001967', 'suckling behavior', 1959, 'nonsense')]	0	['eating less/eat home morei want dine meal weekeat home\u2003evening/night eating (e.g., healthier and/or restricting)no eating 8:00pmlimit snacks night\u2003follow\xa0canada’s food guidefollow canada’s food guide\u2003follow \ufeffvegetarian/vegan dietseat vegan\u2003follow\xa0fad diets (not gluten free)more alkaline acidic foods\u2003gluten (includes wheat free)follow celiac diet\u2003follow\xa0other (includes fodmap guidelines, healthy, diabetes, optifast®, watchers®, dash, dietitian meal plans, lifting, pregnancy diet, diet plans)following dietitian’s plan, eat shakes week, diet, diabetes diet\u2003glycemic indexkeep glycemic diet\u2003clean eating (includes unprocessed, whole, fresh, raw, natural foods)eating cleaner, eat raw possible, eat fresh food\u2003supplementstake 600-800 iu  daily\u2003planning preparing food†cook dinner scratch minimum 3 times week, 4–5 meals daybetter preparing food, healthy meals, meals\u2003goals food eaten eaten/eating patternseat breakfast, lunch, dinner & snack day, eat mealseat regularly, snack throughout day\u2003breakfasteating healthy breakfastincorporate cereal smoothies breakfast\u2003psychological aspects eatingdon’t binge, drink water 0 cal drink hungry, stop emotional eatingto  food intake, respect food nutrition hunger\u2003general eating improvementseat healthy meals snacks, eat dv minerals vitamins, eat foodseat healthy, eat diet, eat ibs symptoms\noverall, n\u2009= \u20091,986, n\u2009= \u2009614, n\u2009= \u2009233, n\u2009= \u20091,134 daily, weekly, monthly, one-time write statements, respectively (excluding health/nonsense goals); tracked.']
S83-PMC5028238	PMC5028238	10/2016	S83-PMC5028238	['in addition, BENEFITS from Prenatal Vitamin D supplementation are also Modulated by geographic location and OTHER FACTORS.47THEREFORE biological mechanisms that maximize Vitamin D production and absorption would be selected for in the north.']	[('IMPORTANT_CONSIDERATION', 13), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 108), ('SUPERFICIAL_RELATIONSHIP', 114), ('ANOMALY_CURIOUS_FINDING', 122), ('ANOMALY_CURIOUS_FINDING', 122), ('ANOMALY_CURIOUS_FINDING', 122)]	6	[('GO_0007565', 'female pregnancy', 27, 'prenatal'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('GO_0065007', 'biological regulation', 71, 'modulated'), ('CHEBI_27300', 'vitamin D', 170, 'vitamin D')]	0	['addition, prenatal  supplementation  geographic location factors.47therefore biological mechanisms maximize  production absorption selected north.']
S87-PMC5028238	PMC5028238	10/2016	S87-PMC5028238	"['[""""biological mechanism: Dhcr7\'s EFFECT on Vitamin D and Cholesterol Synthesis\\nthe biological mechanism that CONNECTS Dhcr7 mutations (slos carriers) and northern climate involves Regulation of 7-Dehydrocholesterol, Vitamin D and Cholesterol.""""]']"	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 106)]	2	[('PR_000006474', 'ATP-dependent RNA helicase A', 22, 'DHCR7'), ('CHEBI_27300', 'vitamin D', 40, 'vitamin D'), ('CHEBI_16113', 'cholesterol', 54, 'cholesterol'), ('GO_0006695', 'cholesterol biosynthetic process', 54, 'cholesterol synthesis'), ('PR_000006474', 'ATP-dependent RNA helicase A', 115, 'DHCR7'), ('GO_0065007', 'biological regulation', 177, 'regulation'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 191, '7-dehydrocholesterol'), ('CHEBI_27300', 'vitamin D', 213, 'vitamin D'), ('CHEBI_16113', 'cholesterol', 227, 'cholesterol')]	0	"['[""""biological mechanism: dhcr7*s n cholesterol synthesis\\nthe biological dhcr7 mutations (slos carriers) northern climate involtion 7-dehydrocholesterin cholesterol.""""]']"
S91-PMC5028238	PMC5028238	10/2016	S91-PMC5028238	['an indirect negative feedback LOOP, established in laboratory studies, allows Vitamin D levels to Regulate Dhcr7 activity and PREVENT hypervitaminosis D (that is, toxically high Vitamin d levels).54slos patients have high 7-Dehydrocholesterol levels.']	[('SUPERFICIAL_RELATIONSHIP', 30), ('SUPERFICIAL_RELATIONSHIP', 126)]	2	[('CHEBI_27300', 'vitamin D', 78, 'vitamin D'), ('GO_0065007', 'biological regulation', 98, 'regulate'), ('PR_000006474', 'ATP-dependent RNA helicase A', 107, 'DHCR7'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 151, 'D'), ('CHEBI_33229', 'vitamin (role)', 178, 'vitamin'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 222, '7-dehydrocholesterol')]	0	['feedback loop, laboratory studies,  levels  dhcr7 activity hypervitaminosis (that is, toxically vitamin levels).54slos patients 7-dehydrocholesterol levels.']
S80-PMC5030591	PMC5030591	9/2016	S80-PMC5030591	"['[""""caption (table-wrap): table 4\\n\\nthemes and elements relating to specific Conception and Pregnancy information for women with rheumatoid arthritis and their familiessaying : information that should be discussed by health professionals doing : actions that SHOULD BE undertaken by health professionals review of current Medications in relation to safety during Conception and Pregnancy (100%) prior to Conception and Pregnancy, review current Medication(s) and discuss:\\nmedications vary with respect to their SAFETY during Pregnancy and RISKS related to Fertility, Ovulation, Conception and Miscarriage\\nSOME Medicines used in ra care MAY have EFFECTS on Fertility, Conception and Pregnancy process, for example, regular Nsaids MAY impair fertility and ASSOCIATED RISKS with fetus\\nit is IMPORTANT to time Conceptionprovide GUIDANCE as to WHERE to obtain reliable information about SAFETY of Medicines in Pregnancywhere current Medication(s) is (are) contraindicated for Conception/Pregnancy the following SHOULD BE discussed with the patient:\\nthere are SAFE Medication options pre, during (including Delivery) and Postpregnancy (including Breast feeding)\\ntiming is IMPORTANT in RELATION to ceasing or switching of current Medications and allowing for washout periods prior to Conception\\nthere is a need for close supervision/monitoring by a rheumatologist when discontinuing current Medications prior to Pregnancy, including CONSIDERING POTENTIAL NEED for disease stabilisation on new treatment prior to Conception and Pregnancydiscuss IMPACT of ra pathology on Pregnancy and Pregnancy on ra (100%) there are DIFFERENT SCENARIOS regarding ra disease activity during Pregnancy (eg, POSSIBLE remission/low disease activity)discuss: ra-related pain management options during Pregnancyconception MAY take longer compared with women who do not have rathere is a need to balance disease Control with maternal and fetal health and safetyra MAY AFFECT Pregnancy and Pregnancy MAY AFFECT ra, and there are POSSIBLE adverse outcomes where risks are identified (eg, Prematurity)there are significant risks ASSOCIATED with active or uncontrolled ra for the mother and baby, ESPECIALLY irreversible Joint damage and functional impairmentpregnancy MAY change a patient’s health outlook in the futurethe size of the baby MAY BE smaller than women without ra and MAY also be Delivered pre-term discuss IMPORTANT elements of Preconception care RELEVANT to patient (97.1%) it is IMPORTANT to achieve optimal disease control prior to considering Pregnancy—Planning Conception is preferable after patients achieve and maintain low disease activityencourage and facilitate early discussions with all health practitioners involved in care about family planning to allow for adequate preparationthere is a CRITICAL need for a planned Pregnancy RATHER than an unplanned Pregnancyreview Prenatal nutrition, including need for dietary/vitamin supplements (ie, Folic Acid, calcium, Vitamin D, Iodine, iron)history of previous Attempts To Conceive/Pregnancies or Pregnancy-related complications (eg, Miscarriage) and other relevant patient history (such as smoking/Illicit Drug use history, family history of hereditary issues) MAY AFFECT Pregnancyundertake RELEVANT health checks such as immunisation status (eg, rubella, varicella, pertussis), Sexually Transmitted disease screening, pap test, screening for other Autoimmune disorders that MAY IMPACT on Pregnancyweight management and appropriate exercise are very IMPORTANTCONSIDER the NEED for review of diabetes or impaired Glucose tolerance if RISK factors are present (eg, on Steroid medication or overweight/obese)it is IMPORTANT to manage comorbid conditions, such as diabetes and hypertensionsome women MAY NEED to avoid Conception during a flarera disease activity MAY or MAY not improve with Pregnancy and there is a LIKELIHOOD of Postpartum flares importance of maintaining optimistic outlook and providing positive messages (97.1%) Pregnancy and Breast feeding success rates are near normal in women with mild to moderate ra nowadays (where appropriate for the patient\'s clinical status)ra is not a BARRIER to Pregnancystrategies to address anxiety, stress and depression (if relevant) are IMPORTANT, such as mindfulness meditation need for close monitoring of a patient prior to and during Pregnancy, where indicated (94.1%) it is IMPORTANCE to have a healthcare team with expertise in Autoimmune disorders for SOME women with radetermine THE NEED for high-level obstetric care during a Pregnancy (where indicated), including the need for Anaesthetic inputsome women REQUIRE closer monitoring of their Pregnancy and this is USUALLY proportional to disease activity, comorbidities and maternal historyassess the REQUIREMENTS for any extra treatment or monitoring prior to, or during, Pregnancyit is IMPORTANT to develop a Pregnancy plan, which includes different options for management of ra and support for different scenariosvaginal Delivery MAY NOT always BE POSSIBLE, depending on condition of the patient\'s Hips.""""]']"	[('FUTURE_WORK', 254), ('IMPORTANT_CONSIDERATION', 506), ('IMPORTANT_CONSIDERATION', 534), ('INCOMPLETE_EVIDENCE', 600), ('INCOMPLETE_EVIDENCE', 631), ('SUPERFICIAL_RELATIONSHIP', 640), ('INCOMPLETE_EVIDENCE', 724), ('SUPERFICIAL_RELATIONSHIP', 749), ('IMPORTANT_CONSIDERATION', 760), ('IMPORTANT_CONSIDERATION', 783), ('FUTURE_WORK', 819), ('EXPLICIT_QUESTION', 834), ('IMPORTANT_CONSIDERATION', 877), ('FUTURE_WORK', 1001), ('IMPORTANT_CONSIDERATION', 1049), ('IMPORTANT_CONSIDERATION', 1161), ('SUPERFICIAL_RELATIONSHIP', 1174), ('FUTURE_WORK', 1421), ('IMPORTANT_CONSIDERATION', 1421), ('INCOMPLETE_EVIDENCE', 1433), ('SUPERFICIAL_RELATIONSHIP', 1532), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1605), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 1615), ('INCOMPLETE_EVIDENCE', 1677), ('INCOMPLETE_EVIDENCE', 1788), ('INCOMPLETE_EVIDENCE', 1929), ('SUPERFICIAL_RELATIONSHIP', 1933), ('INCOMPLETE_EVIDENCE', 1964), ('SUPERFICIAL_RELATIONSHIP', 1968), ('INCOMPLETE_EVIDENCE', 1993), ('SUPERFICIAL_RELATIONSHIP', 2091), ('IMPORTANT_CONSIDERATION', 2158), ('INCOMPLETE_EVIDENCE', 2230), ('INCOMPLETE_EVIDENCE', 2302), ('INCOMPLETE_EVIDENCE', 2343), ('IMPORTANT_CONSIDERATION', 2382), ('SUPERFICIAL_RELATIONSHIP', 2423), ('IMPORTANT_CONSIDERATION', 2457), ('IMPORTANT_CONSIDERATION', 2779), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 2817), ('INCOMPLETE_EVIDENCE', 3196), ('SUPERFICIAL_RELATIONSHIP', 3200), ('IMPORTANT_CONSIDERATION', 3226), ('INCOMPLETE_EVIDENCE', 3410), ('SUPERFICIAL_RELATIONSHIP', 3414), ('IMPORTANT_CONSIDERATION', 3485), ('INCOMPLETE_EVIDENCE', 3507), ('SUPERFICIAL_RELATIONSHIP', 3568), ('IMPORTANT_CONSIDERATION', 3646), ('INCOMPLETE_EVIDENCE', 3731), ('FUTURE_WORK', 3735), ('IMPORTANT_CONSIDERATION', 3735), ('INCOMPLETE_EVIDENCE', 3794), ('INCOMPLETE_EVIDENCE', 3801), ('PROBABLE_UNDERSTANDING', 3847), ('DIFFICULT_TASK', 4131), ('IMPORTANT_CONSIDERATION', 4222), ('IMPORTANT_CONSIDERATION', 4364), ('INCOMPLETE_EVIDENCE', 4444), ('INCOMPLETE_EVIDENCE', 4472), ('IMPORTANT_CONSIDERATION', 4600), ('INCOMPLETE_EVIDENCE', 4657), ('IMPORTANT_CONSIDERATION', 4744), ('IMPORTANT_CONSIDERATION', 4831), ('INCOMPLETE_EVIDENCE', 4976), ('DIFFICULT_TASK', 4980)]	66	[('GO_0007631', 'feeding behavior', 72, 'conception ...'), ('GO_0007565', 'female pregnancy', 87, 'pregnancy'), ('CHEBI_25441', 'mycothiols', 317, 'medications'), ('GO_0007620', 'copulation', 358, 'conception'), ('GO_0007565', 'female pregnancy', 373, 'pregnancy'), ('GO_0007620', 'copulation', 399, 'conception'), ('GO_0007565', 'female pregnancy', 414, 'pregnancy'), ('CHEBI_60211', 'compound Z', 440, 'medication'), ('GO_0007565', 'female pregnancy', 520, 'pregnancy'), ('GO_0009566', 'fertilization', 551, 'fertility'), ('GO_0030728', 'ovulation', 562, 'ovulation'), ('GO_0007620', 'copulation', 573, 'conception'), ('GO_0046660', 'female sex differentiation', 588, 'miscarriage'), ('CHEBI_25179', 'melanins', 605, 'medicines'), ('GO_0009566', 'fertilization', 651, 'fertility'), ('GO_0007620', 'copulation', 662, 'conception'), ('GO_0007565', 'female pregnancy', 677, 'pregnancy'), ('CHEBI_16039', 'ITP', 717, 'NSAIDs'), ('GO_0070268', 'cornification', 801, 'conceptionProvide'), ('CHEBI_25179', 'melanins', 887, 'medicines'), ('GO_0000712', 'resolution of meiotic recombination intermediates', 900, 'pregnancyWhere'), ('CHEBI_60211', 'compound Z', 923, 'medication'), ('GO_0007620', 'copulation', 966, 'conception'), ('GO_0007565', 'female pregnancy', 977, 'pregnancy'), ('CHEBI_60211', 'compound Z', 1054, 'medication'), ('GO_0007567', 'parturition', 1096, 'delivery'), ('GO_0007565', 'female pregnancy', 1110, 'postpregnancy'), ('UBERON_0000310', 'breast', 1135, 'breast'), ('CHEBI_25441', 'mycothiols', 1218, 'medications'), ('GO_0007620', 'copulation', 1272, 'conception'), ('CHEBI_25441', 'mycothiols', 1379, 'medications'), ('GO_0007565', 'female pregnancy', 1400, 'pregnancy'), ('GO_0007620', 'copulation', 1500, 'conception'), ('GO_0006915', 'apoptotic process', 1515, 'pregnancyDiscuss'), ('GO_0007565', 'female pregnancy', 1558, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1572, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1662, 'pregnancy'), ('GO_0007602', 'phototransduction', 1768, 'pregnancyConception'), ('GO_0065007', 'biological regulation', 1877, 'control'), ('GO_0007565', 'female pregnancy', 1940, 'pregnancy'), ('GO_0007565', 'female pregnancy', 1954, 'pregnancy'), ('GO_0007565', 'female pregnancy', 2051, 'prematurity'), ('UBERON_0004905', 'articulation', 2182, 'joint'), ('GO_0007567', 'parturition', 2355, 'delivered'), ('GO_0007565', 'female pregnancy', 2404, 'preconception'), ('GO_0007565', 'female pregnancy', 2523, 'pregnancy'), ('GO_0006260', 'DNA replication', 2533, 'planning'), ('GO_0007620', 'copulation', 2542, 'conception'), ('GO_0007565', 'female pregnancy', 2807, 'pregnancy'), ('GO_0006412', 'translation', 2842, 'pregnancyReview'), ('GO_0007565', 'female pregnancy', 2858, 'prenatal'), ('CHEBI_30751', 'formic acid', 2930, 'folic acid'), ('CHEBI_27300', 'vitamin D', 2951, 'vitamin D'), ('CHEBI_24859', 'iodine atom', 2962, 'iodine'), ('GO_0000380', 'alternative mRNA splicing, via spliceosome', 2995, 'attempts to conceive'), ('GO_0007565', 'female pregnancy', 3016, 'pregnancies'), ('GO_0007565', 'female pregnancy', 3031, 'pregnancy'), ('GO_0046660', 'female sex differentiation', 3068, 'miscarriage'), ('CHEBI_35704', 'N(2)-acetyl-L-lysine', 3133, 'illicit drug'), ('GO_0051610', 'serotonin uptake', 3207, 'pregnancyUndertake'), ('GO_0019095', 'pole plasm mitochondrial rRNA localization', 3314, 'sexually transmitted'), ('UBERON_0001442', 'skeleton of manus', 3384, 'autoimmune'), ('GO_0006412', 'translation', 3424, 'pregnancyWeight'), ('CHEBI_17234', 'glucose', 3547, 'glucose'), ('CHEBI_35341', 'steroid', 3601, 'steroid'), ('GO_0007620', 'copulation', 3749, 'conception'), ('GO_0007565', 'female pregnancy', 3822, 'pregnancy'), ('GO_0007565', 'female pregnancy', 3861, 'postpartum'), ('GO_0007565', 'female pregnancy', 3964, 'Pregnancy'), ('UBERON_0000310', 'breast', 3978, 'breast'), ('GO_0006915', 'apoptotic process', 4142, 'pregnancyStrategies'), ('GO_0007565', 'female pregnancy', 4323, 'pregnancy'), ('UBERON_0001442', 'skeleton of manus', 4419, 'autoimmune'), ('GO_0007565', 'female pregnancy', 4520, 'pregnancy'), ('CHEBI_38867', 'anaesthetic', 4572, 'anaesthetic'), ('GO_0007565', 'female pregnancy', 4635, 'pregnancy'), ('GO_0007565', 'female pregnancy', 4816, 'pregnancyIt'), ('GO_0007565', 'female pregnancy', 4854, 'pregnancy'), ('GO_0007567', 'parturition', 4967, 'delivery'), ('UBERON_0000988', 'pons', 5044, 'hips')]	0	"['[""""caption (table-wrap): table 4\\n\\nthemes elements pregnancy women rheumatoid arthritis familiessaying : professionals : professionals medications pregnancy (100%) pregnancy, medication(s) discuss:\\nmedications respect pregnancy fertility, ovulation, miscarriage\\nsome medicines ra fertility, pregnancy process, example, nsaids fertility fetus\\nit conceptionprovide obtain medicines pregnancywhere medication(s) (are) conception/pregnancy following patient:\\nthere medication pre, (including delivery) postpregnancy (including breast feeding)\\ntiming ceasing switching medications allowing washout periods conception\\nthere close supervision/monitoring rheumatologist discontinuing medications pregnancy, disease stabilisation treatment pregnancydiscuss ra pathology pregnancy pregnancy ra (100%) regarding ra disease activity pregnancy (eg, remission/low disease activity)discuss: ra-related pain pregnancyconception longer women rathere balanase maternal fetal safetyra pregnancy pregnancy ra, outcomes (eg, prematurity)there ra mother baby, irreversible joint functional impairmentpregnancy patient’s outlook futurethe baby women ra delivered pre-term elements preconception patient (97.1%) achieve disease pregnancy—planning patients achieve maintain disease activityencourage discussions practitioners family preparationthere pregnancy pregnancyreview prenatal nutrition, dietary/vitamin supplements (ie, folic acid, vitamin d, iodine, iron)history conceive/pregnancies pregnancy-related (eg, miscarriage) patient (such smoking/illicit drug history, family hereditary issues) pregnancyundertake checks immunisation status (eg, rubella, varicella, pertussis), sexually transmitted disease screening, pap test, screening autoimmune disorders pregnancyweight exercise diabetes glucose tolerance (eg, steroid medication overweight/obese)it manage comorbid conditions, diabetes hypertensionsome women flarera disease activity pregnancy postpartum flares maintaining optimistic outlook positive (97.1%) pregnancy breast feeding rates normal women ra nowadays (where patient*s status)ra pregnancystrategies anxiety, depression (if relevant) important, mindfulness meditation close patient pregnancy, (94.1%) healthcare team expertise autoimmune disorders women radetermine high-level obstetric pregnancy (where indicated), anaesthetic inputsome women closer pregnancy proportional disease activity, comorbidities maternal historyassess extra treatment to, during, pregnancyit pregnancy plan, includes ra scenariosvaginal delivery possible, condition patient*s hips.""""]']"
S18-PMC5051327	PMC5051327	9/2016	S18-PMC5051327	['THEREFORE, cardiotocography (ctg) is the main instrument of fetal Surveillance.13it is PLAUSIBLE that Vitamin D deficiency COULD make the fetal Heart more vulnerable to fetal distress/Birth asphyxia.']	[('PROBABLE_UNDERSTANDING', 0), ('INCOMPLETE_EVIDENCE', 87), ('INCOMPLETE_EVIDENCE', 123)]	3	[('GO_0065007', 'biological regulation', 66, 'surveillance'), ('CHEBI_27300', 'vitamin D', 102, 'vitamin D'), ('UBERON_0000948', 'heart', 144, 'heart'), ('GO_0007567', 'parturition', 184, 'birth')]	0	['therefore, cardiotocography (ctg) main instrument fetal .13it  fetal fetal distress/birth asphyxia.']
S70-PMC5054480	PMC5054480	9/2016	S70-PMC5054480	['caption (table-wrap): table 2\n\nchanges in Calcium Homeostasis during Pregnancy and Lactationmeasured levelspregnant womanplacentafetuslactating womanserum Catotal Ca ↓Ionized Ca↔Intestinal Absorption twofold ↑active transfer DEPENDENT on Pthrp+ passive transferhigher than maternal levels; Regulated by fetal pthrpionized Ca slightly ↑Bone Resorption ↑Urinary Ca↑unknown↔pth↓↔no transferlowlowpthrpprogressively ↑ secretion by Decidua and Breastsno transfer; Placental and amniotic secretionhigher than in mothersecretion by the Umbilical Cord and Fetal Parathyroid Glands as early as 10 weeks↑↑: secretion by breasts25‐Vitamin D↔transfer; Placental hydroxylationrenal hydroxylation↔1,25‐dihydroxyvitamin dprogressive ↑ by 100%; Calbindin‐D9K ↑no transferlow↔1 α ‐hydroxylase activity↑stimulated by Estradiol, prolactin, Placental Lactogen, pthrppresentpresent in the Kidney↔Calcitonin↑ by 20%secretion by Thyroid and breastsno transfer; Placental secretion↑ in the first 6 weeks\nca, calcium level; Pthrp, Parathyroid Hormone‐Related Protein; Calbindin‐D9K, Vitamin D‐dependent calcium‐binding protein.']	[('SUPERFICIAL_RELATIONSHIP', 225)]	1	[('GO_0055073', 'cadmium ion homeostasis', 42, 'calcium homeostasis'), ('GO_0007565', 'female pregnancy', 69, 'pregnancy'), ('GO_0001764', 'neuron migration', 83, 'lactationMeasured'), ('CHEBI_17793', 'calycosin', 155, 'CaTotal'), ('CHEBI_32588', 'potassium chloride', 163, 'Ca'), ('CHEBI_24870', 'ion', 166, '↓'), ('CHEBI_5893', 'indapamide', 167, 'Ionized'), ('GO_0070481', 'nuclear-transcribed mRNA catabolic process, non-stop decay', 167, 'Ionized'), ('CHEBI_32588', 'potassium chloride', 175, 'Ca'), ('GO_0050892', 'intestinal absorption', 178, 'Intestinal absorption'), ('UBERON_0000160', 'intestine', 178, 'Intestinal'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 238, 'PTHrP'), ('GO_0065007', 'biological regulation', 290, 'regulated'), ('CHEBI_32588', 'potassium chloride', 322, 'Ca'), ('GO_0097578', 'sequestering of copper ion', 335, 'Bone resorption'), ('UBERON_0001088', 'urine', 352, 'Urinary'), ('CHEBI_32588', 'potassium chloride', 360, 'Ca'), ('UBERON_0002450', 'decidua', 427, 'decidua'), ('UBERON_0000310', 'breast', 439, 'breastsNo'), ('UBERON_0001987', 'placenta', 459, 'placental'), ('UBERON_0002331', 'umbilical cord', 529, 'umbilical cord'), ('UBERON_0000922', 'embryo', 548, 'fetal'), ('UBERON_0001132', 'parathyroid gland', 554, 'parathyroid glands'), ('CHEBI_27300', 'vitamin D', 620, 'vitamin D'), ('UBERON_0001987', 'placenta', 640, 'placental'), ('PR_000004968', 'calretinin', 729, 'calbindin'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 739, 'D9k'), ('CHEBI_23965', 'estradiol', 799, 'estradiol'), ('CHEBI_81588', 'Placental lactogen', 821, 'placental lactogen'), ('PR_000012764', 'piwi-like protein 3', 821, 'placental lactogen'), ('UBERON_0001987', 'placenta', 821, 'placental'), ('UBERON_0002113', 'kidney', 868, 'kidney'), ('CHEBI_17793', 'calycosin', 875, 'Calcitonin'), ('UBERON_0002046', 'thyroid gland', 906, 'thyroid'), ('UBERON_0001987', 'placenta', 938, 'placental'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 999, 'PTHrP'), ('PR_000013439', 'prostate tumor-overexpressed gene 1 protein', 1006, 'parathyroid hormone'), ('UBERON_0001132', 'parathyroid gland', 1006, 'parathyroid'), ('PR_000014009', 'regulating synaptic membrane exocytosis protein 1', 1026, 'related protein'), ('PR_000004968', 'calretinin', 1043, 'calbindin'), ('PR_000002325', 'dynein light chain 1, cytoplasmic', 1053, 'D9k'), ('CHEBI_27300', 'vitamin D', 1058, 'vitamin D')]	0	['caption (table-wrap): table 2\n\nchanges calcium homeostasis pregnancy lactationmeasured levelspregnant womanplacentafetuslactating womanserum catotal ca ↓ionized ca↔intestinal absorption twofold ↑active transfer pthrp+ passive transferhigher maternal levels;  fetal pthrpionized ca ↑bone resorption ↑urinary ca↑unknown↔pth↓↔no transferlowlowpthrpprogressively ↑ secretion decidua breastsno transfer; placental amniotic secretionhigher mothersecretion umbilical cord fetal parathyroid glands 10 weeks↑↑: secretion breasts25‐↔transfer; placental hydroxylationrenal hydroxylation↔1,25‐dihydroxyvitamin dprogressive ↑ 100%; calbindin‐d9k ↑no transferlow↔1 α ‐hydroxylase activity↑stimulated estradiol, prolactin, placental lactogen, pthrppresentpresent kidney↔calcitonin↑ 20%secretion thyroid breastsno transfer; placental secretion↑ 6 weeks\nca, calcium level; pthrp, parathyroid hormone‐related protein; calbindin‐d9k, ‐dependent calcium‐binding protein.']
S39-PMC5062906	PMC5062906	10/2016	S39-PMC5062906	['HOWEVER, RECENT FINDINGS implicate Vitamin D in Regulating Histone Modifications [16,17] and Dna Methylation [18].']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('INCOMPLETE_EVIDENCE', 9)]	2	[('CHEBI_27300', 'vitamin D', 35, 'vitamin D'), ('GO_0065007', 'biological regulation', 48, 'regulating'), ('CHEBI_15358', 'histone', 59, 'histone'), ('GO_0016570', 'histone modification', 59, 'histone modifications'), ('PR_000043452', 'core histone', 59, 'histone'), ('GO_0006306', 'DNA methylation', 93, 'DNA methylation')]	0	['however,   histone modifications [16,17] dna methylation [18].']
S55-PMC5062906	PMC5062906	10/2016	S55-PMC5062906	['we INVESTIGATED both maternally and paternally methylated dmrs and compared methylation changes in offspring Liver and Sperm to characterize Vitamin D-dependent Regulation of epigenetic state in Soma and germline over two generations.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 3)]	1	[('UBERON_0002107', 'liver', 109, 'liver'), ('CL_0000019', 'sperm', 119, 'sperm'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin D'), ('GO_0065007', 'biological regulation', 161, 'regulation'), ('GO_0044297', 'cell body', 195, 'soma')]	0	['maternally paternally methylated dmrs methylation changes offspring liver sperm characterize -dependent  epigenetic soma germline generations.']
S283-PMC5062906	PMC5062906	10/2016	S283-PMC5062906	['these observations SUGGEST that Vitamin D-induced changes in methylation are MOST LIKELY the result of sporadic epimutations due TO global dysregulation of epigenetic maintenance and that disruption of epigenetic Regulatory mechanisms is MOST LIKELY the causal FACTOR.']	[('INCOMPLETE_EVIDENCE', 19), ('PROBABLE_UNDERSTANDING', 77), ('PROBABLE_UNDERSTANDING', 82), ('QUESTION_ANSWERED_BY_THIS_WORK', 129), ('PROBABLE_UNDERSTANDING', 238), ('PROBABLE_UNDERSTANDING', 243), ('SUPERFICIAL_RELATIONSHIP', 261)]	7	[('CHEBI_27300', 'vitamin D', 32, 'vitamin D'), ('GO_0065007', 'biological regulation', 213, 'regulatory')]	0	['-induced changes methylation result sporadic epimutations dysregulation epigenetic maintenance epigenetic  mechanisms causal factor.']
S292-PMC5062906	PMC5062906	10/2016	S292-PMC5062906	['percent variation explained by each component is listed in parentheses on each axis\nin SUPPORT of our hypotheses that maternal Vitamin D deficiency leads to global dysregulation of epigenetic maintenance via disruption of epigenetic Regulatory factors, we find that dnmt3b Transcript levels are upregulated in cross 1 neonatal Liver from lvd group compared to con.']	[('INCOMPLETE_EVIDENCE', 87)]	1	[('CHEBI_27300', 'vitamin D', 127, 'vitamin D'), ('GO_0065007', 'biological regulation', 233, 'regulatory'), ('SO_0000673', 'transcript', 273, 'transcript'), ('UBERON_0002107', 'liver', 327, 'liver')]	0	['percent listed parentheses axis\nin maternal  dysregulation epigenetic maintenance via epigenetic  factors, dnmt3b transcript levels upregulated neonatal liver lvd con.']
S296-PMC5062906	PMC5062906	10/2016	S296-PMC5062906	['our data SUGGESTS that Vitamin D-dependent dysregulation of epigenetic mechanisms is spatially and temporally Regulated.']	[('INCOMPLETE_EVIDENCE', 9)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0065007', 'biological regulation', 110, 'regulated')]	0	['-dependent dysregulation epigenetic mechanisms spatially temporally .']
S21-PMC5064894	PMC5064894	10/2016	S21-PMC5064894	['Vitamin D HAS BEEN SHOWN to Modulate the Innate Immune Response in Lung Epithelial Cells [6,7], and Antimicrobial peptides induced by Vitamin D MAY have antiviral EFFECTS BASED on observed activity against Herpes Simplex Virus-1 (Hsv-1) [8], adenovirus [9], human immunodeficiency virus (hiv) [10] and vaccinia [11].']	[('INCOMPLETE_EVIDENCE', 10), ('INCOMPLETE_EVIDENCE', 144), ('SUPERFICIAL_RELATIONSHIP', 163), ('QUESTION_ANSWERED_BY_THIS_WORK', 171)]	4	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('GO_0065007', 'biological regulation', 28, 'modulate'), ('GO_0045087', 'innate immune response', 41, 'innate immune response'), ('UBERON_0002405', 'immune system', 48, 'immune'), ('CL_0000082', 'epithelial cell of lung', 67, 'lung epithelial cells'), ('UBERON_0000115', 'lung epithelium', 67, 'lung epithelial'), ('CHEBI_65381', 'albizoside C', 100, 'antimicrobial'), ('CHEBI_27300', 'vitamin D', 134, 'vitamin D'), ('PR_000008476', 'orexin', 206, 'herpes simplex virus'), ('NCBITaxon_10088', 'Mus <genus>', 230, 'HSV'), ('PR_000008775', 'estradiol 17-beta-dehydrogenase 11', 230, 'HSV-1')]	0	['vitamin  innate immune response lung epithelial cells [6,7], antimicrobial peptides induced  antiviral activity herpes simplex virus-1 (hsv-1) [8], adenovirus [9], human immunodeficiency virus (hiv) [10] vaccinia [11].']
S118-PMC5084016	PMC5084016	10/2016	S118-PMC5084016	['IN FACT, ONLY the FIRST of the two Hydroxylation processes occurring in Vitamin D Metabolism (e.g., that responsible for the production of 25-Hydroxy-Vitamin D) is Modulated by the dietary contribution to SOME extent (the increase of circulating levels is not proportional to the amount Ingested).']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 9), ('INCOMPLETE_EVIDENCE', 18), ('INCOMPLETE_EVIDENCE', 205)]	4	[('GO_0044444', 'cytoplasmic part', 35, 'hydroxylation'), ('CHEBI_27300', 'vitamin D', 72, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 72, 'vitamin D metabolism'), ('CHEBI_43141', '3-hydroxypropoxy group', 139, '25-hydroxy'), ('CHEBI_27300', 'vitamin D', 150, 'vitamin D'), ('GO_0065007', 'biological regulation', 164, 'modulated'), ('GO_0007631', 'feeding behavior', 287, 'ingested')]	0	['fact, hydroxylation processes occurring  metabolism (e.g., production 25-hydroxy-)  dietary (the increase circulating levels proportional amount ingested).']
S119-PMC5084016	PMC5084016	10/2016	S119-PMC5084016	['the hydroxylation into 1,25-Hydroxy-Vitamin D in the Proximal Renal Tubules is closely Regulated by feedback mechanisms and PRIMARILY DEPENDS on the requirement for calcium and Phosphorus [57].']	[('PROBABLE_UNDERSTANDING', 124), ('SUPERFICIAL_RELATIONSHIP', 134)]	2	[('CHEBI_67771', 'Xestoproxamine C, (rel)-', 23, '1,25-hydroxy-'), ('CHEBI_27300', 'vitamin D', 36, 'vitamin D'), ('UBERON_0001092', 'vertebral bone 1', 53, 'proximal'), ('UBERON_0009773', 'renal tubule', 62, 'renal tubules'), ('GO_0065007', 'biological regulation', 87, 'regulated'), ('CHEBI_35885', 'secondary phosphine', 177, 'phosphorus')]	0	['hydroxylation 1,25-hydroxy- proximal renal tubules  feedback mechanisms calcium phosphorus [57].']
S126-PMC5084016	PMC5084016	10/2016	S126-PMC5084016	['in the first stage of Pregnancy, Vitamin D (mainly Vitamin D3, the predominant form in the maternal Blood) is INVOLVED in the Regulation Of Cytokine Metabolism and in the Modulation Of the Immune System, thereby contributing to the Embryo Implantation and Regulating the secretion of several hormones.']	[('SUPERFICIAL_RELATIONSHIP', 110)]	1	[('GO_0007565', 'female pregnancy', 22, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 33, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 51, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 51, 'Vitamin D3'), ('UBERON_0000178', 'blood', 100, 'blood'), ('GO_0007565', 'female pregnancy', 126, 'regulation of'), ('GO_0009690', 'cytokinin metabolic process', 140, 'cytokine metabolism'), ('GO_0002022', 'detection of dietary excess', 171, 'modulation of ... immune system'), ('UBERON_0002405', 'immune system', 189, 'immune system'), ('GO_0007601', 'visual perception', 232, 'embryo'), ('UBERON_0000922', 'embryo', 232, 'embryo'), ('GO_0007566', 'embryo implantation', 239, 'implantation'), ('GO_0065007', 'biological regulation', 256, 'regulating')]	0	['pregnancy,  (mainly vitamin d3, form maternal blood) cytokine metabolism immune system, embryo implantation  secretion hormones.']
S22-PMC5129897	PMC5129897	10/2016	S22-PMC5129897	['diseases included in THIS STUDY along with a brief overview of the mechanisms of Vitamin D for each disease and a listing of a few observational studies and clinical trials in support.diseasemechanismsobservational studiesclinical trialscancereffects on cells, Angiogenesis, and metastasis10breast and Colorectal cancer incidence11; survival12breast and all-cancer incidence13cvdeffects on Serum Cholesterol levels, Arterial stiffness, Insulin resistance, hyperglycemia, and increased incident Metabolic syndrome are POTENTIALLY PLAUSIBLE mediators8refs.14,15effect on cvd risk factors16dementiaregulation of Calcium Homeostasis, clearance of Amyloid-Β peptide, antioxidant and anti-inflammatory EFFECTS, and POSSIBLE protection against the neurodegenerative mechanisms ASSOCIATED with ad17incidence18\xa0dmimproves Insulin sensitivity and secretion, mainly via its anti-inflammatory properties19incidence20; meta-analysis21\xa0falls and fracturesreduces bone mass loss by reducing inflammation22; maintains cognition23; helps maintain muscle mass24ref.25ref.26mseffects on Regulatory T and B Cells27Ref.28\xa0respiratory infectionsinduction of Cathelicidin and defensins29; strengthens Adaptive and innate Immune System30Pneumonia31Influenza32,33; ari34\nad, alzheimer disease; ari, acute Respiratory Tract infection; cvd, Cardiovascular disease; dm, diabetes mellitus; ms, multiple sclerosis.']	[('QUESTION_ANSWERED_BY_THIS_WORK', 21), ('INCOMPLETE_EVIDENCE', 517), ('INCOMPLETE_EVIDENCE', 529), ('SUPERFICIAL_RELATIONSHIP', 696), ('INCOMPLETE_EVIDENCE', 709), ('SUPERFICIAL_RELATIONSHIP', 770)]	6	[('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('GO_0001525', 'angiogenesis', 261, 'angiogenesis'), ('UBERON_0012652', 'colorectum', 302, 'colorectal'), ('UBERON_0001977', 'blood serum', 390, 'serum'), ('CHEBI_16113', 'cholesterol', 396, 'cholesterol'), ('UBERON_0001637', 'artery', 416, 'arterial'), ('PR_000045358', 'insulin family protein', 436, 'insulin'), ('GO_0008152', 'metabolic process', 494, 'metabolic'), ('GO_0055073', 'cadmium ion homeostasis', 609, 'calcium homeostasis'), ('PR_000004519', 'autism susceptibility gene 2 protein', 643, 'amyloid-β'), ('PR_000045358', 'insulin family protein', 813, 'insulin'), ('CL_0000815', 'regulatory T cell', 1068, 'regulatory T ...'), ('GO_0065007', 'biological regulation', 1068, 'regulatory'), ('CL_0000960', 'T3 B cell', 1085, 'B cells27Ref'), ('PR_000006009', 'alpha-catulin', 1136, 'cathelicidin'), ('GO_0051886', 'negative regulation of timing of anagen', 1178, 'adaptive ...'), ('UBERON_0003822', 'forelimb stylopod', 1198, 'immune system30Pneumonia31Influenza32'), ('UBERON_0000065', 'respiratory tract', 1280, 'respiratory tract'), ('UBERON_0004535', 'cardiovascular system', 1314, 'cardiovascular')]	0	['diseases along mechanisms  disease listing support.diseasemechanismsobservational studiesclinical trialscancereffects cells, angiogenesis, metastasis10breast colorectal cancer incidence11; survival12breast all-cancer incidence13cvdeffects serum cholesterol levels, arterial stiffness, insulin resistance, hyperglycemia, incident metabolic syndrome mediators8refs.14,15effect cvd factors16dementiaregulation calcium homeostasis, clearance amyloid-β peptide, antioxidant anti-inflammatory effects, neurodegenerative mechanisms ad17incidence18\xa0dmimproves insulin sensitivity secretion, via anti-inflammatory properties19incidence20; meta-analysis21\xa0falls fracturesreduces bone mass loss reducing inflammation22; cognition23; maintain muscle mass24ref.25ref.26mseffects  b cells27ref.28\xa0respiratory infectionsinduction cathelicidin defensins29; adaptive innate immune system30pneumonia31influenza32,33; ari34\nad, alzheimer disease; ari, acute respiratory tract infection; cvd, cardiovascular disease; dm, diabetes mellitus; ms, sclerosis.']
S190-PMC5129897	PMC5129897	10/2016	S190-PMC5129897	['one is reduction in Blood pressure through liberating Nitric Oxide from subcutaneous Nitrogen stores.101another is that uv MAY Modulate the Immune Response to psoriasis, asthma, ms, and infection through mechanisms independent of Vitamin D.102uvb exposure APPARENTLY reduces the risk of ms through both Vitamin D–DEPENDENT and –INDEPENDENT mechanisms.103\nthe CONCERNS regarding RISK of skin cancer and melanoma are OFTEN overstated in comparison with the benefits of non burning, moderate uv exposure.']	[('INCOMPLETE_EVIDENCE', 123), ('ANOMALY_CURIOUS_FINDING', 256), ('SUPERFICIAL_RELATIONSHIP', 313), ('SUPERFICIAL_RELATIONSHIP', 328), ('PROBLEM_COMPLICATION', 359), ('IMPORTANT_CONSIDERATION', 378), ('PROBABLE_UNDERSTANDING', 415)]	7	[('UBERON_0000178', 'blood', 20, 'blood'), ('CHEBI_16480', 'nitric oxide', 54, 'nitric oxide'), ('CHEBI_33300', 'pnictogen', 85, 'nitrogen'), ('GO_0065007', 'biological regulation', 127, 'modulate'), ('GO_0006955', 'immune response', 140, 'immune response'), ('UBERON_0002405', 'immune system', 140, 'immune'), ('CHEBI_27300', 'vitamin D', 230, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 303, 'vitamin D')]	0	['one reduction blood pressure liberating nitric oxide subcutaneous nitrogen stores.101another uv  immune response psoriasis, asthma, ms, infection mechanisms .102uvb exposure reduces ms –dependent –independent mechanisms.103\nthe regarding skin cancer melanoma burning, uv exposure.']
S180-PMC5332602	PMC5332602	3/2017	S180-PMC5332602	['in addition to decreased Serum protein, Albumin, and Glucose levels, we observed that protein malnutrition AFFECTED the Homeostatic Control of Selenium and Vitamins A and e, CONSISTENT with SIMILAR observations on secondary Micronutrient deficiencies ASSOCIATED with childhood malnourishment (1).']	[('SUPERFICIAL_RELATIONSHIP', 107), ('INCOMPLETE_EVIDENCE', 174), ('INCOMPLETE_EVIDENCE', 190), ('SUPERFICIAL_RELATIONSHIP', 251)]	4	[('UBERON_0001977', 'blood serum', 25, 'serum'), ('PR_000005908', 'alpha-crystallin B chain', 40, 'albumin'), ('CHEBI_17234', 'glucose', 53, 'glucose'), ('GO_0042592', 'homeostatic process', 120, 'homeostatic'), ('GO_0065007', 'biological regulation', 132, 'control'), ('CHEBI_27568', 'selenium atom', 143, 'selenium'), ('GO_0007601', 'visual perception', 143, 'selenium'), ('CHEBI_27300', 'vitamin D', 156, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 156, 'vitamins A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 224, 'micronutrient')]	0	['addition decreased serum protein, albumin, glucose levels, protein malnutrition homeostatic  selenium  e, secondary micronutrient childhood malnourishment (1).']
S181-PMC5332602	PMC5332602	3/2017	S181-PMC5332602	['THUS, UNLIKE in our MODEL of Prenatal Vitamin A deficiency (single-Micronutrient deficiency) (31), protein deficiency AFFECTED the levels or Homeostatic Control of multiple Macro- and Micronutrients, limiting the ability of neonatal Pigs to adapt/maintain Homeostasis through compensatory mechanisms.']	[('PROBABLE_UNDERSTANDING', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 6), ('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 118)]	4	[('GO_0007565', 'female pregnancy', 29, 'prenatal'), ('CHEBI_27300', 'vitamin D', 38, 'vitamin A'), ('CHEBI_33962', 'mu4-sulfido-quadro-tetracopper(6+)', 67, 'micronutrient'), ('GO_0042592', 'homeostatic process', 141, 'homeostatic'), ('GO_0065007', 'biological regulation', 153, 'control'), ('CHEBI_34830', 'mefenacet', 173, 'macro'), ('CHEBI_33839', 'macromolecule', 184, 'micronutrients'), ('NCBITaxon_10088', 'Mus <genus>', 233, 'pigs'), ('GO_0042592', 'homeostatic process', 256, 'homeostasis')]	0	['thus, prenatal  (single-micronutrient deficiency) (31), protein levels homeostatic  macro- micronutrients, ability neonatal pigs adapt/maintain homeostasis compensatory mechanisms.']
S185-PMC5368580	PMC5368580	4/2017	S185-PMC5368580	['the Regulation of fat-soluble Vitamins A and E APPEARS TO occur through a specific transport system independent from Lipid Transfer, but the mechanisms INVOLVED have not been revealed (36,37).']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ANOMALY_CURIOUS_FINDING', 47), ('SUPERFICIAL_RELATIONSHIP', 152)]	3	[('GO_0065007', 'biological regulation', 4, 'regulation'), ('CHEBI_27300', 'vitamin D', 30, 'vitamins A'), ('PR_000004480', 'V-type proton ATPase catalytic subunit A', 30, 'vitamins A'), ('CHEBI_52024', '4-(4-dihexadecylaminostyryl)-N-methylpyridium iodide', 45, 'E'), ('CHEBI_18059', 'lipid', 117, 'lipid'), ('GO_0060986', 'endocrine hormone secretion', 117, 'lipid transfer')]	0	[' fat-soluble  e occur transport system lipid transfer, mechanisms (36,37).']
S16-PMC5372327	PMC5372327	3/2017	S16-PMC5372327	['IN FACT, Vitamin D HAS BEEN ESTIMATED to directly and indirectly Regulate the Expression of 2–3% of the Human Genome [4].']	[('ANOMALY_CURIOUS_FINDING', 0), ('INCOMPLETE_EVIDENCE', 19), ('INCOMPLETE_EVIDENCE', 28)]	3	[('CHEBI_27300', 'vitamin D', 9, 'vitamin D'), ('GO_0065007', 'biological regulation', 65, 'regulate'), ('GO_0010467', 'gene expression', 78, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 104, 'human'), ('SO_0001026', 'genome', 110, 'genome')]	0	['fact,   expression 2–3% human genome [4].']
S25-PMC5372327	PMC5372327	3/2017	S25-PMC5372327	['ROLE of Vitamin D in health and disease\n\ngrowth and bone mineralisation\nSerum calcium and Phosphate concentrations are tightly Regulated by Parathyroid hormone (pth) and 1,25-oh2d by negative feedback.']	[('SUPERFICIAL_RELATIONSHIP', 0)]	1	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0001977', 'blood serum', 72, 'Serum'), ('CHEBI_18367', 'phosphate(3-)', 90, 'phosphate'), ('GO_0065007', 'biological regulation', 127, 'regulated'), ('UBERON_0001132', 'parathyroid gland', 140, 'parathyroid')]	0	['role  disease\n\ngrowth bone mineralisation\nserum calcium phosphate concentrations tightly  parathyroid hormone (pth) 1,25-oh2d feedback.']
S39-PMC5372327	PMC5372327	3/2017	S39-PMC5372327	['THEREFORE, Vitamin D does NOT ONLY have a ROLE in Modulating Host Defence To Infections, BUT is LIKELY to Control FACTORS in autoimmunity, also in allergic disease.']	[('PROBABLE_UNDERSTANDING', 0), ('ANOMALY_CURIOUS_FINDING', 26), ('SUPERFICIAL_RELATIONSHIP', 42), ('ANOMALY_CURIOUS_FINDING', 89), ('PROBABLE_UNDERSTANDING', 96), ('SUPERFICIAL_RELATIONSHIP', 114)]	6	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('GO_0065007', 'biological regulation', 50, 'modulating'), ('GO_0030989', 'dynein-driven meiotic oscillatory nuclear movement', 61, 'host defence to infections'), ('GO_0065007', 'biological regulation', 106, 'control')]	0	['therefore,   host defence infections,  autoimmunity, allergic disease.']
S16-PMC5405075	PMC5405075	4/2017	S16-PMC5405075	['it is, HOWEVER, INTERESTING that, during this period, Vitamin D Metabolism is shifted from the classical determinants of Calcium Homeostasis to OTHER Regulatory mechanisms.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 7), ('ANOMALY_CURIOUS_FINDING', 16), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 144)]	3	[('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0042359', 'vitamin D metabolic process', 54, 'vitamin D metabolism'), ('GO_0055073', 'cadmium ion homeostasis', 121, 'calcium homeostasis'), ('GO_0065007', 'biological regulation', 150, 'regulatory')]	0	['is, however, that, period,  metabolism calcium homeostasis  mechanisms.']
S85-PMC5405075	PMC5405075	4/2017	S85-PMC5405075	['additionally, Vitamin D is a marker of uv exposure, which CAN Modulate Immunity via non-Vitamin D RELATED pathways (80,81).']	[('INCOMPLETE_EVIDENCE', 58), ('SUPERFICIAL_RELATIONSHIP', 98)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0065007', 'biological regulation', 62, 'modulate'), ('GO_0007566', 'embryo implantation', 71, 'immunity'), ('CHEBI_27300', 'vitamin D', 88, 'vitamin D')]	0	['additionally,  uv exposure,  immunity via non- (80,81).']
S25-PMC5474873	PMC5474873	6/2017	S25-PMC5474873	['reviewed seven STUDIES on Vitamin D and psychosis and CONCLUDED that Individuals with psychosis showed lower Vitamin D levels than healthy controls (16), and a COMPREHENSIVE meta-analysis of observation studies SUGGESTED a strong RELATIONSHIP between Vitamin D deficiency and schizophrenia (17) Vitamin D HAS BEEN FOUND to Modulate Dopamine Neurotransmission (5), and SEVERAL STUDIES REPORTED an ASSOCIATION between early Life Vitamin D deficiency and later psychotic disorder.']	[('INCOMPLETE_EVIDENCE', 15), ('INCOMPLETE_EVIDENCE', 54), ('PROBABLE_UNDERSTANDING', 160), ('INCOMPLETE_EVIDENCE', 211), ('SUPERFICIAL_RELATIONSHIP', 230), ('INCOMPLETE_EVIDENCE', 305), ('INCOMPLETE_EVIDENCE', 368), ('INCOMPLETE_EVIDENCE', 384), ('SUPERFICIAL_RELATIONSHIP', 396)]	9	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('NCBITaxon_1', 'root', 69, 'individuals'), ('CHEBI_27300', 'vitamin D', 109, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 251, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 295, 'Vitamin D'), ('GO_0065007', 'biological regulation', 323, 'modulate'), ('CHEBI_18243', 'dopamine', 332, 'dopamine'), ('GO_0061527', 'dopamine secretion, neurotransmission', 332, 'dopamine neurotransmission'), ('UBERON_0000104', 'life cycle', 422, 'life'), ('CHEBI_27300', 'vitamin D', 427, 'vitamin D')]	0	['reviewed seven  psychosis individuals psychosis  levels healthy (16), meta-analysis  schizophrenia (17) vitamin  dopamine neurotransmission (5), life  psychotic disorder.']
S201-PMC5487839	PMC5487839	3/2016	S201-PMC5487839	['the data obtained in a relatively SMALL group of patients are IN LINE WITH REPORTS on the advantages of vegetal proteins in reducing Kidney disease progression in non-Pregnant Humans, with a systematic review on vegan-vegetarian diets in Pregnancy, and with the position of the american dietary association, provided that b12, iron and Vitamin D are Controlled and supplied upon NEED [170–178].']	[('INCOMPLETE_EVIDENCE', 34), ('INCOMPLETE_EVIDENCE', 62), ('INCOMPLETE_EVIDENCE', 75), ('IMPORTANT_CONSIDERATION', 379)]	4	[('UBERON_0002113', 'kidney', 133, 'kidney'), ('GO_0007565', 'female pregnancy', 167, 'pregnant'), ('NCBITaxon_9606', 'Homo sapiens', 176, 'humans'), ('GO_0007565', 'female pregnancy', 238, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 336, 'vitamin D'), ('GO_0065007', 'biological regulation', 350, 'controlled')]	0	['patients vegetal proteins reducing kidney disease progression non-pregnant humans, vegan-vegetarian diets pregnancy, position american dietary association, b12, iron   supplied [170–178].']
S7-PMC5489519	PMC5489519	6/2017	S7-PMC5489519	['CONSISTENTLY, Vitamin D Regulated Trail mrna Expression in hme-1 cells.']	[('PROBABLE_UNDERSTANDING', 0), ('SUPERFICIAL_RELATIONSHIP', 24)]	2	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0065007', 'biological regulation', 24, 'regulated'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 34, 'TRAIL'), ('GO_0010467', 'gene expression', 45, 'expression')]	0	['consistently,   trail mrna expression hme-1 cells.']
S8-PMC5489519	PMC5489519	6/2017	S8-PMC5489519	['our results INDICATE that Vitamin D status in mothers Modulates Trail Expression in Breast Milk, which MAY have IMPLICATIONS for both mother and infant health.']	[('INCOMPLETE_EVIDENCE', 12), ('INCOMPLETE_EVIDENCE', 103), ('IMPORTANT_CONSIDERATION', 112)]	3	[('CHEBI_27300', 'vitamin D', 26, 'vitamin D'), ('GO_0065007', 'biological regulation', 54, 'modulates'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 64, 'TRAIL'), ('GO_0010467', 'gene expression', 70, 'expression'), ('UBERON_0001348', 'brown adipose tissue', 84, 'breast milk')]	0	['results  status mothers  trail expression breast milk, mother infant health.']
S10-PMC5489519	PMC5489519	6/2017	S10-PMC5489519	['it HAS BEEN SHOWN that Vitamin D Regulates Calcium Uptake, Bone Homeostasis, Mammalian Cell Growth and Division.']	[('INCOMPLETE_EVIDENCE', 3)]	1	[('CHEBI_27300', 'vitamin D', 23, 'vitamin D'), ('GO_0065007', 'biological regulation', 33, 'regulates'), ('GO_0070509', 'calcium ion import', 43, 'calcium uptake'), ('GO_0055064', 'chloride ion homeostasis', 59, 'bone homeostasis'), ('NCBITaxon_40674', 'Mammalia', 77, 'mammalian'), ('GO_0001775', 'cell activation', 87, 'cell growth ... division')]	0	['  calcium uptake, bone homeostasis, mammalian cell division.']
S11-PMC5489519	PMC5489519	6/2017	S11-PMC5489519	['in addition, Vitamin D is IMPLICATED in the Regulation of T-Lymphocytes, Monocytes and Macrophages Of the Immune System3–5.']	[('SUPERFICIAL_RELATIONSHIP', 26), ('SUPERFICIAL_RELATIONSHIP', 44)]	2	[('CHEBI_27300', 'vitamin D', 13, 'vitamin D'), ('GO_0065007', 'biological regulation', 44, 'regulation'), ('CL_0000084', 'T cell', 58, 'T-lymphocytes'), ('CL_0000576', 'monocyte', 73, 'monocytes'), ('CL_0000091', 'Kupffer cell', 87, 'macrophages of ... immune system3'), ('UBERON_0002405', 'immune system', 106, 'immune system3')]	0	['addition,   t-lymphocytes, monocytes macrophages immune system3–5.']
S20-PMC5489519	PMC5489519	6/2017	S20-PMC5489519	['HOWEVER, it is UNKNOWN WHETHER Vitamin D deficiency in Lactating mothers Modulates the Expression of cellular factor(s) in Human Milk that is ASSOCIATED with Immune health and Skeletal Development in breastfeeding infants.']	[('ALTERNATIVE_OPTIONS_CONTROVERSY', 0), ('ANOMALY_CURIOUS_FINDING', 0), ('FULL_UNKNOWN', 15), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 23), ('SUPERFICIAL_RELATIONSHIP', 142)]	5	[('CHEBI_27300', 'vitamin D', 31, 'vitamin D'), ('GO_0007594', 'puparial adhesion', 55, 'lactating'), ('GO_0065007', 'biological regulation', 73, 'modulates'), ('GO_0010467', 'gene expression', 87, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 123, 'human'), ('UBERON_0001913', 'milk', 129, 'milk'), ('UBERON_0002405', 'immune system', 158, 'immune'), ('GO_0001501', 'skeletal system development', 176, 'skeletal development'), ('UBERON_0004288', 'skeleton', 176, 'skeletal')]	0	['however,  lactating mothers  expression cellular factor(s) human milk immune skeletal breastfeeding infants.']
S26-PMC5489519	PMC5489519	6/2017	S26-PMC5489519	['SIMILAR to Vitamin D, Trail HAS BEEN SHOWN to Regulate Immune Cell functions, Bone Remodeling and Cell Growth/Differentiation20,22.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 28)]	2	[('CHEBI_27300', 'vitamin D', 11, 'vitamin D'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 22, 'TRAIL'), ('GO_0065007', 'biological regulation', 46, 'regulate'), ('CL_0000738', 'leukocyte', 55, 'immune cell'), ('UBERON_0002405', 'immune system', 55, 'immune'), ('GO_0046849', 'bone remodeling', 78, 'bone remodeling'), ('GO_0034614', 'cellular response to reactive oxygen species', 98, 'cell growth ... differentiation20')]	0	['similar trail  immune cell functions, bone remodeling cell growth/differentiation20,22.']
S30-PMC5489519	PMC5489519	6/2017	S30-PMC5489519	['furthermore, our experiments REVEALED that Vitamin D levels differentially Regulates Trail Isoform Expression in Mammary Epithelial Cells in vitro .']	[('INCOMPLETE_EVIDENCE', 29)]	1	[('CHEBI_27300', 'vitamin D', 43, 'vitamin D'), ('GO_0065007', 'biological regulation', 75, 'regulates'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 85, 'TRAIL'), ('SO_0001060', 'sequence_variant', 91, 'isoform'), ('GO_0010467', 'gene expression', 99, 'expression'), ('CL_0002327', 'mammary gland epithelial cell', 113, 'mammary epithelial cells'), ('UBERON_0006954', 'mammary gland myoepithelium', 113, 'mammary epithelial')]	0	['furthermore, experiments  levels  trail isoform expression mammary epithelial cells .']
S46-PMC5489519	PMC5489519	6/2017	S46-PMC5489519	['these results SUGGEST that Vitamin D status in mothers Modulate Trail Expression levels in Human Breast Milk.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('CHEBI_27300', 'vitamin D', 27, 'vitamin D'), ('GO_0065007', 'biological regulation', 55, 'modulate'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 64, 'TRAIL'), ('GO_0010467', 'gene expression', 70, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 91, 'human'), ('UBERON_0000310', 'breast', 97, 'breast'), ('UBERON_0001913', 'milk', 104, 'milk')]	0	['results  status mothers  trail expression levels human breast milk.']
S71-PMC5489519	PMC5489519	6/2017	S71-PMC5489519	['these results INDICATE that the active form of Vitamin D Regulates Trail Expression in normal Human Breast Epithelial Cells.']	[('INCOMPLETE_EVIDENCE', 14)]	1	[('CHEBI_27300', 'vitamin D', 47, 'vitamin D'), ('GO_0065007', 'biological regulation', 57, 'regulates'), ('PR_000001949', 'tumor necrosis factor ligand superfamily member 4', 67, 'TRAIL'), ('GO_0010467', 'gene expression', 73, 'expression'), ('NCBITaxon_9606', 'Homo sapiens', 94, 'human'), ('CL_0002327', 'mammary gland epithelial cell', 100, 'breast epithelial cells'), ('UBERON_0008367', 'breast epithelium', 100, 'breast epithelial')]	0	['results form   trail expression normal human breast epithelial cells.']
S89-PMC5489519	PMC5489519	6/2017	S89-PMC5489519	['Vitamin D supplementation of mothers results in Vitamin D sufficiency in Breast-Fed infants13, THUS POTENTIALLY Modulating the Immune signature of maternal Breast Milk to her recipient infant.']	[('PROBABLE_UNDERSTANDING', 95), ('INCOMPLETE_EVIDENCE', 100)]	2	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 48, 'vitamin D'), ('UBERON_0000310', 'breast', 73, 'breast'), ('GO_0007631', 'feeding behavior', 80, 'fed'), ('GO_0065007', 'biological regulation', 112, 'modulating'), ('UBERON_0002405', 'immune system', 127, 'immune'), ('UBERON_0001348', 'brown adipose tissue', 156, 'breast milk')]	0	['vitamin supplementation mothers results  breast-fed infants13,  immune maternal breast milk recipient infant.']
S31-PMC5513133	PMC5513133	7/2017	S31-PMC5513133	['these include Vitamin D’s ROLE in Modulating pro-inflammatory responses and decreasing oxidative stress in pe, promoting Angiogenesis through Vegf and Gene modulation, and decreasing Blood Pressure through the Renin-angiotensin system (ras) [19–25].']	[('SUPERFICIAL_RELATIONSHIP', 26)]	1	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('GO_0065007', 'biological regulation', 34, 'modulating'), ('GO_0001525', 'angiogenesis', 121, 'angiogenesis'), ('PR_000017279', 'testis-specific basic protein Y 1', 142, 'VEGF'), ('SO_0000704', 'gene', 151, 'gene'), ('UBERON_0000178', 'blood', 183, 'blood'), ('GO_0060208', 'proestrus', 189, 'pressure'), ('PR_000014368', 'RuvB-like 1', 210, 'renin')]	0	['’s  pro-inflammatory responses decreasing oxidative pe, promoting angiogenesis vegf gene modulation, decreasing blood pressure renin-angiotensin system (ras) [19–25].']
S32-PMC5513133	PMC5513133	7/2017	S32-PMC5513133	['caption (table-wrap): table 1\n\nsummary of effects of increased Vitamin D on the pathogenesis of pre-eclampsia (pe)stage of pecharacteristic of pe↑ Vitamin dstage 1inflammation-linked abnormal Placental Implantation↓ predisposition to pro-inflammatory response [20]↑ Regulation of Genes associated with Placental invasion and normal Implantation [20]stage 2vascular Endothelial dysfunction↑ Vascular structure, elasticity and Intima-Media thickness↓ Blood pressure (Regulation of Renin-angiotension system) [63]↓oxidative stress [24]proteinuria mediated by Renal Vascular Endothelial Growth Factor (Vegf)↑ Vascular Smooth Muscle Cell Proliferation by increasing vegf Gene transcription [19]\n\nbiological PLAUSIBILITY of the ROLE of Vitamin D in pe\nVitamin D3, or Cholecalciferol, is formed endogenously when 7-Dehydrocholesterol in Keratinocytes is converted to a seco-Steroid pro-hormone upon irradiation by uv-b light.']	[('INCOMPLETE_EVIDENCE', 702), ('PROBABLE_UNDERSTANDING', 702), ('SUPERFICIAL_RELATIONSHIP', 722)]	3	[('CHEBI_27300', 'vitamin D', 63, 'vitamin D'), ('CHEBI_33229', 'vitamin (role)', 147, 'Vitamin'), ('UBERON_0001987', 'placenta', 192, 'placental'), ('GO_0007566', 'embryo implantation', 202, 'implantation'), ('GO_0007567', 'parturition', 214, '↓'), ('GO_0065007', 'biological regulation', 266, 'Regulation'), ('SO_0000704', 'gene', 280, 'genes'), ('UBERON_0001987', 'placenta', 302, 'placental'), ('GO_0007566', 'embryo implantation', 332, 'implantation'), ('UBERON_0001986', 'endothelium', 365, 'Endothelial'), ('GO_0031674', 'I band', 390, 'Vascular'), ('GO_0005622', 'intracellular anatomical structure', 425, 'intima'), ('UBERON_0009472', 'axilla', 425, 'intima'), ('UBERON_0000951', 'rotator muscle of the vertebral column', 432, 'media'), ('UBERON_0000178', 'blood', 449, 'Blood'), ('GO_0065007', 'biological regulation', 465, 'regulation'), ('PR_000014368', 'RuvB-like 1', 479, 'renin'), ('UBERON_0002113', 'kidney', 556, 'renal'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 562, 'vascular endothelial growth factor'), ('UBERON_0001986', 'endothelium', 571, 'endothelial'), ('PR_000017279', 'testis-specific basic protein Y 1', 598, 'VEGF'), ('CL_0000359', 'vascular associated smooth muscle cell', 605, 'Vascular smooth muscle cell'), ('UBERON_0006849', 'scapula', 605, 'Vascular'), ('UBERON_0001135', 'smooth muscle tissue', 614, 'smooth muscle'), ('GO_0007601', 'visual perception', 621, 'muscle'), ('GO_0008283', 'cell proliferation', 628, 'cell proliferation'), ('SO_0000704', 'gene', 666, 'gene'), ('CHEBI_27300', 'vitamin D', 730, 'vitamin D'), ('CHEBI_33237', 'vitamin D4', 746, 'Vitamin D3'), ('PR_000017319', 'vacuolar protein sorting-associated protein 13A', 746, 'Vitamin D3'), ('CHEBI_52550', 'theopalauamide', 761, 'cholecalciferol'), ('CHEBI_17500', '7alpha-hydroxycholesterol', 806, '7-dehydrocholesterol'), ('CL_0000312', 'keratinocyte', 830, 'keratinocytes'), ('CHEBI_35341', 'steroid', 867, 'steroid')]	0	['caption (table-wrap): table 1\n\nsummary  pathogenesis pre-eclampsia (pe)stage pecharacteristic pe↑ vitamin dstage 1inflammation-linked abnormal placental implantation↓ pro-inflammatory response [20]↑  genes placental invasion normal implantation [20]stage 2vascular endothelial dysfunction↑ vascular structure, elasticity intima-media thickness↓ blood pressure renin-angiotension system) [63]↓oxidative [24]proteinuria renal vascular endothelial (vegf)↑ vascular smooth muscle cell proliferation vegf gene transcription [19]\n\nbiological  pe\nvitamin d3, cholecalciferol, formed endogenously 7-dehydrocholesterol keratinocytes converted seco-steroid pro-hormone irradiation uv-b light.']
S52-PMC5513133	PMC5513133	7/2017	S52-PMC5513133	['additionally, Vitamin D LIKELY plays a KEY ROLE in the pathology of pre-eclamptic conditions by AFFECTING Blood pressure through Calcium Homeostasis and/or Modulating inflammation and Immunity, which are examined further in THIS review.']	[('PROBABLE_UNDERSTANDING', 24), ('IMPORTANT_CONSIDERATION', 39), ('SUPERFICIAL_RELATIONSHIP', 43), ('SUPERFICIAL_RELATIONSHIP', 96), ('QUESTION_ANSWERED_BY_THIS_WORK', 224)]	5	[('CHEBI_27300', 'vitamin D', 14, 'vitamin D'), ('UBERON_0000178', 'blood', 106, 'blood'), ('GO_0055073', 'cadmium ion homeostasis', 129, 'calcium homeostasis'), ('GO_0065007', 'biological regulation', 156, 'modulating'), ('GO_0007566', 'embryo implantation', 184, 'immunity')]	0	['additionally,  plays pathology pre-eclamptic conditions blood pressure calcium homeostasis and/or  inflammation immunity, review.']
S72-PMC5513133	PMC5513133	7/2017	S72-PMC5513133	['role of Vitamin D and Blood Pressure Regulation\nan inverse RELATIONSHIP between Plasma 1,25(Oh)2D and Plasma Renin activity HAS BEEN OBSERVED.']	[('SUPERFICIAL_RELATIONSHIP', 59), ('INCOMPLETE_EVIDENCE', 124), ('INCOMPLETE_EVIDENCE', 133)]	3	[('CHEBI_27300', 'vitamin D', 8, 'vitamin D'), ('UBERON_0000178', 'blood', 22, 'blood'), ('GO_0060208', 'proestrus', 28, 'pressure'), ('GO_0065007', 'biological regulation', 37, 'regulation'), ('UBERON_0001969', 'blood plasma', 80, 'plasma'), ('CHEBI_82784', 'PVP38-Ag NP', 87, '1,25(OH)2D'), ('UBERON_0001969', 'blood plasma', 102, 'plasma'), ('PR_000014368', 'RuvB-like 1', 109, 'renin')]	0	['role  blood pressure \nan plasma 1,25(oh)2d plasma renin activity observed.']
S91-PMC5513133	PMC5513133	7/2017	S91-PMC5513133	['given the ROLE of Vitamin D in Modulation of inflammation and Immune function, Placental Implantation, Angiogenesis and adverse Birth outcomes such as low Birth weight and sga, we EXAMINED the EVIDENCE that Vitamin D MAY play a ROLE in the etiology and PREVENTION of pe in this manuscript.']	[('SUPERFICIAL_RELATIONSHIP', 10), ('QUESTION_ANSWERED_BY_THIS_WORK', 180), ('INCOMPLETE_EVIDENCE', 193), ('INCOMPLETE_EVIDENCE', 217), ('SUPERFICIAL_RELATIONSHIP', 228), ('SUPERFICIAL_RELATIONSHIP', 253)]	6	[('CHEBI_27300', 'vitamin D', 18, 'vitamin D'), ('GO_0065007', 'biological regulation', 31, 'modulation'), ('UBERON_0002405', 'immune system', 62, 'immune'), ('GO_0007565', 'female pregnancy', 79, 'placental'), ('UBERON_0001987', 'placenta', 79, 'placental'), ('GO_0007566', 'embryo implantation', 89, 'implantation'), ('GO_0001525', 'angiogenesis', 103, 'angiogenesis'), ('GO_0007567', 'parturition', 128, 'birth'), ('GO_0007567', 'parturition', 155, 'birth'), ('CHEBI_27300', 'vitamin D', 207, 'vitamin D')]	0	['given   inflammation immune function, placental implantation, angiogenesis birth outcomes birth sga,  play etiology pe manuscript.']
S238-PMC5513133	PMC5513133	7/2017	S238-PMC5513133	['studies that find a ROLE early in Pregnancy, before the clinical onset of pe, SUGGEST that Vitamin D MAY play a ROLE in the Modulation of a pro-inflammatory response or Regulation of Angiogenic factors.']	[('SUPERFICIAL_RELATIONSHIP', 20), ('INCOMPLETE_EVIDENCE', 78), ('INCOMPLETE_EVIDENCE', 101), ('SUPERFICIAL_RELATIONSHIP', 112)]	4	[('GO_0007565', 'female pregnancy', 34, 'pregnancy'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0065007', 'biological regulation', 124, 'modulation'), ('GO_0065007', 'biological regulation', 169, 'regulation'), ('GO_0001525', 'angiogenesis', 183, 'angiogenic')]	0	['studies pregnancy, onset pe,  play  pro-inflammatory response  angiogenic factors.']
S11-PMC5521778	PMC5521778	7/2017	S11-PMC5521778	['taken TOGETHER, THESE FINDINGS provide the FIRST EVIDENCE that Gcs Regulate Vitamin A (Retinoid) Signaling via inhibition of bco1 Gene Expression in a Pparα-dependent manner.']	[('INCOMPLETE_EVIDENCE', 6), ('INCOMPLETE_EVIDENCE', 16), ('INCOMPLETE_EVIDENCE', 43)]	3	[('CL_0000740', 'retinal ganglion cell', 63, 'GCs'), ('GO_0065007', 'biological regulation', 67, 'regulate'), ('CHEBI_27300', 'vitamin D', 76, 'vitamin A'), ('GO_0038094', 'Fc-gamma receptor signaling pathway', 76, 'vitamin A ... signaling'), ('CHEBI_26537', 'retinoid', 87, 'retinoid'), ('GO_0010467', 'gene expression', 130, 'gene expression'), ('SO_0000704', 'gene', 130, 'gene'), ('PR_000013057', 'peroxisome proliferator-activated receptor delta', 151, 'PPARα')]	0	['taken together, gcs   (retinoid) signaling via inhibition bco1 gene expression pparα-dependent manner.']
S42-PMC5521778	PMC5521778	7/2017	S42-PMC5521778	['we HYPOTHESIZED that: ( a ) bco1 activity provides a local source for Pulmonary Retinoid Synthesis, and ( b ) gc alters Pulmonary EFFECTS of Vitamin A through Regulating Bco1 Expression.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 130), ('SUPERFICIAL_RELATIONSHIP', 159)]	3	[('UBERON_0002048', 'lung', 70, 'pulmonary'), ('CHEBI_26537', 'retinoid', 80, 'retinoid'), ('GO_0016063', 'rhodopsin biosynthetic process', 80, 'retinoid synthesis'), ('UBERON_0002048', 'lung', 120, 'pulmonary'), ('CHEBI_27300', 'vitamin D', 141, 'vitamin A'), ('GO_0065007', 'biological regulation', 159, 'regulating'), ('PR_000004693', 'Bcl-2-like protein 10', 170, 'BCO1'), ('GO_0010467', 'gene expression', 175, 'expression')]	0	['that: bco1 activity local pulmonary retinoid synthesis, b gc alters pulmonary   bco1 expression.']
S106-PMC5537884	PMC5537884	7/2017	S106-PMC5537884	['further IMPORTANT points are the avoidance of nutritional deficits, in particular of Vitamin B12, Vitamin D, and iron, all of which are regularly Controlled in our on-diet patients [26,27,28].']	[('IMPORTANT_CONSIDERATION', 8)]	1	[('CHEBI_33279', 'vitamin D5', 85, 'vitamin B12'), ('PR_000004738', 'class E basic helix-loop-helix protein 22', 93, 'B12'), ('CHEBI_27300', 'vitamin D', 98, 'vitamin D'), ('GO_0065007', 'biological regulation', 146, 'controlled')]	0	['avoidance nutritional deficits, vitamin b12, iron, regularly  on-diet patients [26,27,28].']
S63-PMC5579643	PMC5579643	8/2017	S63-PMC5579643	['when specifically CONSIDERING a POTENTIAL ROLE for Vitamins in Food allergy, Vitamin D HAS BEEN SHOWN to AFFECT several mechanisms that promote immunologic tolerance, including T Regulatory Cell function and the induction of tolerogenic Dendritic Cells.']	[('IMPORTANT_CONSIDERATION', 18), ('INCOMPLETE_EVIDENCE', 32), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 87), ('SUPERFICIAL_RELATIONSHIP', 105)]	5	[('CHEBI_33277', 'gamma-tocotrienol', 51, 'vitamins'), ('CHEBI_33290', 'food', 63, 'food'), ('CHEBI_27300', 'vitamin D', 77, 'vitamin D'), ('CL_0000902', 'induced T-regulatory cell', 177, 'T regulatory cell'), ('GO_0065007', 'biological regulation', 179, 'regulatory'), ('CL_0000451', 'dendritic cell', 237, 'dendritic cells')]	0	['vitamins food allergy,  mechanisms immunologic tolerance,  cell induction tolerogenic dendritic cells.']
S122-PMC5679631	PMC5679631	11/2017	S122-PMC5679631	['the function of Vitamin D in Regulating Amp Production, THEREFORE, SUGGESTS that Vitamin D status COULD INFLUENCE the composition of the Intestinal microbiota.']	[('PROBABLE_UNDERSTANDING', 56), ('INCOMPLETE_EVIDENCE', 67), ('INCOMPLETE_EVIDENCE', 98), ('SUPERFICIAL_RELATIONSHIP', 104)]	4	[('CHEBI_27300', 'vitamin D', 16, 'vitamin D'), ('GO_0065007', 'biological regulation', 29, 'regulating'), ('CHEBI_16027', 'adenosine 5*-monophosphate', 40, 'AMP'), ('GO_0006754', 'ATP biosynthetic process', 40, 'AMP production'), ('CHEBI_27300', 'vitamin D', 81, 'vitamin D'), ('UBERON_0000160', 'intestine', 137, 'intestinal')]	0	['  amp production, therefore,  status composition intestinal microbiota.']
S129-PMC5679631	PMC5679631	11/2017	S129-PMC5679631	['in SUMMARY, the ROLE of Vitamin D is MOST LIKELY to Regulate the Immune Response to maintain Immune Homeostasis [25] by balancing activation of tolerance and the innate Immune System.']	[('INCOMPLETE_EVIDENCE', 3), ('SUPERFICIAL_RELATIONSHIP', 16), ('PROBABLE_UNDERSTANDING', 37), ('PROBABLE_UNDERSTANDING', 42)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0065007', 'biological regulation', 52, 'regulate'), ('GO_0006955', 'immune response', 65, 'immune response'), ('UBERON_0002405', 'immune system', 65, 'immune'), ('GO_0055090', 'acylglycerol homeostasis', 93, 'immune homeostasis'), ('UBERON_0002405', 'immune system', 93, 'immune'), ('GO_0007566', 'embryo implantation', 169, 'immune'), ('UBERON_0002405', 'immune system', 169, 'immune system')]	0	['summary,   immune response maintain immune homeostasis [25] balancing activation tolerance innate immune system.']
S138-PMC5679631	PMC5679631	11/2017	S138-PMC5679631	['the INFLUENCE of direct Vitamin D supplementation of the child DIFFERED between the two recruitment groups SUGGESTING that lifestyle factors are Modulating the ASSOCIATION between Vitamin D and the Intestinal bacterial Taxa.']	[('SUPERFICIAL_RELATIONSHIP', 4), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 63), ('INCOMPLETE_EVIDENCE', 107), ('SUPERFICIAL_RELATIONSHIP', 160)]	4	[('CHEBI_27300', 'vitamin D', 24, 'vitamin D'), ('GO_0065007', 'biological regulation', 145, 'modulating'), ('CHEBI_27300', 'vitamin D', 180, 'vitamin D'), ('UBERON_0000160', 'intestine', 198, 'intestinal'), ('NCBITaxon_10088', 'Mus <genus>', 219, 'taxa')]	0	[' supplementation child recruitment lifestyle   intestinal bacterial taxa.']
S1-PMC5941617	PMC5941617	5/2018	S1-PMC5941617	['besides its historical Skeletal functions, in the last years it HAS BEEN DEMONSTRATED that Vitamin D directly OR indirectly Regulates up to 1250 Genes, playing so-called Extraskeletal actions.']	[('INCOMPLETE_EVIDENCE', 64), ('INCOMPLETE_EVIDENCE', 73), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 110)]	3	[('UBERON_0004288', 'skeleton', 23, 'skeletal'), ('CHEBI_27300', 'vitamin D', 91, 'vitamin D'), ('GO_0065007', 'biological regulation', 124, 'regulates'), ('SO_0000704', 'gene', 145, 'genes'), ('UBERON_0001431', 'distal carpal bone 2', 170, 'extraskeletal')]	0	['besides skeletal functions, last   1250 genes, playing extraskeletal actions.']
S284-PMC5941617	PMC5941617	5/2018	S284-PMC5941617	['Extraskeletal actions of Vitamin D\n\nrespiratory infections\nVitamin D has COMPLEX immunoregolatory properties, exerted by Modulating both Innate and Adaptive Immunity and Regulating the inflammatory Response.']	[('DIFFICULT_TASK', 73)]	1	[('UBERON_0001431', 'distal carpal bone 2', 0, 'Extraskeletal'), ('CHEBI_27300', 'vitamin D', 25, 'vitamin D'), ('CHEBI_28384', 'vitamin K', 59, 'Vitamin D'), ('GO_0065007', 'biological regulation', 121, 'modulating'), ('GO_0007631', 'feeding behavior', 137, 'innate ...'), ('GO_0051866', 'general adaptation syndrome', 148, 'adaptive immunity'), ('GO_0065007', 'biological regulation', 170, 'regulating'), ('GO_0060033', 'anatomical structure regression', 198, 'response')]	0	['extraskeletal \n\nrespiratory infections\nvitamin immunoregolatory properties,  innate adaptive immunity  inflammatory response.']
S357-PMC5941617	PMC5941617	5/2018	S357-PMC5941617	['SEVERAL STUDIES SHOWED that Vitamin D deficiency in utero and in early Life was ASSOCIATED with an increase in Th2 Lymphocyte Cells and a reduction in T Regulatory Cells and Production Of Interleukin (Il)-10, which subsequently MAY activate pro-inflammatory Cytokine Production through Macrophages and Dendritic Cells [306–308].']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 16), ('SUPERFICIAL_RELATIONSHIP', 80), ('INCOMPLETE_EVIDENCE', 228)]	4	[('CHEBI_27300', 'vitamin D', 28, 'vitamin D'), ('UBERON_0000104', 'life cycle', 71, 'life'), ('CL_0000546', 'T-helper 2 cell', 111, 'Th2 lymphocyte cells'), ('CL_0000902', 'induced T-regulatory cell', 151, 'T regulatory cells'), ('GO_0065007', 'biological regulation', 153, 'regulatory'), ('GO_0030154', 'cell differentiation', 174, 'production of interleukin ... IL ... 10'), ('PR_000001470', 'interleukin-28B', 188, 'interleukin ...'), ('PR_000009000', 'interleukin-22 receptor subunit alpha-2', 201, 'IL)-10'), ('GO_0001814', 'negative regulation of antibody-dependent cellular cytotoxicity', 258, 'cytokine production'), ('CL_0000235', 'macrophage', 286, 'macrophages'), ('CL_0000451', 'dendritic cell', 302, 'dendritic cells')]	0	['several  utero life increase th2 lymphocyte cells reduction  cells production interleukin (il)-10, activate pro-inflammatory cytokine production macrophages dendritic cells [306–308].']
S378-PMC5941617	PMC5941617	5/2018	S378-PMC5941617	['RECENTLY, three studies SHOWED a positive CORRELATION between Vitamin D supplementation and the improvement of asthma Control [335–337], accordingly with two RECENT meta-analyses.']	[('INCOMPLETE_EVIDENCE', 0), ('INCOMPLETE_EVIDENCE', 24), ('SUPERFICIAL_RELATIONSHIP', 42), ('INCOMPLETE_EVIDENCE', 158)]	4	[('CHEBI_27300', 'vitamin D', 62, 'vitamin D'), ('GO_0065007', 'biological regulation', 118, 'control')]	0	['recently, three positive  supplementation asthma  [335–337], meta-analyses.']
S457-PMC5941617	PMC5941617	5/2018	S457-PMC5941617	['particularly, large rcts ARE NEEDED to BETTER investigate the ROLE of Vitamin D in disease remission and Control.']	[('FUTURE_WORK', 25), ('INCOMPLETE_EVIDENCE', 39), ('SUPERFICIAL_RELATIONSHIP', 62)]	3	[('CHEBI_27300', 'vitamin D', 70, 'vitamin D'), ('GO_0065007', 'biological regulation', 105, 'control')]	0	['particularly, rcts  disease remission .']
S515-PMC5941617	PMC5941617	5/2018	S515-PMC5941617	['MORE rcts ARE NEEDED to evaluate the INFLUENCE of Vitamin D supplementation on Controlling Metabolic syndrome.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 37)]	2	[('CHEBI_27300', 'vitamin D', 50, 'vitamin D'), ('GO_0065007', 'biological regulation', 79, 'controlling'), ('GO_0008152', 'metabolic process', 91, 'metabolic')]	0	['rcts  supplementation  metabolic syndrome.']
S14-PMC5956785	PMC5956785	5/2018	S14-PMC5956785	['Vitamin D status is POTENTIALLY GOVERNED by these same FACTORS; Vitamin D receptor genotype, ethnically RELATED skin tone and clothing, environmental variations in exposure to ultraviolet b radiation RELATING to the latitude of residence and season, and Vitamin D nutritional intake are FACTORS that Modulate Vitamin D concentrations.']	[('INCOMPLETE_EVIDENCE', 20), ('SUPERFICIAL_RELATIONSHIP', 32), ('SUPERFICIAL_RELATIONSHIP', 55), ('SUPERFICIAL_RELATIONSHIP', 104), ('SUPERFICIAL_RELATIONSHIP', 200), ('SUPERFICIAL_RELATIONSHIP', 287)]	6	[('CHEBI_28384', 'vitamin K', 0, 'Vitamin D'), ('CHEBI_27300', 'vitamin D', 64, 'vitamin D'), ('CHEBI_27300', 'vitamin D', 254, 'vitamin D'), ('GO_0065007', 'biological regulation', 300, 'modulate'), ('CHEBI_27300', 'vitamin D', 309, 'vitamin D')]	0	['vitamin status factors;  receptor genotype, ethnically skin tone clothing, environmental exposure ultraviolet b radiation latitude residence season,  nutritional intake   concentrations.']
S258-PMC5956785	PMC5956785	5/2018	S258-PMC5956785	['UNDERSTANDING IF Genetic variants increase the risk of disease development will HELP tailor Vitamin D management in individual patients and CONTRIBUTE to improving Control of disease activity and improve outcomes.']	[('FUTURE_WORK', 0), ('ALTERNATIVE_OPTIONS_CONTROVERSY', 14), ('FUTURE_WORK', 80), ('SUPERFICIAL_RELATIONSHIP', 140)]	4	[('SO_0000704', 'gene', 17, 'genetic'), ('CHEBI_27300', 'vitamin D', 92, 'vitamin D'), ('GO_0065007', 'biological regulation', 164, 'control')]	0	['understanding genetic variants increase disease tailor  individual patients  disease activity outcomes.']
S283-PMC5956785	PMC5956785	5/2018	S283-PMC5956785	['INVESTIGATING the Genetic and environmental ROLE that Vitamin D plays in the PREVENTION and Control of jia in the same children will HELP to tease out the multifaceted ROLE played by Vitamin D in this disease.']	[('FUTURE_WORK', 0), ('SUPERFICIAL_RELATIONSHIP', 44), ('SUPERFICIAL_RELATIONSHIP', 77), ('FUTURE_WORK', 133), ('SUPERFICIAL_RELATIONSHIP', 168)]	5	[('SO_0000704', 'gene', 18, 'genetic'), ('CHEBI_27300', 'vitamin D', 54, 'vitamin D'), ('GO_0065007', 'biological regulation', 92, 'control'), ('CHEBI_27300', 'vitamin D', 183, 'vitamin D')]	0	['investigating genetic environmental  plays  jia children tease multifaceted played  disease.']
S289-PMC6039335	PMC6039335	7/2018	S289-PMC6039335	['in addition, Vitamin C MAY help to Regulate Adipogenesis.']	[('INCOMPLETE_EVIDENCE', 23)]	1	[('CHEBI_27300', 'vitamin D', 13, 'vitamin C'), ('GO_0065007', 'biological regulation', 35, 'regulate'), ('GO_0060612', 'adipose tissue development', 44, 'adipogenesis')]	0	['addition,   adipogenesis.']
